cephalosporin c has been researched along with Escherichia coli Infections in 633 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 126 (19.91) | 18.7374 |
1990's | 72 (11.37) | 18.2507 |
2000's | 104 (16.43) | 29.6817 |
2010's | 255 (40.28) | 24.3611 |
2020's | 76 (12.01) | 2.80 |
Authors | Studies |
---|---|
Adebayo, A; Ante, M; Beisken, S; Bergman, Y; Dzintars, K; Mostafa, HH; Simner, PJ; Tamma, PD; Tekle, T | 1 |
Abraham, R; Abraham, S; Harb, A; Hunt, K; Jordan, D; Lee, T; Lee, ZZ; O'Dea, M | 1 |
Pitout, JDD | 1 |
Hashimoto, R; Ishiguro, A; Miyairi, I; Shoji, K | 1 |
Iguchi, M; Kamei, K; Mori, R; Morioka, H; Nagaya, M; Nakai, M; Oka, K; Tetsuka, N; Tsukada, N; Ukai, Y; Watanabe, G; Yagi, T | 1 |
Abraham, R; Abraham, S; Barlow, R; Duffy, L; Jordan, D; McMillan, K; Mellor, G; O'Dea, M; Sahibzada, S | 1 |
Apostolakos, I; Fasolato, L; Ferraresso, J; Piccirillo, A | 1 |
Groat, EF; Pinchbeck, G; Schmidt, VM; Simpson, A; Warner, B; Williams, NJ | 1 |
Bakhtiar, A; Chong, CW; Khalid, KE; Khan, RA; Tan, SY | 1 |
Abraham, R; Abraham, S; Laird, T; O'Dea, M; Sahibzada, S | 1 |
Nordmann, P; Ortiz de la Rosa, JM; Poirel, L; Sadek, M | 1 |
Ahsan, A; Ali, A; Irshad, H; Jamil, A; Rehman, TAU; Shahzad, MA; Siddique, A | 1 |
Abu-Raideh, J; Al-Tamimi, M; Albalawi, H; Alhaj, F; Khasawneh, AI; Shalabi, M | 1 |
Bosch, T; Kluytmans, J; Mascaro, V; Verschuuren, T; Willems, R | 1 |
Chang, MX; Jiang, HX; Sun, YH; Zheng, XR | 1 |
Maor, Y; Schwartz, O; Tocut, M; Yossepowitch, O; Zohar, I | 1 |
Armstrong, JR; Bender, JB; Jamborova, I; Johnson, JR; Johnson, TJ; Johnston, B; Merino-Velasco, I; Singer, RS | 1 |
Awosile, B; Loneragan, GH; Rahman, MK; Williams, RB | 1 |
Avison, MB; Gould, VC; Hammond, A; Mounsey, O; Reyher, KK; Sealey, JE | 1 |
Bollinger, C; Brinks, T; Goon, K; Handy, E; Micallef, SA; Sapkota, AR; Sharma, M; Solaiman, S | 1 |
Kusaksizoglu, A; Nordmann, P; Ortiz de la Rosa, JM; Poirel, L; Sadek, M; Sakaoglu, Z | 1 |
Brouwer, MSM; de Freitas Costa, E; Engel, B; Gonzalez, TJB; Hoorweg, FA; Marcato, F; Schnabel, SK; van den Brand, H; van Reenen, CG; Wolthuis-Fillerup, M | 1 |
Agga, GE; Arthur, TM; Galloway, HO; Netthisinghe, AMP; Schmidt, JW | 1 |
Beirão, BCB; Châtre, P; de Macedo, REF; Dos Anjos Adur, M; Drapeau, A; Haenni, M; Lopes, JK; Madec, JY; Métayer, V; Penkal, ML; Pillonetto, M | 1 |
Botteldoorn, N; Bradley, AJ; Gehring, R; Hopman, NEM; Krömker, V; Kusters, NE; Penterman, PAA; Speksnijder, DC; Swinkels, JM; Timmerman, A; Zomer, AL | 1 |
Guo, C; Guo, X; Huang, S; Li, M; Lv, C; Shang, J; Sun, B; Zhang, W; Zhou, N; Zhu, Y | 1 |
Albarracin, B; Altier, C; Cazer, C; Gröhn, YT; Osman, M | 1 |
Acampora, A; Albano, R; Buonsenso, D; Ferrari, V; Fiori, B; Pata, D; Sanguinetti, M; Spanu, T; Valentini, P | 1 |
Adams-Sapper, S; Allegretti, YH; Awasthi, S; Belmont, CR; Bittencourt, CE; Borges, CA; Chandrasekaran, S; Coralic, Z; Crandall, C; deBoer, TR; Diaz, J; Fee, C; Florence-Petrovic, D; Frazee, BW; Garner, O; Huang, YY; Hufana, C; Jackson, N; Kane, I; Marcha, JC; Mastrangelo, CF; Miller, S; Noorbakhsh, MH; Parker, A; Riley, LW; Rodrigues-Wong, P; Tarlton, NJ | 1 |
Beyrouthy, R; Boerlin, P; Bonnet, R; Chalmers, G; Cormier, A; Eichhorn, I; Garcia-Fierro, R; Haenni, M; Kaspar, H; Madec, JY; Mather, AE; Mulvey, MR; Schwarz, S; Wood, JLN; Zamudio, R; Zhanel, GG | 1 |
Liu, S; Lopes, B; Patil, S; Wagh, K; Wen, F | 1 |
Harada, K; Kawahara, M; Kido, N; Miyashita, N; Morikaku, K; Omiya, T; Shimizu, T; Tanaka, S | 1 |
Amon, T; Behrens, W; Börger, M; Dolsdorf, C; Frentrup, M; Jaleta, M; Junker, V; Kabelitz, T; Kolte, B; Nübel, U; Werner, D | 1 |
Casey, JA; Davis, MF; Do, V; Gupta, V; Innes, GK; Liu, C; Nachman, KE; Pressman, AR; Price, L; Rudolph, KE; Tartof, SY; Tseng, HF; Yu, K | 1 |
Awuah-Mensah, G; Blankson, NK; Frimodt-Møller, N; Hansen, DS; Krogfelt, KA; Newman, MJ; Obeng-Nkrumah, N; Opintan, JA | 1 |
Avison, MB; Barrows, MG; Horspool, T; Saunders, R; Sealey, JE | 1 |
Aebi, CB; Fernandez, JE; Kittl, S; Overesch, G; Perreten, V; Tresch, ML | 1 |
Abbey, L; Abdelghany, TM; Abdellatif, MH; Abdelmohsen, UR; Abduljaleel Alzawar, NS; Abid, MF; Abu Kasim, AFB; Abu Saad, H; Adolpho, LF; Agostini, F; Agrizii, AP; Ahmed, S; Akce, M; Åkesson, D; Al-Awaadh, AM; Al-Mutar, DMK; Al-Odayni, AB; Al-Rajhi, AMH; Alaaeldin, R; Alam, M; Alam, MM; Alanazi, MA; Alattar, H; Alawlaqi, MM; Aldebis, HK; Algehainy, NA; Almeida, AA; Aloisi, F; Alrahlah, A; Alsenani, F; Alshabib, A; Altemani, FH; Althagafi, A; Amari, A; Andronesi, AG; Antonyuk, M; Arantes, TD; Araújo, R; Arrotti, S; Asakura, T; Asib, N; Atlaskin, AA; Aung, MS; Axiaq, A; Azekawa, S; Bacon, S; Bagalagel, A; Balbinot, GS; Barnet, LS; Baroyi, SAHM; Barreto, F; Barth, Y; Barysheva, AV; Bassa, E; Basu, R; Basu, S; Bates, C; Bautista, LS; Beitl, K; Beloti, MM; Benatti, G; Benavent-Celma, C; Bentaher, A; Bergsland, N; Bernardino, AF; Bernhardt, A; Bhandari, RK; Bhaskaran, K; Bhate, K; Bhattacharjee, A; Bian, X; Bien, EM; Birch, M; Bishara, K; Biswas, JP; Bleha, R; Bocale, R; Bona, S; Boriani, G; Bouyssi, A; Bradley, D; Bravo-Sánchez, MG; Bressan, GC; Brik, A; Brizuela, A; Brockbank, KGM; Buchner, F; Bunc, M; Buscombe, JR; Butler, AJ; Buzaleh, AM; Buzin, MI; Cabrera-Capetillo, CA; Calvo, AM; Camerota, A; Campagna, G; Campisi, M; Cano, K; Cao, HST; Cardellini, S; Carvalho, AP; Carvalho, BCR; Castillo-Baltazar, OS; Cataldo, P; Chai, P; Chakraborty, S; Chalo, DM; Chan, MY; Chander, S; Changbunjong, T; Chappuis, CJF; Chee, RCH; Chen, C; Chen, CJ; Chen, E; Chen, M; Chen, X; Chen, Y; Cheng, HT; Cheng, MC; Cheow, HK; Chi, Y; Chirikova, NK; Chiu, SH; Cho, G; Cho, HR; Cho, S; Cho, SJ; Choe, A; Choe, YH; Chun, BS; Chun, Z; Cinque, A; Ciopec, M; Cladas, Y; Cleary, SP; Clermont, O; Cléroux, M; Cockburn, J; Collares, FM; Colombini-Ishikiriama, BL; Conn, BN; Cortina, JL; Cox, DRA; Crini, G; Croker, R; Cursaru, DL; Curtis, HJ; da Silva, KJG; Dalla Costa, T; Davy, S; de Araújo, BV; de Cassia Ribeiro Gonçalves, R; de Gaetano, F; de Gregorio, C; de Oliveira, MG; De Vera, MAT; de Vos, M; de-la-Fuente, I; Dell'Oca, I; Delles, M; Déméautis, T; Dempster, M; Deng, YH; Denisenko, Y; Descombes, C; Desideri, G; Devarbhavi, H; Devouassoux, G; Di Bella, G; Di Marco, F; Diao, Y; Dias, BB; Dilgin, Y; Dimopoulou, I; Dionísio, TJ; Dobrovic, A; Dokin, ES; Dolby, T; Dong, X; Dong, Y; Dou, SX; Douglas, IJ; Dousset, S; Du, Z; Duan, M; Duan, SB; Duke-Williams, O; Duteanu, N; Dutertre, S; Dutta, S; Dwyer, MG; Ebenbauer, J; Eggo, RM; El-Mordy, FMA; Elbhnsawi, NA; Elrehany, MA; Elshewemi, SS; Elwakil, BH; Emadzadeh, D; Eraso, E; Ermolenko, E; Erten, K; Ettorre, E; Evans, D; Evans, SJ; Faheem, M; Fallanza, M; Faramarzi, M; Faria, FAC; Faro, DC; Fatma, YS; Fazil, S; Feng, Y; Ferguson, J; Fernandes, MH; Fernández-Domínguez, M; Ferrari, LAL; Ferraz, EP; Ferreira, LC; Ferri, C; Fikry, M; Floris, M; Forbes, H; Fotouh, B; Franke, K; Freitas, AC; Freitas, GP; Frieboes, HB; Fu, B; Fu, Y; Fukina, DG; Fukuda, DH; Fukunaga, K; Fulham, GJ; Furlan, L; Furtado Mesa, M; Furtunescu, FL; Gabbieri, D; Ganash, M; Gebers, JC; Gehman, V; Ghaedi, A; Ghazali, NSM; Ghebrekristos, Y; Gil, J; Gilbert, NM; Gimenes, R; Giordano, L; Glehen, O; Godeau, C; Goh, SK; Goldacre, B; Gomes, AM; Gomes, MPO; Gomes, PS; Gomes, RMODS; Gómez-Coma, L; Grenho, L; Gu, Q; Gu, T; Gu, YC; Guiducci, V; Guillemin, JP; Guo, W; Guo, YW; Gur, E; Guridi, A; Guzmán-López, A; Gvozdenko, T; H Elmaidomy, A; Hagar, M; Haider, S; Han, JM; Hanratty, J; Hans, R; Haque, N; Harharah, HN; Harharah, RH; Harper, S; Hasegawa, N; Hassanin, AH; Hastuti, YP; Hatem, AE; He, R; He, Y; Heinemann, C; Heinmaa, I; Heinzl, F; Helfer, VE; Hester, F; Hickman, G; Hill, MA; Hill, WG; Hintze, V; Ho, JSY; Ho, LY; Hoang, T; Holzer, I; Houbraken, J; Hsu, CN; Hu, J; Hu, X; Hu, Y; Hua, T; Huang, Z; Hulme, WJ; Hunter, A; Ianăşi, C; Ibañez, R; Iezzi, R; Iliuță, L; Im, YM; Imran, M; Inglesby, P; Inguimbert, N; Iqbal, A; Izawa, N; Jahaj, E; Jain, S; Jakimovski, D; Jalal, MM; Jaroszuk-Ściseł, J; Jasim, DJ; Jauregizar, N; Javle, MM; Jędryczka, M; Ji, H; Jiang, Y; Jin, J; Johnson, NT; Joshi, S; Jullok, N; Kachapulula, PW; Kaczmarek, J; Kaczmarek-Szczepańska, B; Kadota, K; Kaji, M; Kakeji, Y; Kakizoe, S; Kakudidi, E; Kalitukha, L; Kamata, H; Kang, YJ; Kapinos, AA; Karakaya, S; Kashchenko, NI; Kasyanov, S; Kataky, R; Katati, B; Kato, G; Katsina, AU; Kaya, A; Kaya, H; Kazarina, OV; Ke, Y; Keenan, C; Keilson, JM; Keshavan, A; Keskinidou, C; Khalifa, MA; Khan, R; Khan, S; Kim, D; Kim, K; Kim, MS; Kim, SM; Kim, WH; Kim, Y; Kim, YJ; Kishimura, H; Kitagawa, RR; Klemenkova, ZS; Kloss, F; Kobayashi, N; Kohlhoff, M; Kong, WKF; Konsek, H; Kornaros, M; Kotanidou, A; Kovacs, S; Kraska, J; Kruppke, B; Kumagai, Y; Kumar, S; Kumari, R; Kuruva, V; Kuster, RM; Kusumoto, T; Kutyła, M; Kwon, JH; Kwon, SH; Kwong, KY; Kyser, AJ; Lackner, M; Lass-Flörl, C; Lauri, C; Lavandera, JV; Lee, BH; Lee, ECY; Lee, HJ; Lee, J; Lee, PS; Lee, S; Lee, SE; Lee, SY; Lefort, F; Leite, JPV; Leo, G; Leonard, R; Leow, AST; Lepori, N; Leyden, K; Leys, L; Ležaić, L; Li, D; Li, H; Li, J; Li, S; Li, TYW; Li, X; Li, XH; Li, Y; Li, Z; Li, ZH; Liao, S; Liaqat, K; Lim, H; Lin, BS; Lin, MY; Lin, NH; Lin, X; Lin, Y; Liu, C; Liu, H; Liu, HK; Liu, HX; Liu, P; Liu, R; Liu, T; Liu, X; Liu, Y; Lock, GA; Lokaj, G; Lopes, HB; Losi, V; Lotsios, NS; Low, KE; Lu, Z; Luhana, S; Luo, X; Luo, XQ; Lutz, MB; Lysova, AA; Lyssenko, KA; Macit, M; MacIver, B; MacKenna, B; Magalhães, GAP; Magnavacchi, P; Mahadevan, J; Mahboubi, A; Maher, SA; Mahipal, A; Mahmoud, MY; Maithel, SK; Makhtar, MMZ; Makurat-Kasprolewicz, B; Malysheva, YB; Mansourizadeh, A; Marek, EJ; Maresca-Fichter, H; Martin, JT; Maslov, AA; Mastora, Z; Mastroiacovo, D; Mastropetros, SG; Matei, D; Mathur, R; Matos, AO; Matsuda, Y; Maurya, SK; Mayor, Á; Mayrhofer, D; Mazzuco, AC; McCaffrey, J; McClure, T; McDonald, HI; Mchunu, NP; McLaggan, D; Mehrkar, A; Meilik, B; Melito, VA; Mellem, J; Mengozzi, A; Menotti, J; Mesquita, V; Miao, Z; Mihai, S; Miller, S; Minassian, C; Mirabile, A; Mitra, S; Mladin, G; Mo, Z; Moawad, H; Mohamed, EM; Mohammed, TJ; Mohanlall, V; Mohyeldin, RH; Moldovan, H; Monneret, G; Monopoli, DE; Monte, IP; Monteiro, JRB; Morgante, V; Mori, M; Morin-Crini, N; Morita, A; Morton, CE; Mrak, M; Muhammed, AP; Mulick, A; Muralidharan, V; Murthy, P; Muselli, M; Mustafa, S; Mysore Visweswariah, A; Nagao, G; Naicker, S; Nakagawara, K; Namgoong, B; Namkoong, H; Namukobe, J; Nasir, AA; Nasreen, SA; Natarajan, P; Nchiozem-Ngnitedem, VA; Necozione, S; Negrea, A; Negrea, P; Ngubane, S; Nguyen, TT; Nicke, A; Nightingale, E; Nistor, CL; Nitsch, D; Njapau, H; Noman, M; Novgorodtseva, T; Nowak, A; O'Connor, SR; Ofoe, R; Oh, K; Oh, TH; Oki, E; Olama, ZA; Olennikov, DN; Oliveira, GM; Omar, D; Ong, SJ; Orfanos, SE; Origa-Oryem, H; Orita, H; Ortiz, I; Ota, M; Ott, J; Otvagina, KV; Pacheco, N; Pacheco, RR; Padmanabhan, D; Pagan, JD; Pagnotta, PA; Palangi, V; Palanisamy, G; Palanisamy, K; Palanisamy, S; Pan, SG; Panaitescu, E; Pang, X; Panoutsakopoulos, V; Parera, VE; Park, JI; Park, JS; Park, SW; Park, Y; Park, YS; Parkash, O; Parry, J; Parry, JP; Paul, SK; Pavšič, N; Pałubicka, A; Persat, F; Petriz-Prieto, MA; Petukhov, AN; Pham, T; Pillay, S; Poh, KK; Ponomarev, II; Pontons-Melo, JC; Posa, A; Powell, E; Priya, AK; Punekar, R; Puppin Rontani, RM; Purushottam, M; Pusphanathan, K; Qi, JY; Qin, J; Qin, Z; Qiu, B; Qiu, X; Quattrini, G; Quindós, G; Qureshi, F; Rabbany, MA; Rac-Albu, M; Rac-Albu, ME; Rădulescu, BC; Rafatullah, M; Rajab, TK; Rajna, S; Ramanathan, M; Rao, D; Raviglione, D; Razorenov, DY; Redd, MJ; Rehman, W; Reig, M; Rentsch, CT; Ribeiro, LMS; Robles, D; Rocchi, S; Rocha, FG; Rodrigues, C; Rodrigues, LA; Rodrigues, RP; Roh, GH; Ronowska, A; Root, A; Rosa, AL; Rossi, R; Roy, S; Roy, VC; Rupji, M; Saber, EA; Sadarat, F; Saed, Y; Saeed, WS; Saeki, H; Saha, B; Saiwichai, T; Sakowicz-Burkiewicz, M; Sampedro, T; Sands, K; Santos, CF; Sari, M; Sathi, FA; Sauro, S; Sazanova, TS; Scafa-Udriște, A; Schoustra, SE; Schultze, A; Seo, DJ; Sevillano, E; Sezmis, G; Sgura, FA; Shah, NNAK; Shani, N; Shankarappa, B; Sharkey, LM; Sharma, VK; Sharp, C; Shehata, N; Shelton, N; Shieh, PB; Shimokawa, M; Shin, J; Shin, SH; Shin, YN; Shin, YR; Shipilova, A; Shoparwe, NF; Shukor, H; Sia, CH; Siddiqui, MH; Siddiqui, MR; Siena, V; Signore, A; Silwane, B; Siqueira-Sandrin, VS; Siregar, A; Sirignano, P; Sit, NW; Skidmore, S; Skupov, KM; Smeeth, L; Smoczer, C; Smolyanskiy, E; Sohn, H; Solodeev, I; Solovyev, A; Şomoghi, R; Song, F; Song, H; Song, Z; Souf, YM; Sousa, SC; Souza, MT; Steinbach-Rankins, JM; Stockton, J; Stout, JR; Su, K; Su, MZ; Suarez-Lopez, YA; Sukkurd, R; Sultanov, R; Sun, Y; Sun, Z; Supernak, M; Supriyono, E; Suroshe, SS; Suvorov, SS; Svera M Ianăşi, P; Switchenko, JM; Syarif, NY; Synytsya, A; Taherzadeh, MJ; Tain, YL; Tamburino, C; Tammam, OY; Tan, BYQ; Tan, H; Tan, S; Tanaka, H; Tang, R; Tang, X; Tang, Z; Taurino, M; Tazare, J; Teresi, L; Testro, A; Thanasoponkul, W; Thangarasu, S; Thavaselvam, D; Theodoro, RC; Theron, G; Thomas, RH; Thomson, JJ; Tian, X; Tian, Y; Tomaszewski, CA; Tomlinson, LA; Torres, CMME; Tóth, M; Trecourt, A; Trevisani, F; Trimarchi, G; Tristán, C; Truong, VK; Tsigkou, K; Tsutsumi, S; Ubukata, Y; Uehara, H; Uwamino, Y; Vahedi-Shahandashti, R; Valberg, SJ; Valderrama, C; Valdovinos-García, EM; Valsecchi, D; van Diepeningen, AD; van West, P; Vargas-Osuna, E; Vassall, M; Vassilaki, N; Vassiliou, AG; Vecino, X; Velez-Irizarry, D; Venkatesh, YN; Vignali, L; Virdis, A; Viswanath, B; Voisin, AS; Volkova, YA; Vorotyntsev, AV; Vorotyntsev, IV; Vtyurina, ES; Vu, DH; Waldridge, B; Walker, AJ; Wallon, M; Wang, B; Wang, G; Wang, H; Wang, J; Wang, LJ; Wang, S; Wang, T; Wang, X; Wang, Z; Warren, RM; Warren-Gash, C; Wei, SH; Weinstock-Guttman, B; Wekwejt, M; Wessjohann, LA; Wiesmann, HP; Williams, ZJ; Williamson, EJ; Wilson, M; Wing, K; Wong, AY; Wong, BKL; Woodward, S; Wozniak, KL; Wu, C; Wu, K; Wu, S; Wu, Y; Xiang, D; Xie, H; Xiong, X; Xu, C; Xu, H; Xu, J; Xu, WH; Xu, Y; Xun, T; Yamaguchi, S; Yan, P; Yan, W; Yan, Z; Yang, B; Yang, F; Yang, L; Yao, XB; Yasui, H; Yenesew, A; Yeo, LLL; Yeo, TC; Yi, S; Yin, F; Yip, JWL; Yoon, SH; Yoon, SJ; Yoshida, M; Yoshizumi, T; Young, LA; Yu, C; Yu, DD; Yu, F; Yu, H; Yu, JD; Yu, NJ; Yu, X; Yuan, Y; Yurenko, A; Yusof, YA; Zahedipoor, A; Zahran, EM; Zainuddin, NI; Zanatta, AC; Zanotto, ED; Zanozin, ID; Zavascki, AP; Zenke, M; Zhang, F; Zhang, G; Zhang, H; Zhang, J; Zhang, L; Zhang, MX; Zhang, NY; Zhang, Q; Zhang, W; Zhang, X; Zhang, XM; Zhao, F; Zhao, Q; Zhao, R; Zhao, Y; Zheng, J; Zheng, S; Zhou, L; Zhou, X; Zhu, H; Zivadinov, R; Žižek, D; Zuccoli, JR; Zwaan, BJ | 1 |
Berry, ED; Broadway, PR; Burdick Sanchez, NC; Carroll, JA; Fernando, SC; Hales, KE; Legako, JF; Long, NS; Wells, JE; Woerner, DR | 1 |
Do, KH; Jung, CM; Lee, SW; Lee, WK; Lee, YJ; Lim, SK; Seo, KW | 1 |
Bahrs, C; Bartonickova, L; Burgmann, H; Hagel, S; Paulussen, E; Pletz, MW; Schneider, L; Starzengruber, P; Tobudic, S | 1 |
Lunestad, BT; Norström, M; Slettemeås, JS; Svanevik, CS; Urdahl, AM | 1 |
Atchon, AK; Garch, FE; Hocquet, D; Jong, A; Moyaert, H; Sauget, M; Valot, B | 1 |
Heydecke, A; Sütterlin, S; Tano, E; Yin, H | 1 |
Abe, Y; Fukuma, A; Hirade, T; Horie, A; Ito, T; Katou, F; Koike, D; Nariai, A; Saito, Y; Wakuri, M | 1 |
Cuesta, M; Gonzalez-Zorn, B; Hoefer, A; Ortega-Huedo, R | 1 |
Boerlin, P; Booker, CW; Chalmers, G; Cook, SR; Cormier, AC; Gow, SP; Hannon, SJ; McAllister, TA; Read, RR; Zaheer, R | 1 |
Fuenzalida, MJ; Ruegg, PL | 2 |
Ballanti, S; Busca, A; Candoni, A; Cattaneo, C; Cefalo, M; Criscuolo, M; Daffini, R; Dargenio, M; Del Principe, MI; Delia, M; Dragonetti, G; Fanci, R; Giuliano, G; Laurino, M; Maracci, L; Marchesi, F; Nadali, G; Pagano, L; Simonetti, E; Spolzino, A; Trecarichi, EM; Tumbarello, M; Zannier, ME | 1 |
Baneviciene, R; Kalediene, L; Kavaliauskas, P; Petraitiene, R; Petraitis, V; Planciuniene, R; Prakapaite, R; Saab, F; Semoskaite, R; Walsh, TJ | 1 |
Adamopoulou, M; Christodoulopoulos, G; Filioussis, G; Grinberg, A; Hadjichristodoulou, C; Kachrimanidou, M; Kritas, SK; Kyritsi, M; Tzivara, A | 1 |
Heuer, O; Högberg, LD; Monnet, DL; Peñalva, G; Vlahović-Palčevski, V; Weist, K | 1 |
den Bakker, HC; Lawhon, SD; Loneragan, GH; Norby, B; Norman, KN; Ohta, N; Scott, HM; Vinasco, J | 1 |
Chouchani, C; Dziri, O; Dziri, R; Maraoub, A | 1 |
Karlowsky, JA; Kazmierczak, KM; Motyl, MR; Sahm, DF; Young, K | 1 |
Arpin, C; Barthélémy, P; Benizri, S; Bientz, L; Kauss, T; Vialet, B; Vinh Nguyen, P | 1 |
Bertrand, X; Bouxom, H; Gbaguidi-Haore, H; Jeanvoine, A; Leroy, J; Slekovec, C | 1 |
Bottomley, AL; Harry, EJ; Peters, KM; Phan, MD; Schembri, MA | 1 |
Anandan, S; Daniel, JLK; Devanga Ragupathi, NK; Iyadurai, R; Muthuirulandi Sethuvel, DP; Mutreja, A; Neeravi, AR; Sathyendra, S; Vasudevan, K; Veeraraghavan, B | 1 |
Behnke, M; Feihl, S; Gastmeier, P; Gebhardt, F; Gölz, H; Hamprecht, A; Kern, WV; Kola, A; Mischnik, A; Peter, S; Querbach, C; Rohde, AM; Schneider, C; Schröder, W; Schwab, F; Seifert, H; Tacconelli, E; Vehreschild, MJGT; Wiese-Posselt, M; Wille, T; Zweigner, J | 1 |
Chen, Y; Jiang, S; Lu, X; Shen, P; Xiao, Y; Yang, P | 1 |
Duan, C; Lauridsen, C; Li, D; Qiu, X; Wang, J; Yang, G; Yue, Y; Zhu, Y; Zou, Y | 1 |
Canovas, J; Chau, F; Fantin, B; Le Monnier, A; Lefort, A; Petitjean, G | 1 |
Baltazar, ICL; Bonelli, RR; Caldera, S; de Araújo Longo, LG; de Sousa, VS; de Souza da-Silva, AP; Moreira, BM; Riley, LW; Santoro-Lopes, G | 1 |
Banneke, S; Burow, E; Grobbel, M; Käsbohrer, A; Kürbis, C; Ladwig-Wiegard, M; Simoneit, C; Szabó, I; Tenhagen, BA; Wendt, D | 1 |
García Buitrago, JA; Hagevoort, R; Jordan, ER; Lawhon, SD; Levent, G; Norman, KN; Ossa-Trujillo, C; Piñeiro, JM; Scott, HM; Taylor, EA; Vinasco, J | 1 |
Cisera, K; Hughes, C; Rogers, B; Taylor, L; Xie, O | 1 |
Bernasconi, OJ; Büdel, T; Campos-Madueno, EI; DeCrom-Beer, S; Endimiani, A; Fehr, J; Hassan, NK; Hatz, C; Jakopp, B; Kuenzli, E; Mohammed, AH; Moser, AI; Zinsstag, J | 1 |
Alfonseca-Silva, E; Ortega, E; Posadas, E; Sumano, H; Tapia, G | 1 |
Dong, H; Hu, X; Stålsby Lundborg, C; Sun, X; Zhen, X | 1 |
Hosokawa, H; Isobe, H; Kikuchi, T; Kobayashi, K; Mitsuboshi, S; Moro, H | 1 |
Crowe, A; Jardine, D; Olenski, M; Poy Lorenzo, YS | 1 |
Chauvin, C; Chevance, A; Chouet, S; Delzescaux, D; Hemonic, A; Jouy, E; Le Coz, P; Liber, M; Perrin-Guyomard, A; Verliat, F | 1 |
Fujisawa, M; Harada, M; Hayashi, F; Ishii, A; Kan, Y; Kitagawa, K; Kuntaman, K; Osawa, K; Shigemura, K; Shirakawa, T | 1 |
Benavides, JA; García, P; Listoni, FJP; Moreno-Switt, AI; Munita, JM; Paes, AC; Rivas, L; Salgado-Caxito, M | 1 |
Albert, E; Colomina, J; Costa, RM; Giménez, E; Huntley, D; Navarro, D; Olea, B; Oltra, R; Pascual, T; Pinto, C; Sánchez, D; Torres, I; Valdivia, A | 1 |
Clabots, C; Johnson, JR; Johnston, BD; Porter, SB; Thuras, P | 1 |
Arpaillange, N; Bousquet-Mélou, A; Dupouy, V; Haenni, M; Madec, JY; Métayer, V; Roques, B; Wucher, J | 1 |
Castagnola, E; Losurdo, G; Mariani, M; Medici, C; Mesini, A; Ugolotti, E | 1 |
Barta, JR; Boerlin, P; Chalmers, G; Cobean, J; Snyder, RP | 1 |
Aebi, S; Hilty, M; Moor, J; Mostacci, N; Oppliger, A; Overesch, G; Rickli, S | 1 |
Bonten, MJ; Dohmen, W; Dorado-García, A; Heederik, DJ; Mevius, D; Wagenaar, JA | 1 |
Andersen, LP; Dzajic, E; Hammerum, AM; Hansen, DS; Hansen, F; Hasman, H; Justesen, US; Knudsen, JD; Roer, L; Røder, BL; Samulioniené, J; Schumacher, H; Stegger, M; Søndergaard, TS; Thomsen, MCF; Wang, M; Østergaard, C | 1 |
Bonnet, R; Caniça, M; Clemente, L; Ferreira, E; Graça, R; Manageiro, V | 1 |
Ajilda, AAK; Padmini, N; Selvakumar, G; Sivakumar, N | 1 |
Heir, E; Ilag, HK; Langsrud, S; Mo, SS; Sunde, M | 1 |
Castanheira, M; Johnson, JR; Porter, S; Thuras, P | 1 |
Kim, HS; Kim, HY; Kim, YK; Lee, J; Lee, JA; Lee, SS; Seo, YB; Song, W; Uh, Y | 1 |
Ishimaru, N; Kawamoto, M; Kinami, S; Ohnishi, H; Sakaguchi, A; Sakamoto, S; Takagi, A; Yoshimura, S | 1 |
Boerlin, P; Chalmers, G; Cormier, AC; Côté, G; Nadeau, M; Reid-Smith, RJ | 1 |
Cho, EH; Kang, BH; Kim, DW; Kim, J; Kim, JS; Kim, M; Kim, S; Kim, Y; Kwak, HS; Kwon, MJ; Lee, J; Na, K; Oh, KH; Oh, SS; Park, J; Seong, WK; Shin, E; Yang, HJ | 1 |
Bicalho, RC; Gaeta, N; Ganda, EK; Oikonomou, G; Pomeroy, B; Schukken, YH; Sipka, A | 1 |
Dahdouh, E; Daoud, Z; Doron, S; Irani, J; Matar, GM; Salem-Sokhn, E | 1 |
Antonelli, A; Arena, F; Bracco, S; Caltagirone, M; Giani, T; Luzzaro, F; Mauri, C; Nicchi, J; Nucleo, E; Pagani, L; Pantosti, A; Rossolini, GM | 1 |
Monogue, ML; Nicolau, DP | 2 |
Awosile, BB; Smith, BA | 1 |
Adler, AL; Baseman, JG; Miles-Jay, A; Sokurenko, EV; Tchesnokova, V; Weissman, SJ; Zerr, DM | 1 |
Albuquerque, T; Caniça, M; Clemente, L; Correia, I; Ferreira, E; Graça, R; Manageiro, V | 1 |
Kim, JH; Kim, MJ; Kim, SB; Sohn, JW; Suh, JW; Yang, KS; Yoon, YK | 1 |
Agunos, A; Caffrey, N; Checkley, S; Gow, S; Nekouei, O | 1 |
Bansal, N; Gopalakrishnan, R; Kumar D, S; Nambi, PS; Ramasubramanian, V; Sukhwani, KS | 1 |
Alkan, F; Apa, H; Bayram, N; Devrim, İ; Gözmen, S; Gülfidan, G; Ünal, N | 1 |
Beatson, SA; Ben Zakour, NL; Bhally, H; Crowe, A; Harris, PNA; Izharuddin, E; Jureen, R; Lee, TH; Looke, D; Lye, DC; Paterson, DL; Roberts, LW; Rogers, B; Runnegar, N; Schembri, MA; Tambyah, PA; Wailan, AM; Yin, M; Zowawi, HM | 1 |
Badal, R; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
Boerlin, P; Chalmers, G; Dick, H; Reid-Smith, RJ; Shen, X; Slavic, D; Zhang, PLC | 1 |
Khedkar, S; Khedkar, U; Lind, F; Nerkar, SS; Odsbu, I; Orsini, N; Stålsby Lundborg, C; Tamhankar, AJ | 1 |
Awosile, B; Heider, LC; Keefe, G; McClure, J; Rodriguez-Lecompte, JC; Sanchez, J | 1 |
Batard, E; Caillon, J; Chapelet, G; Javaudin, F; Marquet, A; Montassier, E; Vibet, MA | 1 |
Baron, S; de Boisséson, C; Jouy, E; Kempf, I; Larvor, E; Le Devendec, L; Lucas, P; Touzain, F | 1 |
Bortolaia, V; Dalsgaard, A; Dang, STT; Le, HQ; Tran, NT | 1 |
Caro, L; Huntington, JA; Long, J; Xiao, AJ | 1 |
Awosile, B; German, G; Heider, LC; McClure, JT; Rodriguez-Lecompte, JC; Saab, ME | 1 |
Ferreira, BC; Fonseca, BB; Hoepers, PG; Koerich, PK; Rossi, DA; Silva, PL; Valadares Júnior, EC; Zuffo, JP | 1 |
Abraham, RJ; Abraham, S; Gordon, DM; Kirkwood, RN; Laird, T; Linn, B; Mitchell, T; O'Dea, M; Pang, S; Saputra, S; Singh, M; Trott, DJ | 1 |
Barbuddhe, SB; Kumar, M; Malik, SVS; Pathak, R; Rawool, DB; Sunitha, R; Vergis, J | 1 |
Brick, TA; Coetzee, JF; Gorden, PJ; Griffith, RW; Kleinhenz, MD; Mochel, JP; Rajewski, SM; Sidhu, PK; Smith, JS; Wulf, LW; Ydstie, JA; Zhang, M | 1 |
Johnson, JR; Johnston, BD; Thuras, P | 1 |
Bajaj, R; Devkota, R; Mahalingam, N; Manivannan, B; Pradeep, BE; Pullela, K; Siddaramappa, S; Thimmappa, B | 1 |
Bourély, C; Cazeau, G; Chauvin, C; Gay, É; Jarrige, N; Jouy, É; Leblond, A | 1 |
Aggoune, N; Assaous, F; Ben-Mahdi, MH; Benameur, Q; Guettou, B; Rahal, K; Tahrat, N; Tali-Maamar, H | 1 |
Andrade, LK; Andrade, LN; Casella, T; Darini, ALDC; Haenni, M; Madec, JY; Madela, NK; Nogueira, MCL; Pradela, LK | 1 |
Chen, Z; Kang, M; Li, M; Liu, M; Song, Q; Wu, L; Xie, Y; Zhao, D | 1 |
Cazanave, C; Charlier, C; Doret Dion, M | 1 |
Azevedo, SS; Fernandes, MR; Garino, F; Lincopan, N; Moura, Q; Sellera, FP; Silva, MM | 1 |
Lee, YJ; Seo, KW; Shim, JB | 2 |
Dhanda, RS; Gaind, R; Mittal, G; Nagarjuna, D; Yadav, M | 1 |
Hon, KL; Leung, AAM; Leung, AKC; Wong, AHC | 1 |
Bedenić, B; Drenjančević, D; Kopić, J; Presečki-Stanko, A; Talapko, J; Tomić Paradžik, M; Zarfel, G | 1 |
Cha, SS; Chung, KM; Jeong, BG; Kim, MK; Lee, TH; Na, JH; Park, SB | 1 |
Hase, A; Horimoto, T; Matsuo, M; Ogasawara, J; Umeda, K | 1 |
Cao, H; Del Collo, LP; Haley, BJ; Hovingh, E; Karns, JS; Kim, SW; Salaheen, S; Sonnier, JL; Van Kessel, JAS | 1 |
Cerdeira, L; Di Conza, J; Elena, A; Gentilini, ÉR; Gutkind, G; Lincopan, N; Mas, J; Muñoz, ME; Rumi, MV | 1 |
Ahn, ST; Kim, JW; Kim, SW; Moon, DG; Oh, MM; Park, HS | 1 |
Crook, DW; Davies, T; Day, NPJ; Giess, A; Mao, S; Moore, CE; Parry, CM; Peto, TEA; Phot, N; Sheppard, AE; Stoesser, N; Suy, K; Turner, P; van Aartsen, JJ; Walker, AS | 1 |
Chang, SC; Chen, YC; Huang, YS; Lin, WP; Wang, JT | 1 |
Ghosh, AS; Ghosh, SK; Kumar N, G; Kumar, G; Mallick, S; Pramanick, P | 1 |
Assaous, F; Ben-Mahdi, MH; Benameur, Q; Guettou, B; Rahal, K; Tali-Maamar, H | 1 |
Nordmann, P; Ortiz de la Rosa, JM; Poirel, L | 1 |
Bruderer, V; Greiner, M; Imkamp, F; Keller, PM; Mancini, S | 1 |
Abraham, RJ; Abraham, S; Barton, M; Harb, A; Jordan, D; Laird, T; Mukerji, S; O'Dea, M; Stegger, M; Truswell, AV | 1 |
Algorta, G; Ávila, P; Brasesco, M; Caiata, L; Christophersen, I; Cordeiro, NF; Galiana, A; García-Fulgueiras, V; Grill Diaz, F; Papa-Ezdra, R; Vieytes, M; Vignoli, R | 1 |
Ann Justo, J; Bookstaver, PB; Elizabeth Davis, S; Foster, R; Gould, A; Ham, J; Hucks, J; Nicolau, DP | 1 |
Fujii, N; Okubo, T; Sato, T; Tamura, Y; Usui, M; Yokota, SI | 1 |
Gupta, S; Harwalkar, A; Rao, A; Sataraddi, J; Srinivasa, H; Yoganand, R | 1 |
Aly, SS; Arruda, AG; Champagne, J; Godden, S; Gorden, P; Lehenbauer, TW; Rapnicki, P; Timms, L | 1 |
Ambrose, PG; Bhavnani, SM; Bulik, CC; Castanheira, M; Forrest, A; Friedrich, LV; Jones, RN; Mendes, RE; Nicasio, AM; Okusanya, OO; Steenbergen, JN; VanScoy, B | 1 |
Fukuda, A; Iwasa, T; Okubo, T; Sato, T; Tamura, Y; Usui, M | 1 |
Abdelaziz, MO; Aleo, A; Bonura, C; Calà, C; Fasciana, T; Mammina, C | 1 |
Bell, SM; Ginn, AN; Gottlieb, T; Harkness, J; Iredell, JR; Leroi, MJ; Macleod, C; Merlino, J; Partridge, SR; Thomas, LC; van Hal, S; Wiklendt, AM; Zong, Z | 1 |
Endimiani, A; Hilty, M; Kronenberg, A; Muhlemann, K | 1 |
Goessens, WH; Melles, DC; Pitout, JD; Tommassen, J; van Boxtel, R; van der Bij, AK; van Ulsen, P | 1 |
Edquist, P; Melhus, Å; Starlander, G; Yin, H | 1 |
Droz, S; Endimiani, A; Hilty, M; Kronenberg, A; Perreten, V; Seiffert, SN | 1 |
Cha, MK; Chung, DR; Kang, CI; Kim, SH; Ko, KS; Lee, NY; Peck, KR; Song, JH; Wi, YM | 1 |
Drawz, SM; Johnson, JR; Kuskowski, MA; Porter, S | 1 |
Cai, JC; Chen, GX; Chen, WL; Chi, D; Hu, YY; Zhang, R; Zhang, XF; Zhou, HW | 1 |
Biasi, G; Bonilauri, P; Dottori, M; Gherpelli, Y; Luppi, A; Maioli, G; Martelli, P; Merialdi, G | 1 |
Bilker, WB; Fishman, NO; Han, JH; Lautenbach, E; Mao, X; Nachamkin, I; Tolomeo, P | 1 |
Ambrose, PG; Bhavnani, SM; Bulik, CC; Forrest, A; Friedrich, LV; Jones, RN; McCauley, J; Mendes, RE; Okusanya, OO; Steenbergen, JN; Vanscoy, B | 1 |
Carrique-Mas, JJ; Clouting, C; Davies, RH; Gosling, RJ; Jones, EM; Snow, LC | 1 |
Bokaeian, M; Shahraki, S; Shayan, S | 1 |
Bai, J; Boerlin, P; Chengappa, MM; Cottell, JL; Kanwar, N; Loneragan, GH; McGowan, M; Norby, B; Scott, HM; Vinasco, J | 1 |
Bailey-Horne, V; Brunton, L; Coldham, N; Heinrich, K; Horton, R; Jones, J; McLaren, I; Randall, L; Sharma, M; Sharman, M; Teale, C | 1 |
Athan, E; De Almeida, M; Freeman, JT; Gunning, E; Havers, SM; Ingram, PR; Jones, M; Paterson, DL; Pitman, MC; Rogers, BA; Runnegar, N; Sidjabat, HE; Styles, K | 1 |
Bosch, J; Guiral, E; López, Y; Montero, I; Sáez-López, E; Soto, SM; Vila, J | 1 |
Fuglsang-Damgaard, D; Hammerum, AM; Hansen, F; Heltberg, O; Justesen, US; Knudsen, JD; Olsen, SS | 1 |
Barberino, MG; Berman, H; Moreira, ED; Reis, JN; Riley, L | 1 |
Bae, IK; Cho, YK; Hwang, SS; Jeong, SH; Kim, J; Kim, JM; Lee, K; Park, YS; Seo, YH | 1 |
Arlet, G; Ašmonienė, V; Giedraitienė, A; Pavilonis, A; Plančiūnienė, R; Simonytė, S; Vitkauskienė, A | 1 |
Løvland, A; Mo, SS; Norström, M; Slettemeås, JS; Sunde, M; Urdahl, AM | 1 |
Bisgaard, M; Christensen, H; Löhren, U; Olsen, RH; Robineau, B | 1 |
Doi, Y; Qureshi, ZA | 1 |
Okubo, T; Sato, T; Tamura, Y; Usui, M; Yokota, S | 1 |
Batzias, G; Kaltsogianni, F; Koutinas, A; Miriagou, V; Saridomichelakis, MN; Sianou, E; Siarkou, VI; Sofianou, D; Tzavaras, I; Tzelepi, E; Vingopoulou, EI | 1 |
Heraty, R; Liu, J; Malczynski, M; Qi, C; Rhodes, NJ; Richardson, CL; Scheetz, MH | 1 |
Doi, Y; Hu, F; Lee, CS; Rivera, JI | 1 |
Izumiyama, S; Okubo, T; Sato, T; Tamura, Y; Usui, M; Yokota, S | 1 |
Bolormaa, E; Kao, CY; Khosbayar, T; Udval, U; Wu, HM; Wu, JJ; Yan, JJ | 1 |
Caron, F; Choplin-Renard, J; Etienne, M; Pestel-Caron, M; Van Elslande, H | 1 |
Condon, S; Ginocchio, CC; McWilliams, CS; Schwartz, RM | 1 |
Chattaway, M; Day, M; Guerra, B; Helmuth, R; Mevius, D; Rodríguez, I; Schink, AK; Thomas, K; Van Essen, A; Wu, G | 1 |
Aarestrup, FM; Agersø, Y; Andersen, VD; Hammerum, AM; Hansen, F; Larsen, J; Lester, CH; Mordhorst, H; Olsen, SS; Skov, RL; Skovgaard Skytte, TS | 1 |
Boutin, MA; Harris, AD; Hazen, TH; Johnson, JK; Rasko, DA; Robinson, G; Stancil, A; Zhao, L | 1 |
Agersø, Y; Hasman, H; Jensen, JD; Pedersen, K | 1 |
Chandran, SP; Diwan, V; Joseph, BV; Lundborg, CS; Macaden, R; Mundayoor, S; Rosales-Klintz, S; Tamhankar, AJ | 1 |
Baron, S; Bougeard, S; Eono, F; Jouy, E; Kempf, I; Larvor, E | 1 |
Chen, S; Chen, X; He, D; Liu, JH; Liu, Y; Lv, L; Rao, L; Wang, Y; Wu, C; Wu, P; Yang, T; Zeng, Z | 1 |
Li, J; Liang, C; Shan, Q; Wang, J; Zeng, Z | 1 |
Cheong, HJ; Cho, YK; Choi, TY; Chung, MH; Kang, JO; Ki, M; Kim, J; Kim, SJ; Kim, Y; Kwon, KT; Lee, H; Lee, JS; Lim, SK; Pai, H; Park, DW; Ryu, SY; Seo, MR; Wie, SH | 1 |
Bush, K; Bussell, B; Clugston, SL; Estabrook, M | 1 |
Bernards, A; Goessens, W; Kors, I; Kraakman, M; Paltansing, S; Tommassen, J; van Boxtel, R; Wessels, E | 1 |
Bae, SR; Choi, WS; Kim, DH; Kim, HG; Loh, YS; Paick, SH; Park, HK | 1 |
Bae, EY; Cho, B; Chung, NG; Han, SB; Jeong, DC; Jung, SW; Kang, JH; Kim, HK; Lee, DG; Lee, JW; Park, YJ | 1 |
Demirel, I; Kruse, R; Önnberg, A; Persson, K | 1 |
Choi, HY; Choo, SH; Han, DH; Jeon, HG; Jeon, SS; Jeong, BC; Lee, HM; Lee, KS; Lee, SW; Seo, SI; Song, W; Sung, HH | 1 |
Bandyopadhyay, S; Bhattacharyya, D; Dandapat, P; Das, AK; Dutta, TK; Kar, D; Mahanti, A; Mondal, B; Nanda, PK; Samanta, I; Singh, RK | 1 |
Ding, H; Gu, M; Gu, X; Li, X; Li, Y; Shen, X; Zhang, B; Zhang, N | 1 |
Cameron-Veas, K; Fraile, L; Migura-Garcia, L; Moreno, MA; Solà-Ginés, M | 1 |
Adams, EL; Johns, IC | 1 |
Carp-Carare, C; Dorneanu, O; Guguianu, E; Maciuca, IE; Rimbu, C; Timofte, D; Tuchilus, C; Williams, NJ | 1 |
Clark, SL; Eppes, CS | 1 |
Liu, YH; Peng, YB; Shi, W; Yang, X; Yu, Y; Zhao, DH; Zhou, YF | 1 |
Choi, JY; Chong, Y; Chung, HS; Kim, JM; Ku, NS; Lee, K; Yong, D | 1 |
Baliga, C; D'Angeli, M; Duchin, J; Eckmann, K; Gluck, M; Kang, MG; Kay, M; Ross, AS; Swoveland, J; Verma, P; Weissman, SJ; Wendorf, KA | 1 |
Altier, C; Aprea, VA; Cummings, KJ | 1 |
Chavada, R; Howlin, K; Mac, K; Paull, S; Wong, J | 1 |
Alkatib, S; Chalana, IK; Chaudhry, K; Chopra, T; Johnson, PC; Kaye, KS; Marchaim, D; Mohammed, M; Pogue, JM; Tamam, Z; Tansek, R; Zhao, JJ | 1 |
Agersø, Y; Andersen, VD; Andreasen, M; Jensen, VF; Vigre, H | 1 |
Drap, AS; Gonchar, NV; Nyrkova, OI; Partina, IV | 1 |
Rutala, WA; Weber, DJ | 1 |
Ahmed, S; Ali, SA; Arsalan, A; Naqvi, SB; Shakeel, O | 1 |
Alric, M; Blanquet-Diot, S; Cariolet, R; de Boisseson, C; Eono, F; Fleury, MA; Guérin, A; Jouy, E; Kempf, I; Le Devendec, L; Le Goff, O; Mourand, G; Touzain, F | 1 |
Kawahara, R; Kumeda, Y; Nakajima, C; Seto, K; Suzuki, Y; Taguchi, M | 1 |
Ding, H; Gu, M; Gu, X; Shen, X; Xiong, M; Yang, Y; Zhang, L; Zhang, N | 1 |
Bounar-Kechih, S; Jouy, E; Kempf, I; Le Corvec, M; Le Devendec, L; Meguenni, N; Rabah Bakour, D | 1 |
Kluytmans, JA; Leenstra, T; van der Bij, AK; van der Steen, M | 1 |
Chen, FJ; Chien, CC; Lee, CH; Li, CC; Liu, JW; Su, LH; Tang, YF | 1 |
Bethel, CR; Bonomo, RA; Doi, Y; Endimiani, A; Kasraian, S; Pires, J; Sendi, P; Taracila, M; Tinguely, R | 1 |
Enserink, R; Koningstein, M; Kooistra-Smid, MA; Leenen, MA; Mevius, D; Mughini-Gras, L; Scholts, RM; van Huisstede-Vlaanderen, KW; van Pelt, W; Veldman, K; Zuidema, R | 1 |
Bozavoutoglou, E; Kotsakis, SD; Lebessi, E; Miriagou, V; Tzelepi, E; Tzouvelekis, LS; Vetouli, EE | 1 |
Baumann, S; Beyer, A; Friese, A; Honscha, W; Kietzmann, M; Roesler, U; Scherz, G; Stahl, J; von Bergen, M | 1 |
Call, DR; Liu, J; Orfe, L; Subbiah, M; Zhao, Z | 1 |
Choi, CH; Kim, DH; Kim, HJ; Kim, JM; Koo, SH; Lee, JH; Oh, MH; Park, HS; Son, YJ; Subhadra, B | 1 |
Caniça, M; Ferreira, E; Jones-Dias, D; Manageiro, V; Martins, AP | 1 |
Jalava, J; Kärki, T; Lyytikäinen, O; Martelius, T; Möttönen, T; Ollgren, J | 1 |
Balan, O; Baron, S; Bougeard, S; Delannoy, S; Fach, P; Jouy, E; Kempf, I; Larvor, E | 1 |
Ma, W; Sun, J; Yang, S; Zhang, L | 1 |
Cabrera, C; Cerdeira, L; Lincopan, N; Moreno, AM; Moreno, M; Silva, KC; Spira, B | 1 |
Farrell, DJ; Flamm, RK; Jones, RN; Mendes, RE; Sader, HS | 1 |
Amelot, M; Baron, S; Bougeard, S; de Boisseson, C; Jouy, E; Keita, A; Kempf, I; Larvor, E; Touzain, F | 1 |
Hyatt, DR; Linke, LM; Magnuson, RJ; McConnel, CS; Rao, S; Stenkamp-Strahm, CM | 1 |
Agga, GE; Arthur, TM; Schmidt, JW | 1 |
Bissett, J; Daley, MJ; Hemmige, V; Hobbs, AL; Huth, RG; Jaso, TC; Shea, KM | 1 |
Jiang, Y; Kuang, L; Li, L; Li, M; Wang, H; Zhou, W | 1 |
Cameron-Veas, K; Fraile, L; Migura-Garcia, L; Moreno, MA | 1 |
Chan, EW; Chen, GX; Chen, S; Gu, DX; Huang, YL; Zhang, R | 1 |
Franz, E; Stalenhoef, JE; van Duijkeren, E; van Hoek, AH | 1 |
Fairbrother, JM; Jahanbakhsh, S; Letellier, A | 1 |
Adler, AL; Elward, A; Haaland, W; Kronman, MP; Miles-Jay, A; Newland, JG; Qin, X; Weissman, SJ; Zaoutis, T; Zerr, DM; Zhou, C | 1 |
Clabots, C; Johnson, JR; Mohamed, M; Porter, SB; Thuras, P | 1 |
Bhattacharjee, A; Bora, D; Chakravarty, A; Chanda, DD; Das Talukdar, A; Maurya, AP | 1 |
Abraham, S; Fairbrother, JM; Jahanbakhsh, S; Kohan-Ghadr, HR; Letellier, A; Smith, MG; Trott, DJ | 1 |
Behnke, M; Feihl, S; Gastmeier, P; Gebhardt, F; Hamprecht, A; Kern, WV; Knobloch, JK; Mischnik, A; Obermann, B; Peter, S; Querbach, C; Rohde, AM; Schneider, C; Schröder, W; Schwab, F; Seifert, H; Tacconelli, E; Wiese-Posselt, M; Wille, T; Willmann, M; Zweigner, J | 1 |
Ahmad Murad, K; Chen, YT; Ng, LS; Park, JJ; Seah, JT; Tan, TY | 1 |
Kristoffersen, AB; Mo, SS; Norström, M; Nødtvedt, A; Sunde, M | 1 |
Campbell, J; Carrique-Mas, JJ; Hieu, TQ; Hoa, NT; Mai, HH; Mai, NT; Nhung, HN; Nhung, NT; Schultsz, C; Trung, NV; Tuyen, HT; Van Minh, P; Wagenaar, JA | 1 |
Buter, GJ; Gonggrijp, MA; Hage, JJ; Heuvelink, AE; Lam, TJGM; Santman-Berends, IMGA; van Schaik, G | 1 |
Bliss, CA; Cloutier, D; Hershberger, E; Huntington, JA; Kaye, KS; Miller, B; Paterson, DL; Popejoy, MW; Steenbergen, JN; Umeh, O | 1 |
Araki, M; Ishii, A; Kobayashi, Y; Kumon, H; Nasu, Y; Sadahira, T; Takamoto, A; Wada, K; Watanabe, M; Watanabe, T | 1 |
Bougeard, S; Denamur, E; Fleury, MA; Jouy, E; Kempf, I; Mourand, G; Paboeuf, F | 1 |
Hong, MY; Hsieh, CC; Hung, YP; Ko, WC; Lee, CC; Lee, CH; Lee, NY | 1 |
Boisson, MN; Boulouis, HJ; Haenni, M; Madec, JY; Médaille, C; Melo, LC; Saras, E | 1 |
Bai, L; Chen, Q; Fanning, S; Hurley, D; Li, F; Li, J; Wang, J; Wang, L; Yu, Z | 1 |
Asai, T; Kimura, A; Shibata, S; Yossapol, M | 1 |
Diaz-Martinez, LA; Ramirez-Blanco, CE; Ramirez-Rivero, CE; Sosa-Avila, LM | 1 |
Adler, AL; Burnham, CA; Das, S; Elward, A; Kronman, MP; Miles-Jay, A; Newland, JG; Qin, X; Selvarangan, R; Sullivan, KV; Weissman, SJ; Zaoutis, T; Zerr, DM | 1 |
Ikawa, K; Ikeda, K; Mikamo, H; Morikawa, N; Tamaya, T | 1 |
Akalin, H; Gürcüoglu, E; Helvaci, S; Heper, Y; Kordan, Y; Mistik, R; Ozakin, C; Ozbey, S; Sinirtaş, M; Yilmaz, E | 1 |
Bechtold, A; Gastmeier, P; Lapatschek, M; Meyer, E; Schwab, F; Schwarzkopf, G | 1 |
Chen, YH; Liu, ZY; Wu, R; Yao, WZ; Zhang, XW; Zhou, QT | 1 |
Bergman, M; Hakanen, AJ; Huovinen, P; Nyberg, ST; Paakkari, P | 1 |
Bianchetti, MG; Borsari, AG; Brazzola, P; Bucher, B; Dolina, M; Simonetti, GD | 1 |
Lortholary, O; Martin, C; Nordmann, P; Plesiat, P; Potel, G; Zahar, JR | 1 |
Choe, KW; Jeon, JH; Kim, HB; Kim, NJ; Lee, HS; Oh, MD; Park, SW; Park, WB; Song, KH | 1 |
Alişkan, H; Güçlü, M; Husamettin, E; Serin, E; Yakar, T | 1 |
Huang, KH; Hung, SF; Liu, KL; Yu, HJ | 1 |
Howe, RA; Macfarlane, L; Walsh, TR; Wootton, M | 1 |
Caroff, N; Corvec, S; Crémet, L; Dauvergne, S; Giraudeau, C; Lepelletier, D; Reynaud, A | 1 |
Doherty, JA; Khan, J; Kollef, MH; Micek, ST; Pervez, M; Reichley, RM; Welch, EC | 1 |
Chan, KS; Chuang, YC; Kuo, CY; Tsai, CL; Yu, WL | 1 |
Cao, W; Gao, Y; Wu, Y; Yang, Y; Zhou, Q | 1 |
He, XF; Hu, J; Jia, YJ; Yu, SY; Zhang, O; Zhu, JF | 1 |
Caroff, N; Corvec, S; Crémet, L; Dauvergne, S; Lepelletier, D; Leprince, C; Reynaud, A | 1 |
Chong, Y; Ito, Y; Kamimura, T; Yakushiji, H | 1 |
Hu, F; Wu, W; Xu, X; Ye, X; Zhu, D | 1 |
Castanheira, M; Clabots, C; Johnson, JR; Johnston, B; Kuskowski, MA | 1 |
Fukumoto, K; Matsui, K; Oishi, T; Taguchi, T; Tsukano, S; Uchiyama, M; Ueno, K | 1 |
Berge, AC; Butaye, P; Catry, B; Dewulf, J; Haesebrouck, F; Herman, L; Heyndrickx, M; Martel, A; Persoons, D; Smet, A | 1 |
Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ; Hsueh, PR | 1 |
Branger, C; Clermont, O; Courpon-Claudinon, A; Denamur, E; Dornic, Q; Fantin, B; Lefort, A; Mentré, F; Panhard, X; Wolff, M | 1 |
Domelier-Valentin, AS; Mourens, C; Quentin, R; Savoyen, P; van der Mee-Marquet, N | 1 |
Carmo, MS; Castanheira, M; Cergole-Novella, MC; Guth, BE; Pignatari, AC | 1 |
Abley, MJ; Daniels, JB; Fry, PR; Gebreyes, WA; Mathews, JL; Mollenkopf, DF; Parkinson, AE; Wittum, TE | 1 |
Aho, S; Astruc, K; Cassier, P; Chavanet, P; Lallechère, S; Neuwirth, C; Piroth, L | 1 |
Boutbaoucht, M; Laghla, B; Nejmi, H; Samkaoui, MA | 1 |
Kochhar, R; Noor, MT; Radhakrishna, Y; Ray, P; Singh, K; Sinha, SK; Wig, JD | 1 |
Cox, RM; El Jamal, SM; Lorsbach, RB; Malak, SF | 1 |
Arakawa, S; Hamasuna, R; Hayami, H; Ishikawa, K; Kiyota, H; Matsumoto, T; Monden, K; Muratani, T; Takahashi, S; Tanaka, K; Yamamoto, S; Yasuda, M | 1 |
Bures, J; Cizek, A; Dolejska, M; Hera, A; Jurcickova, Z; Kohoutova, L; Literak, I; Pokludova, L; Smola, J | 1 |
Bhattacharjee, A; Sen, MR; Upadhyay, S | 1 |
Aepfelbacher, M; Heisig, P; Hentschke, M; Kotsakis, SD; Miriagou, V; Wolters, M | 1 |
Mansouri, M; Norabadi, P; Ramazanzadeh, R | 1 |
Ge, Y; Giske, CG; Karlsson, IM; Titelman, E | 1 |
Leung, CH; Liu, CK; Liu, CP; Sun, FJ | 1 |
Aarestrup, FM; Cavaco, LM; Hasman, H; Wasyl, D | 1 |
Biggs, GY; Nitti, VW; Rosenblum, N; Shah, SR | 1 |
Alroumoh, M; El-Kass, G; Galler, M; Husain, S; Mohan, P; Seshan, SV | 1 |
Beceiro, A; Bou, G; Dhanji, H; Doumith, M; Downie, G; Doyle, M; Gaulton, T; Hickey, M; Livermore, DM; Maharjan, S; Soares, NC; Warner, M; Woodford, N | 1 |
Funk, JA; Gebreyes, WA; Lutz, EA; McCarty, MJ; Mollenkopf, DF; Wittum, TE | 1 |
Aldabe, B; Castor, C; Charron, M; Combe, C; Delmas, Y; Desjardin, M; Gault, G; Le Bihan, B; Llanas, B; Mariani-Kurkdjian, P; Ong, N; Rolland, P; Simoes, J; Terrier, F; Vendrely, B; Weill, F | 1 |
Colic, E; Dieperink, H; Tepel, M; Titlestad, K | 1 |
Hornsey, M; Phee, L; Wareham, DW | 1 |
Boothe, DM; Deck, J; Foley, SL; Kweon, O; Nayak, R; Park, M; Rafii, F; Shaheen, BW | 1 |
Chandrasekhar, MR; Krishna, BV; Patil, A | 1 |
Ballanger, P; Forgues, A; Gateau, T; Geissman, A; Junes, F; Merignargues, F; Robert, G | 1 |
Bulik, CC; Keel, RA; Nicolau, DP; Sutherland, CA; Tessier, PR | 1 |
Belomestnykh, N; Bennett, GJ; Ceglowski, B; Rauch, BJ; Saltman, RL; Schukken, YH; Sharkey, HL; Thomas, MJ; Zadoks, RN; Zurakowski, MJ | 1 |
Auvray, F; Forest, K; Haenni, M; Madec, JY; Oswald, E; Saras, E; Valat, C | 1 |
Acosta, F; Cottagnoud, M; Cottagnoud, P; Egerman, U; Laeuffer, JM; Stucki, A | 1 |
Homann, C; Knudsen, JD; Moser, C; Novovic, S; Olsen, H; Semb, S | 1 |
Aarestrup, FM; Agersø, Y; Hasman, H; Pedersen, K; Seyfarth, AM; Struve, T | 1 |
Chen, S; Chen, X; Chen, Z; Deng, Y; Liu, JH; Liu, Y; Lv, L; Yao, Q; Zeng, Z; Zheng, H; Zhuo, C | 1 |
Byun, JW; Chae, MH; Jang, GC; Jung, SC; Kim, SR; Lim, SK; Nam, HM; Park, YH; Tamang, MD | 1 |
Balan, G; Ho, WS; Koh, XP; Kong, BH; Lim, KT; Puthucheary, S; Tan, LK; Thong, KL; Yeo, CC | 1 |
Bartalesi, F; Bartoloni, A; Di Maggio, T; Lara, Y; Magnelli, D; Mantella, A; Pallecchi, L; Riccobono, E; Rossolini, GM; Saavedra, C; Strohmeyer, M; Trigoso, C; Villagran, AL | 1 |
Harada, K; Kataoka, Y; Nakai, Y | 1 |
Cheney, T; Coldham, NG; Harris, K; Snow, LC; Stokes, M; Teale, CJ; Warner, RG; Wearing, H | 1 |
Chen, J; Hao, R; Jia, L; Qiu, S; Song, H; Song, L; Su, W; Wang, L; Wang, Y; Yang, G; Zhang, J | 1 |
Hsueh, PR; Lee, YJ; Lin, YC; Liu, HY; Wu, HH | 1 |
Endimiani, A; Kunz, D; Overesch, G; Perreten, V; Rossano, A | 1 |
Kariuki, S; Maina, D; Ozwara, H; Revathi, G | 1 |
Butaye, P; De Zutter, L; Depoorter, P; Dewulf, J; Dierick, K; Herman, L; Imberechts, H; Persoons, D; Uyttendaele, M; Van Huffel, X | 1 |
Alós, JI; Martín-Pozo, A | 1 |
Aasnæs, B; Dahl, KH; Naseer, U; Sundsfjord, A; Tofteland, S | 1 |
Chan, JF; Cheng, VC; Ho, PL; Lo, WU; To, KK; Tse, H | 1 |
Eller, C; Pfeifer, Y | 1 |
Aarestrup, FM; Agersø, Y | 1 |
Besser, TE; Call, DR; Shah, DH; Subbiah, M; Ullman, JL | 1 |
Boerlin, P; Castillo-Courtade, L; Chalmers, G; Cottell, JL; Kanwar, N; Loneragan, GH; Norby, B; Scott, HM | 1 |
Ballereau, F; Batard, E; Boutoille, D; Caillon, J; Hardouin, JB; Montassier, E; Ollivier, F | 1 |
Pitout, JD | 1 |
Boutbaoucht, M; Chabaa, L; Mouaffak, Y; Oulad Saiad, M; Salama, T; Soraa, N; Younous, S | 1 |
Boothe, DM; Foley, SL; Nayak, R; Shaheen, BW | 1 |
Hächler, H; Nüesch-Inderbinen, M; Stephan, R; Zurfluh, K | 1 |
Brichta-Harhay, DM; Griffin, D; Kuehn, LA; Schmidt, JW | 1 |
Gao, ZH; Li, SM; Shen, JH; Zhang, BY | 1 |
Arakawa, Y; Doi, Y; Kamachi, K; Kurokawa, H; Shibata, N; Shibayama, K; Yagi, T; Yokoyama, K | 1 |
McGeer, A; Muller, M | 1 |
Bartlett, PC; Erskine, RJ; Phipps, CR; VanLente, JL | 1 |
Gesser, RM; McCarroll, K; Teppler, H; Woods, GL | 1 |
Hiyama, E; Kodama, T; Sueda, T; Tsumura, H; Yokoyama, T | 1 |
Chang, SC; Chen, JY; Lin, FM; Lu, PL; Siu, LK | 1 |
Arpin, C; Dubois, V; Nordmann, P; Poirel, L; Quentin, C; Texier-Maugein, J | 1 |
Banks, SM; Cui, X; Eichacker, PQ; Gerstenberger, E; Hartung, T; Karzai, W; Mehlhorn, B; Natanson, C; Reinhart, K; Straube, E | 1 |
Mayayo Dehesa, T; Navas Elorza, E; Quereda Rodríguez-Navarro, C; Rodríguez-Patrón Rodríguez, R | 1 |
Gajewski, A; Johnson, JR; Kuskowski, MA; Owens, K; Winokur, PL | 1 |
Arakawa, Y; Doi, Y; Kamachi, K; Kurokawa, H; Shibata, N; Shibayama, K; Yagi, T | 1 |
Gedikoglu, S; Kazak, E; Ozakin, C; Sevgican, E; Sinirtaş, M | 1 |
Amiridis, GS; Dafopoulos, J; Fthenakis, GC; Mavrogianni, VS; Papanikolaou, T | 1 |
Bethel, CR; Bonomo, RA; Helfand, MS; Hujer, AM | 1 |
Banevicius, MA; Geng, Q; Maglio, D; Nicolau, DP; Nightingale, CH; Ong, C | 1 |
Bou, G; Cartelle, M; del Mar Tomas, M; Molina, F; Moure, R; Villanueva, R | 1 |
Draghi, DC; Jones, ME; Karlowsky, JA; Nathwani, D; Sahm, DF; Thornsberry, C | 1 |
Bae, IK; Jeong, BC; Jeong, SH; Jung, HI; Kim, SJ; Kwon, SB; Lee, JH; Lee, SH; Song, JS | 1 |
Arakawa, Y; Doi, Y; Ishiguro, M; Kato, H; Kurokawa, H; Shibata, N; Shibayama, K; Wachino, J; Yagi, T; Yamane, K; Yokoyama, K | 1 |
Coles, M; Hariharan, H; Page, R; Poole, D | 1 |
Cui, WL; Li, WL; Wang, LX; Xu, DX | 1 |
Léotard, S; Mammeri, H; Naas, T; Nazic, H; Nordmann, P; Poirel, L | 1 |
Betsunoh, H; Hamasuna, R; Nagano, M; Osada, Y; Sueyoshi, T; Takehara, T; Tsukino, H; Yakushiji, K | 1 |
Ito, I; Matsumura, T; Suzuki, T | 1 |
Alba, J; Chang, FY; Ishiguro, M; Ishii, Y; Ma, L; Siu, LK; Yamaguchi, K | 1 |
Batchelor, M; Clifton-Hadley, FA; Davies, RH; Liebana, E; Paiba, GA; Stallwood, AD | 1 |
Bell, LM; Bilker, WB; Chu, JH; Coffin, SE; Goyal, M; Lautenbach, E; McGowan, KL; Nachamkin, I; Zaoutis, TE | 1 |
Benbachir, M; Benchekroun, S; Harif, M; Loukili, A; Mahmal, L; Quessar, A | 1 |
Actor, P; Fare, LR; Joloza, M; Pauls, JF; Phillips, L; Sachs, C; Weisbach, JA | 1 |
Ferrari, F; Goldstein, I; Marquette, CH; Rouby, JJ; Sartorius, A; Tonnellier, M | 1 |
Demiroz, AP; Ertem, G; Hatipoglu, CA; Irmak, H; Kinikli, S; Kocak, Z; Tufan, A | 1 |
Hawkey, PM; Livermore, DM | 1 |
Currie, ML; Greenbaum, LA; Lutter, SA; Mitz, LB | 1 |
Kotapati, S; Kuti, JL; Nicolau, DP; Nightingale, CH | 1 |
Alvarez, M; Briñas, L; de Diego, I; Lantero, M; Torres, C; Zarazaga, M | 1 |
Bochnia, M; Dziewiszek, W; Orendorz-Fraczkowska, K; Smutnicka, D; Stankiewicz, M | 1 |
Angulo, FJ; Haddadin, B; Hannah, EL; Johnson, JR; Samore, MH; Williamson, J | 1 |
Giakkoupi, P; Sestan-Crnek, S; Skrlin, J; Tambic-Andrasevic, A; Tzouvelekis, LS; Vatopoulos, AC; Vourli, S | 1 |
Alkan, A; Köse, D; Kumru, P; Oral, O; Tugrul, S; Yildirim, G | 1 |
Ikonomidis, A; Kristo, I; Maniatis, AN; Markogiannakis, A; Pournaras, S; Tsakris, A | 1 |
Cambier, C; Gustin, PG; Halloy, DJ | 1 |
Ambrose, PG; Ramphal, R | 1 |
Chang, FY; Chen, HM; Chuang, YC; Hsueh, PR; Lin, TP; Liu, YC; Lu, JJ; Shyr, JM; Tsao, SM; Wan, JH; Wang, LS; Wu, HH; Wu, HM; Wu, JJ; Yan, JJ; Yang, YC | 1 |
Abd El-Aty, AM; Goudah, A; Mouneir, SM; Shim, JH | 1 |
Decorby, MR; Hoban, DJ; Karlowsky, JA; Laing, NM; Zhanel, GG | 1 |
DebRoy, C; Donaldson, SC; Hegde, NV; Jayarao, BM; Sawant, AA; Straley, BA | 1 |
Duttaroy, B; Mehta, S | 1 |
Bin, C; Hui, W; Minjun, C; Renyuan, Z; Xiuli, X; Yingchun, X; Yongzhong, N; Yuanjue, Z | 1 |
Bulitta, J; Kirkpatrick, CM; Lipman, J; Roos, JF | 1 |
Kuti, JL; Lee, SY; Nicolau, DP | 1 |
Ensor, VM; Evans, JT; Hawkey, PM; Shahid, M | 1 |
de Cueto, M; Hernández, JR; Muniain, MA; Navarro, MD; Pascual, A; Ríos, MJ; Rodríguez-Baño, J; Romero, L | 1 |
Labombardi, VJ; Rojtman, A; Tran, K | 1 |
Domínguez, L; Escudero, E; García, M; Moreno, MA; Porrero, MA; Teshager, T; Torres, C | 1 |
Mahanta, J; Nath, R; Saikia, L | 1 |
Abd El-Aty, AM; Goudah, A; Jang, JH; Mouneir, SM; Shim, JH; Shimoda, M; Shin, JG; Sunwoo, YE | 1 |
Morelle, AM; Zavascki, AP | 1 |
Passmore, CA; Sherington, J; Stegemann, MR | 2 |
Cavaco, LM; Emborg, HD; Guardabassi, L; Hasman, H; Jørgensen, CJ | 1 |
Chiew, YF; Johnstone, MC; Parnell, KD; Penno, EC; Thompson, KM; Williams, SJ | 1 |
Aarestrup, FM; Collignon, P | 1 |
Fluit, AC; Gaastra, W; van Duijkeren, E; Vo, AT | 1 |
Agarwal, N; Agarwal, S; Arya, SC; Solanki, BS | 1 |
Jung, DS; Ko, KS; Kwon, KT; Lee, MY; Lee, NY; Peck, KR; Song, JH; Suh, JY | 1 |
Du, M; Huang, Y; Zhuang, S | 1 |
Apisarnthanarak, A; Dejsirilert, S; Kiratisin, P; Kitphati, R; Mundy, LM; Saifon, P | 1 |
Eiros Bouza, JM; Ochoa Sangrador, C | 1 |
Bai, YL; Chen, BY; Chu, YZ; Li, JB; Li, LY; Wan, JH; Wang, Q; Wang, X; Zhang, JP; Zhao, ZM | 1 |
Aguilar, L; Alou, L; Cafini, F; Coronel, P; Giménez, MJ; González, N; Prieto, J; Relaño, MT; Sevillano, D; Torrico, M | 1 |
Aksaranugraha, S; Kittisomprayoonkul, W; Suankratay, C; Sukonthamarn, K; Tantisiriwat, N; Tantisiriwat, W; Unhasuta, C | 1 |
Adams-Haduch, JM; Doi, Y; Paterson, DL | 1 |
Gustafsson, I; Hallgren, H; Ripa, T | 1 |
Belohradsky, BH; Bruch, K; Geiss, D; Kafetzis, D; Marget, W; Peters, G | 1 |
Howson, GL; Lacey, RW; Lord, VL; Luxton, DE; Trotter, IS | 1 |
Leimbrock, C; Pranada, F; Pusztai-Markos, Z | 1 |
Denson, S; Kaplan, SL; Mason, EO; Pickering, LK; Ramos, OM | 1 |
Homberger, F; Kayser, FH; Morenzoni, G | 1 |
Jarstrand, C; Lundbergh, P; Morfeldt-Månson, L; Weiland, O | 1 |
Henkel, W; Krüger, C; Marre, R | 1 |
Gootz, TD; Martin, RR; Moellering, RC; Perkins, RL; Sanders, CC; Sanders, WE; Strike, DG | 1 |
Cuddy, PG; Elenbaas, JK | 1 |
Beskid, G; Cleeland, R; Grimm, LM; McCracken, GH; Nelson, JD; Schaad, UB | 1 |
Freiesleben, H; Herhahn, D; Marre, R; Sack, K; Schulz, E | 1 |
Borowski, J; Zaremba, M; Zukowska-Nytko, K | 1 |
Carbon, C | 1 |
Boccazzi, A; McCracken, GH; Sakata, Y | 1 |
Abbas, AM; Cantor, AM; Haste, AR; Jones, RB; Newby, D; Rigby, CC; Taylor, MC | 1 |
Jelinek, R; Schoengut, H | 1 |
Nakayama, I | 1 |
Cox, CE | 1 |
Gadebusch, HH; Jacks, TM; Miller, BM; Schleim, KD; Shungu, DL; Weinberg, E | 1 |
Cherubin, CC; Cleri, D; Corrado, ML; Gombert, M; Landesman, SH | 1 |
McCracken, GH; Schaad, UB; Thomas, ML; Threlkeld, N | 1 |
Goldstein, E; Hoeprich, PD; Nolan, SM; Olson, DA | 1 |
Aziz, MT; Kumar, A | 1 |
Aoki, M; Isono, M; Kawashima, K; Kobayashi, T; Sawa, K; Ueno, K; Watanabe, K; Yamada, N | 1 |
Kasanen, A; Nikoskelainen, J; Saarimaa, H; Toivanen, P | 1 |
Allen, JC; Beam, TR | 1 |
Gerding, DN; Hall, WH; Kozak, AJ; Peterson, LR | 1 |
Jacks, TM; Judith, FR; Miller, BM; Schleim, KD | 1 |
Chrzanowska, I; Prusek, W; Springer, L; Zygmunt, A | 1 |
Ando-Kuroda, I; Murata, T; Sawai, T; Yamagishi, S | 1 |
Hori, M; Kumagai, K; Kurosu, Y; Toyonaga, Y | 1 |
Preheim, LC; Sanders, WE | 1 |
Böhni, E; Seiler, W; Stähelin, HB | 1 |
Crenshaw, CA; Glanges, E; McReynolds, DB; Webber, CE | 1 |
Lirussi, F; Martines, D; Nassuato, G; Okolicsanyi, L; Orlando, R; Venuti, M | 1 |
Green, RA | 1 |
Hirata, S; Hosoe, A; Nishimura, Y; Ohtani, T; Yamamoto, T; Yokoi, Y | 1 |
Calvert, CA | 1 |
Akagi, H; Hanaki, H; Hiramatsu, K; Hyodo, A; Masaru, Y; Otani, T | 1 |
Babálová, M; Blahová, J; Hupková, M; Králiková, K; Krcméry, V | 1 |
Kelly, JW; McAllister, CK; Schrank, JH | 1 |
Iguro, Y; Matsumoto, H; Miyazaki, T; Taira, A; Yamashita, M | 1 |
Erskine, RJ; McClure, KA; Nelson, RS; Spears, HJ; Tyler, JW; Wilson, RC | 1 |
Arstila, T; Auvinen, H; Huovinen, P | 1 |
Fujii, R; Meguro, H; Mori, A; Terashima, I | 1 |
Coulthard, M; Ehrett, S; Friedland, IR; Jafari, H; McCracken, GH; Olsen, K; Paris, M; Rinderknecht, S; Saxen, H | 1 |
Chardon, H; Farzaneh, S; Jarlier, V; Labia, R; Nicolas, MH; Paul, G; Poyart, C; Sirot, D; Sirot, J | 1 |
Edwards, JR; Nairn, K; Shepherd, GL | 1 |
Banke, S; Bruno, AM; Carlsson, M; Cronberg, S; Elmrud, H; Elowsson, S; Josefsson, K; Lindholm, AC; Montelius, H; Neringer, R | 1 |
Dalhoff, A; Nitsche, D; Oesser, S; Sack, M; Schulze, C | 1 |
Furuya, N; Hirakata, Y; Matsumoto, T; Tateda, K; Yamaguchi, K | 1 |
Bang, BK; Chang, YS; Choi, YJ; Kim, SY; Kim, YS; Lee, SH; Yang, CW | 1 |
Benjamin, A; Lozowy, C; Prichard, S; Tison, A; Usher, R | 1 |
Hashemi, FN; Hayden, MK; Matushek, MG; Miyashiro, D; Quinn, JP; Schiappa, DA; Smith, KY; Sullivan, J; Trenholme, GM; Weinstein, RA | 1 |
Goto, S; Matsunaga, T; Nagashima, M; Ogawa, M; Shimohira, H; Yoshida, T | 1 |
Ammons, WS; Leach, WJ; Lin, Y | 1 |
Czerwionka-Szaflarska, M; Sobkowiak, E | 1 |
Malnick, SD; Somin, M; Sthoeger, ZM; Zimchoni, O | 1 |
Bucklin, SE; Morrison, DC | 1 |
Bourlinou, PK; Karachalios, GN; Nasiopoulou, DD; Reppa, A | 1 |
Montagne, JP; Osika, E; Pointe, HD; Prudent, M; Sebbouh, D; Tournier, G | 1 |
Shinagawa, N | 1 |
Böttner, A; Levin, D; Saran, A; Shpigel, NY; Winkler, M; Ziv, G | 1 |
Crellin, J; Medeiros, AA | 1 |
Akino, E; Hiramatsu, K; Ito, T | 1 |
Farca, AM; Maffei, F; Piromalli, G; Re, G | 1 |
Schmid, P; Shpigel, NY | 1 |
Comis, SD; Hayward, TL; Osborne, MP; Stephen, J; Tarlow, MJ; Winter, AJ | 1 |
Alveyn, CG; Davis, AJ; Kolios, G; Robertson, DA | 1 |
Higami, S; Isshiki, G; Kawamura, T; Nishimoto, K; Ookita, A; Tsuruhara, T | 1 |
Bhachech, N; Bradford, PA; Bush, K; Jett, BD; Sahm, DF; Yang, Y | 1 |
Moland, ES; Sanders, CC; Thomson, KS | 1 |
Kessler, A; Nagar, H; Weiss, J | 1 |
Kubo, S; Moriguchi, N; Yagi, K; Yamamoto, T; Yoshioka, K | 1 |
Dohmen, K; Irie, K; Ishibashi, H; Miyamoto, Y; Onohara, S; Shimada, T; Shirahama, M | 1 |
Campbell, BG; Rosin, E | 1 |
Gniadkowski, M; Mikiewicz, B; Pałucha, A | 1 |
Bradford, PA; Bush, K; Goering, RV; Nathan, C; Quinn, JP; Weinstein, RA; Wiener, J | 1 |
Cid, D; De La Fuente, R; García, S; Orden, JA; Ruiz-Santa-Quiteria, JA | 1 |
Inamatsu, T | 1 |
Matsumoto, T | 1 |
Barbier, R; Chevrel, J; Mondeteguy, J | 1 |
Gulzar, GM; Javid, G; Khan, BA; Khan, MA; Shah, AH | 1 |
Bérard, I; Caroff, N; Espaze, E; Reynaud, A; Richet, H | 1 |
Choe, KW; Kim, J; Kim, JW; Kwon, Y; Lee, JH; Lyu, S; Pai, H | 1 |
Bedford, H; Harvey, D; Holt, DE | 1 |
Bradford, PA; Fingerman, IM; Petersen, PJ; White, DG | 1 |
Corso, A; Galas, M; Rossi, A; Soloaga, R; Tokumoto, M | 1 |
Hoberman, A; Wald, ER | 1 |
Igarashi, T; Inatomi, J; Iwata, T; Katayama, H; Takamizawa, M; Wake, A | 1 |
Aguilar, C; Ayala, G; Estrada, MA; Garza-Ramos, U; Lara-Lemus, R; Ledezma, L; Silva, J | 1 |
Chastagner, P; Eyer, D; Lozniewski, A; Plesiat, P; Plouvier, E; Sommelet, D | 1 |
Cisowska, A; Doroszkiewicz, W; Jankowski, S | 1 |
Fanos, V; Mangiarotti, P; Pizzini, C | 1 |
Habeeb, RL; Jelacic, S; Tarr, PI; Watkins, SL; Wong, CS | 1 |
Martín, M; Mateu, E | 1 |
Magadle, R; Weiner, P; Zamir, D | 1 |
Wong, EB | 1 |
Boylan, CJ; Contag, PR; Foley, JW; Iversen, PW; Jenkins, DE; LeTourneau, DL; McMillian, CL; Parr, TR; Rocchetta, HL | 1 |
Crichton, M; Gibb, AP | 1 |
Baquero, F; Cantón, R; Coque, TM; Oliver, A; Pérez-Díaz, JC | 1 |
Iwatsubo, E; Kawakami, Y; Manabe, N; Matsumoto, T; Takahashi, K | 1 |
Chi, CL; Yeh, LL | 1 |
Orrett, FA; Shurland, SM | 1 |
Banke, S; Bergman, B; Boman, H; Cronberg, S; Eilard, T; Elbel, E; Hugo-Persson, M; Johansson, E; Kuylenstierna, N; Lanbeck, P; Lindblom, A; Paulsen, O; Schönbeck, C; Walder, M; Wieslander, P | 1 |
García-Rodríguez, JA; Muñoz Bellido, JL | 1 |
Hamilton-Miller, JM | 1 |
Bañón Pérez, V; López Cubillana, P; Nicolás Torralba, JA; Pérez Albacete, M; Server Pastor, G; Valdelvira Nadal, P | 1 |
Bush, K; Hindler, J; Lee, N; Loeloff, M; Pegues, DA; Queenan, AM; Quinn, JP; Wong-Beringer, A | 1 |
Bearden, DT; Einhorn, AE; Neuhauser, MM; Pendland, SL; Quinn, JP | 1 |
França, A; Giordano, HM; Sevá-Pereira, T; Soares, EC | 1 |
Ljungberg, B; Nilsson-Ehle, I; Nyhlén, A; Odenholt, I | 1 |
Bisson, G; Edelstein, PH; Fishman, NO; Lautenbach, E; Patel, JB | 1 |
Aliaga, R; Mirelis, B; Miró, E; Navarro, F; Prats, G; Sabaté, M; Vergés, C | 1 |
Cajigas, J; Gesser, RM; Imbeault, D; Jasovich, A; Jiang, Q; Jimenez-Cruz, F; Woods, GL | 1 |
Hirata, Y; Kato, M; Matsuzaki, M; Nakumura, K; Tado, N | 1 |
Ninane, G | 1 |
Davies, BI | 1 |
Lipman, RP; Silverman, W | 1 |
Ansbacher, R; Davison, BL; Lett, WJ; Otterson, WN | 1 |
Greenwood, D; O'Grady, F | 2 |
Naumann, P | 2 |
Berman, SJ; Boughton, WH; Siemsen, AW; Sugihara, JG; Wong, EG | 1 |
Kunst, MW; Mattie, H | 2 |
Hoyme, U; Madsen, PO | 1 |
Gentry, LO | 1 |
Beck, H; Marre, R; Sack, K; Züllich, B | 1 |
Courtis, GR; Fowler, R; Hewstone, AS; Raine, PA; Ritchie, MA | 1 |
Goldberger, MJ; Neu, HC; Parry, MF | 1 |
Imashiro, Y; Kuritani, M; Minamida, I; Numata, M; Yamaoka, M | 1 |
Minamida, I; Miyawaki, T; Numata, M; Shiraishi, M; Yamaoka, M | 1 |
Akimoto, H; Kida, M; Minamida, I; Miyawaki, T; Naito, K; Numata, M; Shiraishi, M; Yamaoka, M | 1 |
Naumann, P; Rosin, H | 2 |
Kunst, MW; Mattie, H; van Furth, R | 1 |
Akita, H; Hara, N; Hotta, M; Ichihashi, Y; Izeki, M; Morikawa, Y; Nanri, S; Osano, M; Sunakawa, K; Yamashita, N | 1 |
Fujiwara, T; Haruta, T; Kobayashi, Y; Kuroki, S; Morikawa, Y | 1 |
Freiesleben, H; Henkel, W; Marre, R; Sack, K | 1 |
Quante, T; Ritzerfeld, W | 1 |
Hitzenberger, G | 1 |
Ughy, E | 1 |
Hutschenreiter, G; Klippel, KF | 1 |
Mickal, A; Morris, GB; Zehnder, JL | 1 |
Benner, EJ; Bush, WG; Kranhold, JF | 1 |
Actor, P; Berges, DA; Davis, LD; Dietz, EM; Dunn, GL; Hoover, JR; Jakas, DR; Taggart, JJ; Uri, JV; Weisbach, JA; Yim, N | 1 |
Fukase, H; Hasegawa, T; Hatano, K; Iwasaki, H; Yoneda, M | 1 |
Actor, P; Guarini, JR; Phillips, L; Uri, JV; Weisbach, JA | 1 |
Actor, P; DeMarinis, RM; Guarini, JR; Hoover, JR; Lam, LL; Phillips, L; Uri, JV; Weisbach, JA | 1 |
Berges, DA | 1 |
Clarke, TK; Low, RA | 1 |
Asmal, AC; Bima, B; Leary, WP; Lockett, CJ | 1 |
Brogard, JM; Lavillaureix, J; Ledoux, F; Pinget, M | 1 |
Böttzauw, JL; Fuglsang, G | 1 |
Mattie, H; Sekh, BA; van Ogtrop, ML; van Strijen, E | 1 |
Cleary, TG; Contrini, M; Devoto, S; Gómez, H; Liu, H; López, E; Murray, BE; Prado, D; Woloj, M | 1 |
Hopkins, JA; Lami, JL; Wilson, SE | 1 |
Ajiki, Y; Koga, T; Ohya, S; Takenouchi, T; Ueno, K; Watanabe, K; Yasuda, H | 1 |
Jafari, HS; McCracken, GH; Ramilo, O; Sáez-Llorens, X; Shelton, SL | 1 |
Hara, R; Nagano, N; Satoh, M | 1 |
Lionell, C; Magni, L | 1 |
Brus-Weijer, L; Krul, AM; Mattie, H; van Dokkum, AM; van Strijen, E | 1 |
Albrecht, HA; Beskid, G; Chan, KK; Christenson, JG; Cleeland, R; Deitcher, KH; Georgopapadakou, NH; Keith, DD; Pruess, DL; Sepinwall, J | 1 |
Inouye, S; Iwamatsu, K; Katano, K; Kondo, S; Nakabayashi, S; Ogino, H; Tsuruoka, T; Yoshida, T | 1 |
Inouye, S; Iwamatsu, K; Katano, K; Kondo, S; Nakabayashi, S; Ogino, H; Shibahara, S; Tsuruoka, T; Yoshida, T | 1 |
Carmer, SG; Evans, RA; Kratzer, DD; Paulissen, JB; Yancey, RJ | 1 |
Clark, N; Cooksey, R; Gay, E; Swenson, J; Thornsberry, C | 1 |
Cheadle, WG; Hershman, MJ; Mays, B; Short, L | 1 |
Guiot, HF; Hazekamp-van Dokkum, AM; Mattie, H; van Furth, R; van Ogtrop, ML; van Strijen, E | 1 |
Inouye, S; Kondo, S; Kudo, T; Murai, Y; Okonogi, T; Shibahara, S; Yoshida, T | 1 |
Isert, D; Klesel, N; Limbert, M; Markus, A; Schrinner, E; Seibert, G | 1 |
Beale, AS; Gisby, J | 1 |
Janssens, J; Kauer, FM; van de Wiel, HB; van Saene, HK; Wijma, J | 1 |
Inoue, M; Mitsuhashi, S; Utsui, Y | 1 |
Jones, CW; Scher, KS; Wroczynski, AF | 1 |
Brister, S; Brown, RA; Chiu, RC; Fradet, G; Mulder, DS; Prentis, J; Richards, GK | 1 |
Haruta, T; Kobayashi, Y; Kuroki, S; Okura, KE; Yamamoto, H | 1 |
Inouye, S; Ito, T; Kazuno, Y; Murata, S; Shomura, T; Yoshida, T | 1 |
Phillips, L; Pitkin, DH; Uri, JV | 1 |
Jones, CW; Scher, KS | 1 |
Kida, K; Nakazawa, S; Otsuki, M; Sakamichi, T; Tanaka, S | 1 |
Bodey, GP; Horikoshi, N; Rodriguez, V; Valdivieso, M | 1 |
Kurashige, S; Mitsuhashi, S; Ono, H; Yaginuma, S | 1 |
Schwab, W | 1 |
Kulikova, NN; Minasova, GS | 1 |
Lang, GR; Levin, S | 1 |
Boxerbaum, B | 1 |
Henning, C; Kallings, LO; Lidman, K; Sterner, G | 1 |
Brumfitt, W; Pursell, R | 1 |
Watson, CE | 1 |
Dunn, GL; Guarini, JR; Hoover, JR; Jakas, DR; Lam, LL; Phillips, L; Taggart, JJ | 1 |
Murakawa, T; Nishida, M | 1 |
Eudy, WW | 1 |
Steinitz, H | 1 |
Ellorhaoui, M; Tauchnitz, C | 1 |
Haschek, H; Porpaczy, P; Schmidt, W | 1 |
Brunner, H; Gelzer, J; Hess, R; Konopka, EA; Kradolfer, F; Sackmann, W; Zak, O | 1 |
Amson, K; Maurice, PN; Riess, W; Welke, A | 1 |
Gómez Francisco, A | 1 |
Minakawa, M; Miyoshi, K; Seika, K; Sugiyama, Y; Yamaji, K | 1 |
Nakazawa, S; Tsuji, A; Tsujimoto, S; Watanaba, Y | 1 |
Fujisawa, K; Kawaguchi, H; Naito, T; Nakagawa, S; Takahashi, K | 1 |
Beck, D; Siegenthaler, W | 1 |
Kawabe, H; Nakazawa, S; Nishino, T; Okubo, S; Ono, H | 1 |
Bieder, L | 1 |
Kawamura, J | 1 |
Guttmann, D | 1 |
Kirby, SM; O'Callaghan, CH | 1 |
Schwarz, H; Wise, HA | 1 |
Marr, JJ | 1 |
Brewin, AW; Bruyn, HB | 1 |
Lüthy, R; Siegenthaler, G; Siegenthaler, W; Vetter, H | 1 |
Saubermann, G | 1 |
Dennis, M; Hastings, HK; Rasch, JR | 1 |
Daikos, GK; Kontomichalou, P; Tsekos, G | 1 |
Nakagawa, K; Shoji, F | 1 |
Brown, D; Graham, R; Landes, RR; McCormick, B; Melnick, I | 1 |
21 review(s) available for cephalosporin c and Escherichia coli Infections
Article | Year |
---|---|
High level of colonization with third-generation cephalosporin-resistant Enterobacterales in African community settings, Ghana.
Topics: beta-Lactamases; Cephalosporins; Cross-Sectional Studies; Escherichia coli; Escherichia coli Infections; Ghana; Humans; Klebsiella pneumoniae | 2023 |
Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing | 2023 |
Extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae: critical tools for antibiotic resistance pattern.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2017 |
Extended-spectrum β-lactamase-producing Escherichia coli isolated from poultry: a review of current problems, illustrated with some laboratory findings.
Topics: Animals; beta-Lactamases; Cephalosporins; Chickens; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Multilocus Sequence Typing; Plasmids; Poultry Diseases; Sequence Analysis, DNA; Virulence; Zoonoses | 2014 |
Escherichia coli sequence type 131: epidemiology and challenges in treatment.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; United States | 2014 |
Extended-spectrum β-lactamase infections during pregnancy: a growing threat.
Topics: Adult; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Microbial Sensitivity Tests; Pregnancy; Pregnancy Complications, Infectious; Urinary Tract Infections | 2015 |
Addressing the challenge of extended-spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; Urinary Tract Infections | 2009 |
Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Humans; Microbial Sensitivity Tests | 2012 |
Extended-spectrum beta-lactamases and clinical outcomes: current data.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella; Klebsiella Infections; Treatment Outcome | 2006 |
[Etiological profile of urinary tract infections and antimicrobial susceptibility of urinary pathogens].
Topics: Adult; Age Factors; Aminoglycosides; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Bacteria; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Consensus Development Conferences as Topic; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Evidence-Based Medicine; Fosfomycin; Hospitalization; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Risk Factors; Spain; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2007 |
[The pathophysiology and treatment of severe intra-abdominal abscess].
Topics: Abdominal Abscess; Cefazolin; Cephalosporins; Enterococcus faecalis; Escherichia coli Infections; Gram-Positive Bacterial Infections; Humans; Intestines; Penicillins; Peritoneal Diseases; Piperacillin | 1996 |
[Contribution to the treatment of acute bovine mastitis with cefquinome].
Topics: Animals; Cattle; Cephalosporins; Clinical Trials as Topic; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Mastitis, Bovine; Multicenter Studies as Topic | 1997 |
[Sepsis by Escherichia coli].
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Diagnosis, Differential; Escherichia coli; Escherichia coli Infections; Humans | 1999 |
[Acute cystitis].
Topics: Acute Disease; Anti-Infective Agents; Cephalosporins; Cystitis; Escherichia coli Infections; Fluoroquinolones; Humans; Mycoplasma hominis; Mycoplasma Infections; Staphylococcal Infections; Ureaplasma Infections | 1999 |
Bacterial meningitis in the newborn: a prospective study of mortality and morbidity.
Topics: Cephalosporins; Escherichia coli Infections; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Meningitis, Bacterial; Morbidity; Prospective Studies; Streptococcal Infections; Streptococcus agalactiae | 1999 |
Antibiotic prophylaxis in children with relapsing urinary tract infections: review.
Topics: Anti-Infective Agents; Anti-Infective Agents, Urinary; Antibiotic Prophylaxis; Cephalosporins; Child; Escherichia coli Infections; Fluoroquinolones; Humans; Nitrofurantoin; Penicillins; Recurrence; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract; Urinary Tract Infections | 2000 |
Oral cephalosporins in uncomplicated urinary tract infections.
Topics: Administration, Oral; Adolescent; Adult; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Urinary Tract Infections | 2000 |
Overview of cefixime use in community-acquired infections.
Topics: Cefixime; Cephalosporins; Community-Acquired Infections; Escherichia coli Infections; Female; Haemophilus Infections; Humans; Male; Neisseriaceae Infections; Patient Compliance; Respiratory Tract Infections; Staphylococcal Infections; Streptococcal Infections; Urinary Tract Infections | 2000 |
[Sulfonamide and antibiotic usage in otolaryngology (author's transl)].
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Child; Chloramphenicol; Erythromycin; Escherichia coli Infections; Gentamicins; Humans; Infant; Klebsiella Infections; Microbial Sensitivity Tests; Neomycin; Otorhinolaryngologic Diseases; Penicillins; Pneumococcal Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Streptococcal Infections; Streptomycin; Sulfonamides; Tetracycline; Tracheoesophageal Fistula | 1974 |
Diagnosis and treatment of urinary tract infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteriuria; Cephalosporins; Chloramphenicol; Culture Media; Cycloserine; Cystitis; Erythromycin; Escherichia coli Infections; Gentamicins; Hemagglutination Tests; Humans; Kanamycin; Methenamine; Methods; Nalidixic Acid; Nitrofurantoin; Penicillins; Polymyxins; Pseudomonas Infections; Pyelonephritis; Rifampin; Streptomycin; Sulfonamides; Tetracycline; Trimethoprim; Urinary Tract Infections | 1971 |
[Clinical picture and antibiotic therapy of bacterial septicemias in internal medicine].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Chloramphenicol; Drug Combinations; Endocarditis, Bacterial; Enterobacter; Escherichia coli Infections; Germany, West; Humans; Klebsiella Infections; Penicillins; Proteus Infections; Pseudomonas Infections; Sepsis; Staphylococcal Infections | 1971 |
53 trial(s) available for cephalosporin c and Escherichia coli Infections
Article | Year |
---|---|
Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing | 2023 |
Antibimicrobial Susceptibility of Trimethoprim-Sulfamethoxazole and 3rd-Generation Cephalosporin-Resistant
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Male; Meropenem; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
Short communication: Longitudinal study of quarter-level somatic cell responses after naturally occurring, nonsevere clinical mastitis diagnosed as culture negative, or caused by Escherichia coli or Klebsiella pneumoniae, and randomly assigned to a no-tre
Topics: Animals; Anti-Bacterial Agents; Cattle; Cell Count; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Longitudinal Studies; Mammary Glands, Animal; Mastitis, Bovine; Milk | 2019 |
Quantitative dynamics of Salmonella and E. coli in feces of feedlot cattle treated with ceftiofur and chlortetracycline.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Cattle; Cephalosporins; Chlortetracycline; Colony Count, Microbial; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Foodborne Diseases; Longitudinal Studies; Male; Microbial Sensitivity Tests; Prevalence; Red Meat; Salmonella; Salmonella Infections, Animal | 2019 |
A non-inferiority study evaluating a new extended-release preparation of tilmicosin injected subcutaneously vs. ceftiofur administered intramammary, as dry-cow therapy in Holstein Friesian cows.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Cephalosporins; Delayed-Action Preparations; Escherichia coli; Escherichia coli Infections; Female; Injections, Subcutaneous; Mastitis, Bovine; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus; Tylosin | 2020 |
Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Genotype; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Republic of Korea; Tazobactam; Urinary Tract Infections | 2017 |
Normal milk microbiome is reestablished following experimental infection with Escherichia coli independent of intramammary antibiotic treatment with a third-generation cephalosporin in bovines.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Mammary Glands, Animal; Mastitis, Bovine; Microbiota; Milk | 2017 |
Comparative plasma and interstitial fluid pharmacokinetics and tissue residues of ceftiofur crystalline-free acid in cattle with induced coliform mastitis.
Topics: Animals; Biological Availability; Cattle; Cephalosporins; Escherichia coli Infections; Female; Mastitis, Bovine; Tissue Distribution | 2018 |
Negatively controlled, randomized clinical trial to evaluate intramammary treatment of nonsevere, gram-negative clinical mastitis.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Dairying; Escherichia coli; Escherichia coli Infections; Farms; Female; Klebsiella Infections; Klebsiella pneumoniae; Lactation; Mammary Glands, Animal; Mastitis, Bovine; Milk; Random Allocation | 2019 |
Randomized noninferiority clinical trial evaluating 3 commercial dry cow mastitis preparations: I. Quarter-level outcomes.
Topics: Animals; Anti-Bacterial Agents; California; Cattle; Cephalosporins; Cephapirin; Dihydrostreptomycin Sulfate; Escherichia coli Infections; Female; Lactation; Mastitis, Bovine; Milk; Minnesota; New York; Penicillin G; Staphylococcal Infections; Streptococcal Infections; Wisconsin | 2013 |
Shedding of cephalosporin resistant Escherichia coli in pigs from conventional farms after early treatment with antimicrobials.
Topics: Animal Husbandry; Animals; Anti-Bacterial Agents; Bacterial Shedding; Cephalosporin Resistance; Cephalosporins; Disaccharides; Escherichia coli; Escherichia coli Infections; Feces; Heterocyclic Compounds; Risk Factors; Spain; Swine; Swine Diseases | 2016 |
Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Double-Blind Method; Escherichia coli; Escherichia coli Infections; Female; Genotype; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Meropenem; Metronidazole; Middle Aged; Penicillanic Acid; Tazobactam; Thienamycins; Treatment Outcome; Urinary Tract Infections; Young Adult | 2017 |
Efficacy and safety of 3 day versus 7 day cefditoren pivoxil regimens for acute uncomplicated cystitis: multicentre, randomized, open-label trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Citrobacter koseri; Cystitis; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle Aged; Staphylococcus saprophyticus; Young Adult | 2017 |
Prophylactic cefdinir for pediatric cases of complicated urinary tract infection.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefdinir; Cephalosporins; Cohort Studies; Drug Administration Schedule; Enterococcus faecalis; Escherichia coli Infections; Female; Gram-Positive Bacterial Infections; Humans; Infant; Male; Secondary Prevention; Treatment Outcome; Urinary Tract Infections | 2011 |
Randomized clinical trial to evaluate the efficacy of a 5-day ceftiofur hydrochloride intramammary treatment on nonsevere gram-negative clinical mastitis.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Klebsiella Infections; Mammary Glands, Animal; Mastitis, Bovine | 2011 |
Efficacy of systemic ceftiofur as a therapy for severe clinical mastitis in dairy cattle.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Clindamycin; Escherichia coli; Escherichia coli Infections; Female; Injections, Intramuscular; Klebsiella; Klebsiella Infections; Mastitis, Bovine; Milk | 2002 |
Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data.
Topics: Adult; Aged; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Enterobacteriaceae Infections; Ertapenem; Escherichia coli Infections; Humans; Lactams; Middle Aged; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome; Urinary Tract Infections | 2003 |
Use of cefquinome for prevention and treatment of bovine endometritis.
Topics: Animals; Cattle; Cattle Diseases; Cephalosporins; Endometritis; Escherichia coli Infections; Female; Injections, Intramuscular; Severity of Illness Index; Treatment Outcome | 2003 |
Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Ceftazidime; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Species Specificity; Treatment Outcome | 2006 |
Efficacy and safety of cefovecin (Convenia) for the treatment of urinary tract infections in dogs.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cephalosporins; Dog Diseases; Dogs; Double-Blind Method; Escherichia coli Infections; Europe; Female; Injections, Subcutaneous; Male; Treatment Outcome; Urinary Tract Infections | 2007 |
Efficacy and safety of cefovecin for the treatment of urinary tract infections in cats.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Cephalosporins; Double-Blind Method; Escherichia coli Infections; Female; Injections, Subcutaneous; Male; Safety; Treatment Outcome; Urinary Tract Infections | 2008 |
Double-blind study to compare the selection of antibiotic resistance by amoxycillin or cephradine in the commensal flora.
Topics: Acute Disease; Aged; Amoxicillin; Cephalosporins; Cephradine; Clinical Trials as Topic; Double-Blind Method; Escherichia coli; Escherichia coli Infections; Female; Humans; Intestines; Male; Middle Aged; Penicillin Resistance; Random Allocation; Saliva; Skin; Urinary Tract Infections | 1983 |
[Septicemia and focal infection. Efficacy of moxalactam. Results of the cooperative study conducted in France].
Topics: Adult; Bacterial Infections; Cephalosporins; Cephamycins; Clinical Trials as Topic; Escherichia coli Infections; Female; Focal Infection; France; Humans; Male; Moxalactam; Sepsis | 1983 |
Comparative study of the effects of ceftazidime compared with tobramycin plus cefamandole in the treatment of gall bladder empyema.
Topics: Adult; Cefamandole; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Empyema; Escherichia coli Infections; Female; Gallbladder Diseases; Humans; Male; Prospective Studies; Tobramycin | 1983 |
A comparison of ceftazidime and tobramycin in the treatment of complicated urinary tract infections.
Topics: Adult; Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Escherichia coli Infections; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pseudomonas Infections; Random Allocation; Tobramycin; Urinary Tract Infections | 1983 |
Clinical and bacteriological results in urinary tract infections with single-dose Ro 13-9904 (Rocephin).
Topics: Aged; Bacterial Infections; Ceftriaxone; Cephalosporins; Clinical Trials as Topic; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Tobramycin; Urinary Tract Infections | 1981 |
A prospective, randomized, double blind study of preventive cefamandole therapy in patients at high risk for undergoing cholecystectomy.
Topics: Adolescent; Adult; Aged; Bile; Cefamandole; Cephalosporins; Cephalothin; Cholecystectomy; Double-Blind Method; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Premedication; Prospective Studies; Random Allocation; Risk; Sepsis; Surgical Wound Infection | 1981 |
Randomized comparison of cefepime and ceftazidime for treatment of hospitalized patients with gram-negative bacteremia.
Topics: Aged; Bacteremia; Cefepime; Ceftazidime; Cephalosporins; Drug Eruptions; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Safety | 1995 |
[Postoperative infections in cardiovascular surgery: what is an appropriate prophylactic administration of antibiotics?].
Topics: Aged; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cephalosporins; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Postoperative Care; Premedication; Staphylococcal Infections; Surgical Wound Infection | 1995 |
Ampicillin plus mecillinam vs. cefotaxime/cefadroxil treatment of patients with severe pneumonia or pyelonephritis: a double-blind multicentre study evaluated by intention-to-treat analysis.
Topics: Amdinocillin; Ampicillin; Cefadroxil; Cefotaxime; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Escherichia coli Infections; Female; Fever; Humans; Male; Middle Aged; Penicillins; Pneumonia, Bacterial; Pyelonephritis | 1995 |
[Evaluation of the effectiveness of ceftazidime in treatment of nosocomial infections in children].
Topics: Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Escherichia coli Infections; Humans; Infant; Pneumonia; Urinary Tract Infections | 1996 |
Treatment of acute biliary tract infections with ofloxacin: a randomized, controlled clinical trial.
Topics: Anti-Infective Agents; Bacteremia; Ceftriaxone; Cephalosporins; Cholangitis; Cholecystitis; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Ofloxacin; Phlebitis | 1996 |
Antibiotic prophylaxis for ERCP: a comparison of oral ciprofloxacin with intravenous cephazolin in the prophylaxis of high-risk patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bile; Cefazolin; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Ciprofloxacin; Diarrhea; Escherichia coli; Escherichia coli Infections; Female; Humans; Injections, Intravenous; Male; Microbial Sensitivity Tests; Risk Factors; Sepsis; Streptococcal Infections; Streptococcus; Treatment Outcome; Urticaria | 1998 |
Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ceftibuten; Cefuroxime; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Injections, Intravenous; Male; Middle Aged; Norfloxacin; Prospective Studies; Pyelonephritis; Recurrence; Treatment Outcome | 2001 |
Five days of ceftriaxone to treat spontaneous bacterial peritonitis in cirrhotic patients.
Topics: Adolescent; Adult; Aged; Ceftriaxone; Cephalosporins; Drug Administration Schedule; Escherichia coli; Escherichia coli Infections; Female; Hospital Mortality; Humans; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Peritonitis | 2002 |
A prospective, multicenter, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults.
Topics: Administration, Oral; Adult; Age Factors; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Double-Blind Method; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Infusions, Intravenous; Lactams; Prospective Studies; Treatment Outcome; Urinary Tract Infections | 2002 |
Cephradine and ampicillin in urinary infection.
Topics: Adult; Ampicillin; Cephalosporins; Cephradine; Clinical Trials as Topic; Escherichia coli Infections; Female; Humans; Proteus Infections; Staphylococcal Infections; Urinary Tract Infections | 1977 |
An evaluation of cephradine oral suspension in the treatment of bacterial infections of infants and children.
Topics: Administration, Oral; Bacterial Infections; Cephalexin; Cephalosporins; Cephradine; Child; Child, Preschool; Clinical Trials as Topic; Dermatitis; Double-Blind Method; Escherichia coli Infections; Female; Haemophilus Infections; Humans; Infant; Infant, Newborn; Male; Pneumococcal Infections; Proteus Infections; Respiratory Tract Infections; Staphylococcal Infections; Streptococcal Infections; Streptococcus pyogenes; Urinary Tract Infections | 1977 |
Prophylactic antibiotics for women undergoing vaginal hysterectomy.
Topics: Adult; Aged; Cefazolin; Cephaloridine; Cephalosporins; Clinical Trials as Topic; Escherichia coli Infections; Female; Humans; Hysterectomy; Hysterectomy, Vaginal; Middle Aged; Preoperative Care; Prospective Studies; Surgical Wound Infection | 1977 |
[Microbiological and pharmacological parameters as evaluation criteria for chemotherapeutics].
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Biopharmaceutics; Cephalosporins; Clinical Trials as Topic; Disease Models, Animal; Escherichia coli Infections; Evaluation Studies as Topic; Gentamicins; Humans; Mice; Microbial Sensitivity Tests; Penicillins; Streptococcal Infections; Streptococcus pyogenes | 1977 |
Cefamandole and cefazolin in the therapy of complicated urinary tract infections.
Topics: Aged; Cefamandole; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli Infections; Humans; Klebsiella Infections; Male; Proteus Infections; Staphylococcal Infections; Streptococcal Infections; Urinary Tract Infections | 1978 |
[Clinical experience with cephradine].
Topics: Adolescent; Adult; Aged; Cephalosporins; Cephradine; Clinical Trials as Topic; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Respiratory Tract Infections; Staphylococcal Infections; Surgical Wound Infection; Urinary Tract Infections | 1977 |
[Cephradine in urology].
Topics: Adolescent; Adult; Aged; Cephalosporins; Cephradine; Clinical Trials as Topic; Drug Evaluation; Enterococcus faecalis; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Streptococcal Infections; Urinary Tract Infections | 1977 |
Cephradine in urinary tract infections: a double-blind comparison with ampicillin.
Topics: Adolescent; Adult; Aged; Ampicillin; Cephalosporins; Cephradine; Clinical Trials as Topic; Escherichia coli; Escherichia coli Infections; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Proteus Infections; Urinary Tract Infections | 1975 |
A preliminary report on cephradine.
Topics: Administration, Oral; Adolescent; Adult; Aged; Candidiasis; Cephalosporins; Cephradine; Escherichia coli Infections; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Proteus Infections; Pseudomonas Infections; Urinary Tract Infections | 1975 |
Ceftibuten and trimethoprim-sulfamethoxazole for treatment of Shigella and enteroinvasive Escherichia coli disease.
Topics: Adolescent; Ceftibuten; Cephalosporins; Child; Child, Preschool; Dysentery, Bacillary; Escherichia coli Infections; Humans; Infant; Prospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
Adjunctive antimicrobials in surgery of soft tissue infections: evaluation of cephalosporins and carbapenems.
Topics: Adult; Aged; Bacterial Infections; Carbapenems; Cefmetazole; Cefoperazone; Cefotetan; Cefoxitin; Cephalosporins; Drug Combinations; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Remission Induction; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections; Thienamycins | 1991 |
Antibiotics and suction drainage as prophylaxis in vaginal and abdominal hysterectomy.
Topics: Abscess; Bacteroides Infections; Cefuroxime; Cephalosporins; Cystitis; Escherichia coli Infections; Female; Humans; Hysterectomy; Hysterectomy, Vaginal; Metronidazole; Premedication; Prospective Studies; Random Allocation; Suction; Surgical Wound Infection | 1987 |
Double-blind trial to compare ampicillin, cephalexin, co-trimoxazole, and trimethoprim in treatment of urinary infection.
Topics: Ampicillin; Bacteriuria; Cephalexin; Cephalosporins; Drug Hypersensitivity; Escherichia coli Infections; Female; Folic Acid Antagonists; Humans; Pregnancy; Pregnancy Complications, Infectious; Pyrimidines; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections | 1972 |
[Results of clinical trials with cephadrine in children].
Topics: Adolescent; Bacterial Infections; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Cyclohexanes; Diarrhea; Drug Evaluation; Enterobacteriaceae Infections; Escherichia coli Infections; Haemophilus Infections; Hematoma; Humans; Infant; Klebsiella Infections; Leukocytosis; Nausea; Osteomyelitis; Otitis; Pharyngitis; Pneumococcal Infections; Pneumonia; Proteus Infections; Pyelonephritis; Pyoderma; Sepsis; Sinusitis; Staphylococcal Infections; Streptococcal Infections; Time Factors; Vomiting | 1973 |
[Cefazolin. 3. Double blind controlled trial in urinary tract infections].
Topics: Adult; Cephaloridine; Cephalosporins; Clinical Trials as Topic; Enterococcus faecalis; Escherichia coli Infections; Female; Humans; Injections, Intravenous; Klebsiella pneumoniae; Microbial Sensitivity Tests; Micrococcus; Middle Aged; Proteus Infections; Proteus mirabilis; Proteus vulgaris; Pseudomonas Infections; Staphylococcal Infections; Streptococcal Infections; Urinary Tract Infections | 1972 |
Clinical evaluation of cephaloridine.
Topics: Cephaloridine; Cephalosporins; Clinical Trials as Topic; Escherichia coli Infections; Humans; Infections | 1965 |
Clinicolaboratory experience with cephaloridine.
Topics: Cephaloridine; Cephalosporins; Clinical Trials as Topic; Enterobacteriaceae; Escherichia coli Infections; Humans; In Vitro Techniques; Infections; Pyelonephritis; Staphylococcal Infections | 1965 |
560 other study(ies) available for cephalosporin c and Escherichia coli Infections
Article | Year |
---|---|
Progressive Development of Cefiderocol Resistance in Escherichia coli During Therapy is Associated With an Increase in blaNDM-5 Copy Number and Gene Expression.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefiderocol; Cephalosporins; DNA Copy Number Variations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Expression; Humans; Microbial Sensitivity Tests; Plasmids; RNA, Messenger | 2022 |
Validation of Selective Agars for Detection and Quantification of Escherichia coli Strains Resistant to Critically Important Antimicrobials.
Topics: Agar; Animals; Anti-Bacterial Agents; Cephalosporins; Diagnostic Tests, Routine; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Humans; Livestock; Microbial Sensitivity Tests | 2021 |
Population Dynamics of Escherichia coli Causing Bloodstream Infections over Extended Time Periods.
Topics: Anti-Bacterial Agents; Bacteremia; Canada; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; England; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Humans; Population Dynamics | 2021 |
Clinical characteristics of bacteremic urinary tract infection due to third-generation cephalosporin-resistant Escherichia coli in children.
Topics: Anti-Bacterial Agents; beta-Lactamases; Case-Control Studies; Cephalosporins; Child; Escherichia coli; Escherichia coli Infections; Humans; Urinary Tract Infections | 2022 |
Epidemiology and molecular characterization of fecal carriage of third-generation cephalosporin-resistant Enterobacterales among elderly residents in Japan.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Feces; Humans; Japan | 2022 |
Phenotypic and Genotypic Assessment of Antimicrobial Resistance in Escherichia coli from Australian Cattle Populations at Slaughter.
Topics: Animals; Anti-Bacterial Agents; Australia; Cattle; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Fluoroquinolones; Microbial Sensitivity Tests | 2022 |
Third-generation cephalosporin (3GC) resistance and its association with Extra-intestinal pathogenic Escherichia coli (ExPEC). Focus on broiler carcasses.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Chickens; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli | 2022 |
UK dogs eating raw meat diets have higher risk of Salmonella and antimicrobial-resistant Escherichia coli faecal carriage.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Diet; Dogs; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Meat; Microbial Sensitivity Tests; Salmonella; United Kingdom | 2022 |
Correlation between antibiotic consumption and the occurrence of multidrug-resistant organisms in a Malaysian tertiary hospital: a 3-year observational study.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Inappropriate Prescribing; Klebsiella; Klebsiella Infections; Malaysia; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Tertiary Care Centers | 2022 |
Topics: Animals; Anti-Bacterial Agents; Bacteriophages; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Phage Therapy | 2022 |
Impact of Acquired Broad-Spectrum β-Lactamases on Susceptibility to Cefiderocol and Newly Developed β-Lactam/β-Lactamase Inhibitor Combinations in Escherichia coli and Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Escherichia coli; Escherichia coli Infections; Humans; Lactams; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2022 |
Antibiotic resistance pattern and molecular detection of ESBL-associated genes in E. coli from surface and wastewater of Islamabad capital territory, Pakistan.
Topics: Anti-Infective Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Pakistan; Wastewater; Water | 2022 |
Cefixime and cefixime-clavulanate for screening and confirmation of extended-spectrum beta-lactamases in Escherichia coli.
Topics: Adolescent; Adult; Aged; beta-Lactamases; Cefixime; Cephalosporins; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2022 |
External validation of WGS-based antimicrobial susceptibility prediction tools, KOVER-AMR and ResFinder 4.1, for Escherichia coli clinical isolates.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests | 2022 |
Plasmid and chromosomal copies of bla
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Chromosomes; Escherichia coli; Escherichia coli Infections; Plasmids | 2022 |
Short- and long-term mortality in patients with urosepsis caused by Escherichia coli susceptible and resistant to 3rd generation cephalosporins.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Retrospective Studies; Risk Factors; Urinary Tract Infections | 2022 |
Occurrence and potential transmission of extended-spectrum beta-lactamase-producing extraintestinal pathogenic and enteropathogenic Escherichia coli in domestic dog faeces from Minnesota.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Dog Diseases; Dogs; Enteropathogenic Escherichia coli; Escherichia coli Infections; Feces; Humans; Minnesota; Pets; Quinolones; Sulfonamides; Tetracyclines | 2022 |
Resistance to extended-spectrum cephalosporins in Escherichia coli and Salmonella enterica isolated from food-producing animals: Ecological study from selected national surveillance programs.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Humans; Salmonella enterica | 2022 |
Molecular ecology and risk factors for third-generation cephalosporin-resistant Escherichia coli carriage by dogs living in urban and nearby rural settings.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cattle; Cephalosporins; Dogs; Escherichia coli; Escherichia coli Infections; Humans; Phylogeny; Risk Factors | 2022 |
Extended Spectrum β-Lactamase Activity and Cephalosporin Resistance in Escherichia coli from U.S. Mid-Atlantic Surface and Reclaimed Water.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefoxitin; Cephalosporin Resistance; Cephalosporins; Escherichia coli; Escherichia coli Infections; Humans; Phylogeny | 2022 |
NDM-35-Producing ST167
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests | 2022 |
Longitudinal study on the prevalence of extended spectrum cephalosporins-resistant Escherichia coli colonization in Dutch veal farms.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Escherichia coli; Escherichia coli Infections; Farms; Female; Longitudinal Studies; Prevalence; Red Meat | 2022 |
Tetracycline-Resistant, Third-Generation Cephalosporin-Resistant, and Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Beef Cow-Calf Production System.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cattle; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Tetracycline | 2022 |
Escherichia coli ST224 and IncF/bla
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Cephalosporins; Chickens; Escherichia coli; Escherichia coli Infections; Humans; Phylogeny; Plasmids; Poultry | 2022 |
Potential of ESBL-producing Escherichia coli selection in bovine feces after intramammary administration of first generation cephalosporins using in vitro experiments.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cattle; Cephalosporins; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Manure; Microbial Sensitivity Tests | 2022 |
Dynamic antimicrobial resistant patterns of Escherichia coli from healthy poultry and swine over 10 years in Chongming Island, Shanghai.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; China; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests; Penicillins; Polymyxins; Poultry; Sulfonamides; Swine; Tetracyclines | 2022 |
Antimicrobial resistance trends among canine Escherichia coli isolated at a New York veterinary diagnostic laboratory between 2007 and 2020.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Gentamicins; Microbial Sensitivity Tests; New York; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Escherichia coli resistance patterns, empiric and targeted antibiotic prescriptions in children: a single center experience.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Child; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Humans; Infant; Microbial Sensitivity Tests; Prescriptions; Retrospective Studies | 2022 |
Genetic Predictive Factors for Nonsusceptible Phenotypes and Multidrug Resistance in Expanded-Spectrum Cephalosporin-Resistant Uropathogenic Escherichia coli from a Multicenter Cohort: Insights into the Phenotypic and Genetic Basis of Coresistance.
Topics: beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Humans; Monobactams; Phenotype; Uropathogenic Escherichia coli | 2022 |
Dynamics of extended-spectrum cephalosporin resistance genes in Escherichia coli from Europe and North America.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Escherichia coli; Escherichia coli Infections; Humans; Plasmids | 2022 |
ESBL encoding third-generation cephalosporin resistance observed in bloodstream infection in India.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Communicable Diseases; Escherichia coli Infections; Humans; India; Microbial Sensitivity Tests; Sepsis | 2023 |
Antimicrobial resistance in
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Japan; Microbial Sensitivity Tests; Monobactams; Raccoon Dogs | 2022 |
Bacterial genome sequencing tracks the housefly-associated dispersal of fluoroquinolone- and cephalosporin-resistant Escherichia coli from a pig farm.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Farms; Fluoroquinolones; Genome, Bacterial; Houseflies; Humans; Male; Monobactams; Phylogeny; Swine | 2023 |
Impact of a Statewide Livestock Antibiotic Use Policy on Resistance in Human Urine
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Livestock; Microbial Sensitivity Tests; Tetracyclines; United States | 2023 |
Molecular ecology of highest priority critically important antibiotic resistant Escherichia coli from mammals housed at an urban zoo.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; beta-Lactamases; Cattle; Cephalosporins; Dogs; Escherichia coli; Escherichia coli Infections; Humans; Mammals | 2023 |
Characterization of third-generation cephalosporin-resistant Escherichia coli from slaughter calves and fattening pigs: A pilot study for monitoring antimicrobial resistance by whole genome sequencing in Switzerland.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cattle; Cattle Diseases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Multilocus Sequence Typing; Phylogeny; Pilot Projects; Swine; Swine Diseases; Switzerland; Whole Genome Sequencing | 2023 |
Comparative genetic characterisation of third-generation cephalosporin-resistant Escherichia coli isolated from integrated and conventional pig farm in Korea.
Topics: Animals; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Farms; Republic of Korea; Swine | 2023 |
Early treatment response to piperacillin/tazobactam in patients with bloodstream infections caused by non-ESBL ampicillin/sulbactam-resistant Escherichia coli: a binational cohort study.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cohort Studies; Escherichia coli; Escherichia coli Infections; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quinolones; Retrospective Studies; Sulbactam | 2023 |
From tide to table: A whole-year, coastal-wide surveillance of antimicrobial resistance in Escherichia coli from marine bivalves.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Bivalvia; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Quinolones | 2023 |
Genome analysis of third-generation cephalosporin-resistant Escherichia coli and Salmonella species recovered from healthy and diseased food-producing animals in Europe.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cattle; Cephalosporins; Chickens; Escherichia coli; Escherichia coli Infections; Europe; Salmonella; Swine | 2023 |
Limitations in predicting reduced susceptibility to third generation cephalosporins in Escherichia coli based on whole genome sequence data.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests | 2023 |
Increased community-acquired upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in children and the efficacy of flomoxef and cefmetazole.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactamases; Cefmetazole; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia; Escherichia coli Infections; Escherichia coli Proteins; Female; Genotype; Humans; Infant; Infant, Newborn; Male; O Antigens; Retrospective Studies; Urinary Tract Infections; Virulence | 2019 |
Econometric ARIMA methodology to elucidate the evolution of trends in nosocomial antimicrobial resistance rates in the European Union.
Topics: Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Europe; European Union; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Models, Econometric; Models, Theoretical; Pseudomonas aeruginosa; Pseudomonas Infections | 2020 |
Presence and Diversity of Extended-Spectrum Cephalosporin Resistance Among
Topics: Alberta; Animal Husbandry; Animals; Anti-Bacterial Agents; beta-Lactamases; Cattle; Cattle Diseases; Cephalosporin Resistance; Cephalosporins; Escherichia coli; Escherichia coli Infections; Feces; Gene Expression; Genetic Variation; Humans; Molecular Epidemiology; Multilocus Sequence Typing; Phylogeny; Plasmids; Wastewater; Whole Genome Sequencing | 2020 |
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Hematologic Neoplasms; Humans; Infection Control; Italy; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Prospective Studies; Risk Factors | 2019 |
Molecular Characterization of Uropathogenic
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Serogroup; Urinary Tract Infections; Uropathogenic Escherichia coli | 2019 |
Short communication: Bovine mastitis caused by a multidrug-resistant, mcr-1-positive (colistin-resistant), extended-spectrum β-lactamase-producing Escherichia coli clone on a Greek dairy farm.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cattle; Cephalosporins; Colistin; Dairying; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Farms; Female; Greece; Mastitis, Bovine; Microbial Sensitivity Tests; Milk; Multilocus Sequence Typing | 2020 |
Decreasing and stabilising trends of antimicrobial consumption and resistance in
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Cephalosporins; Drug Resistance, Multiple, Bacterial; Drug Utilization; Escherichia coli; Escherichia coli Infections; European Union; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Population Surveillance | 2019 |
Characterization of O25b-ST131
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Tunisia; Urinary Tract Infections | 2020 |
In vitro activity of ceftolozane/tazobactam against phenotypically defined extended-spectrum β-lactamase (ESBL)-positive isolates of Escherichia coli and Klebsiella pneumoniae isolated from hospitalized patients (SMART 2016).
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Escherichia coli; Escherichia coli Infections; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tazobactam | 2020 |
Lipid oligonucleotides as a new strategy for tackling the antibiotic resistance.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Cephalosporins; Drug Carriers; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Lipids; Microbial Sensitivity Tests; Oligonucleotides | 2020 |
Resistance to third-generation cephalosporins in Escherichia coli in the French community: The times they are a-changin'?
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; France; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Outpatients; Prevalence; Retrospective Studies | 2020 |
Uncovering novel susceptibility targets to enhance the efficacy of third-generation cephalosporins against ESBL-producing uropathogenic Escherichia coli.
Topics: Cephalosporins; Escherichia coli Infections; Escherichia coli Proteins; Humans; Mutagenesis; Urinary Tract Infections; Uropathogenic Escherichia coli | 2020 |
First Indian report on genome-wide comparison of multidrug-resistant Escherichia coli from blood stream infections.
Topics: Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Genomics; Humans; India; Polymorphism, Single Nucleotide; Virulence; Whole Genome Sequencing | 2020 |
Prevalence of third-generation cephalosporin-resistant Enterobacterales colonization on hospital admission and ESBL genotype-specific risk factors: a cross-sectional study in six German university hospitals.
Topics: Adult; beta-Lactamases; Cephalosporins; Cross-Sectional Studies; Escherichia coli Infections; Europe; Genotype; Germany; Hospitals, University; Humans; Prevalence | 2020 |
Association between the rate of third generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae and antibiotic consumption based on 143 Chinese tertiary hospitals data in 2014.
Topics: Cephalosporins; China; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Practice Patterns, Physicians'; Retrospective Studies; Tertiary Care Centers | 2020 |
Antibacterial and immunomodulatory effects of Pheromonicin-NM on Escherichia coli-challenged bovine mammary epithelial cells.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cells, Cultured; Cephalosporins; Cytokines; Epithelial Cells; Escherichia coli; Escherichia coli Infections; Female; Immunologic Factors; Mammary Glands, Animal; Mastitis, Bovine; Mucin-1 | 2020 |
Expression of CTX-M-15 limits the efficacy of ceftolozane/tazobactam against Escherichia coli in a high-inoculum murine peritonitis model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Cephalosporins; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Imipenem; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Peritonitis; Tazobactam | 2020 |
Prevalence of fluoroquinolone-resistant and broad-spectrum cephalosporin-resistant community-acquired urinary tract infections in Rio de Janeiro: Impact of Escherichia coli genotypes ST69 and ST131.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Brazil; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Fluoroquinolones; Genotype; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Prevalence; Urinary Tract Infections; Uropathogenic Escherichia coli; Young Adult | 2020 |
Antibiotic Resistance in
Topics: Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; Cecum; Cephalosporins; Chickens; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Duodenum; Escherichia coli; Escherichia coli Infections; Germany; Jejunum; Poultry Diseases | 2020 |
Use of critically important antimicrobial classes early in life may adversely impact bacterial resistance profiles during adult years: potential co-selection for plasmid-borne fluoroquinolone and macrolide resistance via extended-spectrum beta-lactam use
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Gene Transfer, Horizontal; Longitudinal Studies; Macrolides; Plasmids; Selection, Genetic; United States | 2021 |
Clinical syndromes and treatment location predict utility of carbapenem sparing therapies in ceftriaxone-non-susceptible Escherichia coli bloodstream infection.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; Carbapenems; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Tazobactam | 2020 |
Travellers returning from the island of Zanzibar colonized with MDR Escherichia coli strains: assessing the impact of local people and other sources.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Switzerland; Tanzania; Travel | 2021 |
Clinical and Economic Impact of Third-Generation Cephalosporin-Resistant Infection or Colonization Caused by
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Child; Child, Preschool; China; Comorbidity; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Family Characteristics; Female; Hospital Costs; Humans; Infant; Infant, Newborn; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Retrospective Studies; Young Adult | 2020 |
Association between extended-spectrum β-lactamase-producing
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests | 2022 |
Mecillinam susceptibility in Victorian third generation cephalosporin-nonsusceptible Escherichia coli urinary isolates.
Topics: Amdinocillin; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Urinary Tract Infections | 2021 |
An efficient cephalosporin stewardship programme in French swine production.
Topics: Animal Husbandry; Animals; Anti-Bacterial Agents; Antimicrobial Stewardship; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; France; Prevalence; Sus scrofa; Swine; Swine Diseases | 2021 |
Cross-Resistance and the Mechanisms of Cephalosporin-Resistant Bacteria in Urinary Tract Infections Isolated in Indonesia.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Humans; Indonesia; Microbial Sensitivity Tests; Urinary Tract Infections | 2021 |
Risk factors associated with faecal carriage of extended-spectrum cephalosporin-resistant Escherichia coli among dogs in Southeast Brazil.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Brazil; Carrier State; Cephalosporins; Dog Diseases; Dogs; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Hospitals, Animal; Hospitals, Teaching; Risk Factors | 2021 |
Performance of a MALDI-TOF mass spectrometry-based method for rapid detection of third-generation oxymino-cephalosporin-resistant Escherichia coli and Klebsiella spp. from blood cultures.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Blood Culture; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Immunoassay; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2021 |
Comparative activity of plazomicin against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012-2017) in relation to phylogenetic background, sequence type 131 subclones, bla
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Genotype; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Sisomicin; Young Adult | 2021 |
Selection of ESBL-producing Escherichia coli in the gut of calves experimentally fed with milk containing antibiotic residues.
Topics: Age Factors; Animal Feed; Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; Cattle; Cephalosporins; Escherichia coli; Escherichia coli Infections; Feces; Female; Gastrointestinal Microbiome; Genetic Variation; Male; Milk | 2021 |
Colonization by Escherichia coli strains with increased minimal inhibitory concentration for cefiderocol: When resistance anticipates drug use.
Topics: Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Pharmaceutical Preparations | 2021 |
Extended-spectrum cephalosporin resistance in Escherichia coli from broiler chickens raised with or without antibiotics in Ontario, Canada.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Chickens; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Ontario; Poultry Diseases | 2021 |
Dynamics of extended-spectrum cephalosporin-resistant Escherichia coli in pig farms: A longitudinal study.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Escherichia coli; Escherichia coli Infections; Farmers; Farms; Feces; Female; Genome-Wide Association Study; Humans; Longitudinal Studies; Male; Middle Aged; Occupational Exposure; Prevalence; Swine; Switzerland | 2021 |
Risk factors for ESBL-producing Escherichia coli on pig farms: A longitudinal study in the context of reduced use of antimicrobials.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Farms; Feces; Longitudinal Studies; Netherlands; Polymerase Chain Reaction; Swine | 2017 |
WGS-based surveillance of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Epidemiological Monitoring; Escherichia coli; Escherichia coli Infections; Gene Transfer, Horizontal; Genome, Bacterial; High-Throughput Nucleotide Sequencing; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Polymerase Chain Reaction | 2017 |
Biochemical characterization of CTX-M-166, a new CTX-M β-lactamase produced by a commensal Escherichia coli isolate.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Microbial Sensitivity Tests | 2017 |
Transfer Potential of Plasmids Conferring Extended-Spectrum-Cephalosporin Resistance in Escherichia coli from Poultry.
Topics: Animals; Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Conjugation, Genetic; Escherichia coli; Escherichia coli Infections; Gene Transfer, Horizontal; Plasmids; Poultry; Poultry Diseases; Serratia marcescens | 2017 |
Epidemic Emergence in the United States of Escherichia coli Sequence Type 131-
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; United States; Virulence | 2017 |
[Retropharyngeal abscess with cervical discitis and vertebral osteomyelitis caused by Escherichia coli in a patient with liver cirrhosis].
Topics: Aged; Airway Obstruction; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cervical Vertebrae; Discitis; Disease Susceptibility; Drainage; Drug Substitution; Escherichia coli Infections; Humans; Liver Cirrhosis, Alcoholic; Magnetic Resonance Imaging; Male; Neck Pain; Osteomyelitis; Oxygen Inhalation Therapy; Retropharyngeal Abscess; Tomography, X-Ray Computed | 2017 |
Determinants of virulence and of resistance to ceftiofur, gentamicin, and spectinomycin in clinical Escherichia coli from broiler chickens in Québec, Canada.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Chickens; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gentamicins; Integrons; Plasmids; Poultry Diseases; Quebec; Spectinomycin; Virulence | 2017 |
Outbreak of CTX-M-15-Producing Enterotoxigenic Escherichia coli O159:H20 in the Republic of Korea in 2016.
Topics: beta-Lactamases; Cephalosporins; Disease Outbreaks; Enterotoxigenic Escherichia coli; Escherichia coli Infections; Humans; Plasmids; Republic of Korea | 2017 |
Resistance and clonality in Escherichia coli and Klebsiella spp. and relationship with antibiotic consumption in major Lebanese hospitals.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Klebsiella; Klebsiella Infections; Lebanon; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2017 |
Evolving beta-lactamase epidemiology in Enterobacteriaceae from Italian nationwide surveillance, October 2013: KPC-carbapenemase spreading among outpatients.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Cross-Sectional Studies; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Italy; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Outpatients; Proteus Infections; Proteus mirabilis | 2017 |
Translational Efficacy of Humanized Exposures of Cefepime, Ertapenem, and Levofloxacin against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Complicated Urinary Tract Infection.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Disease Models, Animal; Ertapenem; Escherichia coli Infections; Female; Humans; Levofloxacin; Mice, Inbred ICR; Microbial Sensitivity Tests; Urinary Tract Infections; Uropathogenic Escherichia coli | 2017 |
Risk assessment modelling of fecal shedding caused by extended-spectrum cephalosporin-resistant Escherichia coli transmitted through waste milk fed to dairy pre-weaned calves.
Topics: Animals; Anti-Bacterial Agents; Bacterial Shedding; Cattle; Cattle Diseases; Cephalosporin Resistance; Cephalosporins; Escherichia coli Infections; Escherichia coli O157; Feces; Milk; Models, Theoretical; Risk Assessment; Weaning | 2017 |
Epidemiology and Antimicrobial Resistance Characteristics of the Sequence Type 131-H30 Subclone Among Extraintestinal Escherichia coli Collected From US Children.
Topics: Adolescent; Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Child; Child, Preschool; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Female; Humans; Infant; Infant, Newborn; Male; Prevalence; Prospective Studies; United States; Young Adult | 2018 |
New insights into resistance to colistin and third-generation cephalosporins of Escherichia coli in poultry, Portugal: Novel bla
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Chickens; Colistin; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Food Contamination; Plasmids; Portugal; Poultry Diseases; Turkeys | 2017 |
The use of cefepime as a carbapenem-sparing antibiotic for treating uncomplicated acute pyelonephritis caused by extended-spectrum β-lactamase producing Escherichia coli.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Male; Middle Aged; Pyelonephritis; Republic of Korea; Retrospective Studies; Risk Factors; Treatment Outcome | 2018 |
Risk factors associated with the A2C resistance pattern among E. coli isolates from broiler flocks in Canada.
Topics: Amoxicillin; Animal Husbandry; Animals; Anti-Bacterial Agents; Canada; Cefoxitin; Cephalosporins; Chickens; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Microbial Sensitivity Tests; Poultry Diseases; Risk Factors | 2017 |
Clinical efficacy and safety of cefepime-tazobactam in hospitalized patients in South India.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Hospitalization; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome; Young Adult | 2018 |
Risk factors for bacteremia with extended-spectrum β-lactamase production in positive Escherichia coli bacteremia in a pediatric setting.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Case-Control Studies; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Length of Stay; Male; Pediatrics; Retrospective Studies; Risk Factors; Software; Turkey | 2017 |
Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27.
Topics: Aged; Aged, 80 and over; Australia; Bacteremia; Bacterial Typing Techniques; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Genome, Bacterial; Humans; Male; Middle Aged; Multilocus Sequence Typing; New Zealand; Phylogeny; Prevalence; Prospective Studies; Randomized Controlled Trials as Topic; Singapore; Whole Genome Sequencing | 2018 |
Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
Topics: Abdomen; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Incidence; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2017 |
Prevalence and mechanisms of extended-spectrum cephalosporin resistance in clinical and fecal Enterobacteriaceae isolates from dogs in Ontario, Canada.
Topics: Animals; Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Dog Diseases; Dogs; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae | 2018 |
Trends in Resistance to Extended-Spectrum Cephalosporins and Carbapenems among Escherichia coli and Klebsiella spp. Isolates in a District in Western India during 2004-2014.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Humans; India; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests | 2018 |
Salmonella enterica and extended-spectrum cephalosporin-resistant Escherichia coli recovered from Holstein dairy calves from 8 farms in New Brunswick, Canada.
Topics: Animals; Anti-Bacterial Agents; Bacterial Shedding; beta-Lactam Resistance; Cattle; Cephalosporins; Dairying; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Farms; Feces; Female; Milk; New Brunswick; Plasmids; Quinolones; Salmonella enterica; Salmonella Infections, Animal | 2018 |
Is There an Association Between Use of Amoxicillin-Clavulanate and Resistance to Third-Generation Cephalosporins in Klebsiella pneumoniae and Escherichia coli at the Hospital Level?
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2018 |
Longitudinal study of Escherichia coli plasmid resistance to extended-spectrum cephalosporins in free-range broilers.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Chickens; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Longitudinal Studies; Plasmids; Poultry; Poultry Diseases | 2018 |
Cephalosporin-resistant Escherichia coli isolated from farm workers and pigs in northern Vietnam.
Topics: Animal Husbandry; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Cephalosporins; Disease Reservoirs; Escherichia coli; Escherichia coli Infections; Farmers; Farms; Humans; Livestock; Microbial Sensitivity Tests; Occupational Exposure; Phenotype; Polymerase Chain Reaction; Surveys and Questionnaires; Swine; Zoonoses | 2018 |
Ceftolozane/tazobactam dose regimens in severely/morbidly obese patients with complicated intra-abdominal infection or complicated urinary tract infection.
Topics: Anti-Bacterial Agents; Cephalosporins; Computer Simulation; Escherichia coli; Escherichia coli Infections; Female; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Obesity, Morbid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Urinary Tract Infections | 2018 |
Determination of antimicrobial resistance to extended-spectrum cephalosporin, quinolones, and vancomycin in selected human enteric pathogens from Prince Edward Island, Canada.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Enterococcus; Escherichia coli; Escherichia coli Infections; Humans; Prince Edward Island; Quinolones; Vancomycin | 2018 |
The association between extended spectrum beta-lactamase (ESBL) and ampicillin C (AmpC) beta-lactamase genes with multidrug resistance in Escherichia coli isolates recovered from turkeys in Brazil.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Phenotype; Poultry Diseases; Prevalence; Turkeys | 2018 |
Dissemination and persistence of extended-spectrum cephalosporin-resistance encoding IncI1-bla
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Europe; Humans; Plasmids; Swine | 2018 |
A comparative study for detection of extended spectrum β-lactamase (ESBL) production by Enteroaggregative Escherichia coli (EAEC) strains using double disc, nitrocefin and PCR assays.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2018 |
Activity of ceftolozane-tazobactam against Escherichia coli isolates from U.S. veterans (2011) in relation to co-resistance and sequence type 131 (ST131) H30 and H30Rx status.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Prevalence; Tazobactam; United States; United States Department of Veterans Affairs; Veterans | 2018 |
Characterization of bla
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli Infections; Escherichia coli Proteins; Humans; India; Sequence Analysis, DNA; Uropathogenic Escherichia coli | 2018 |
Comparative epidemiology of E. coli resistance to third-generation cephalosporins in diseased food-producing animals.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Cephalosporins; Epidemiological Monitoring; Escherichia coli; Escherichia coli Infections; Food Microbiology; Poultry; Poultry Diseases; Swine; Swine Diseases | 2018 |
Isolation of Escherichia coli carrying the bla
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Chickens; Drug Resistance, Bacterial; Drug Resistance, Multiple; Eggs; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Genes, Bacterial; Ovary; Poultry Diseases; Quinolones | 2018 |
Extended-spectrum cephalosporin-resistant Escherichia coli isolated from chickens and chicken meat in Brazil is associated with rare and complex resistance plasmids and pandemic ST lineages.
Topics: Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Brazil; Cephalosporins; Chickens; Cloaca; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Genetic Variation; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Plasmids; Poultry; Poultry Products; Virulence Factors | 2018 |
Extended-spectrum β-lactamase-producing E. coli septicemia among rectal carriers in the ICU.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Carrier State; Case-Control Studies; Cephalosporins; China; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Hospital Mortality; Hospitals; Humans; Intensive Care Units; Male; Middle Aged; Rectal Diseases; Retrospective Studies; Risk Factors | 2018 |
[Antibiotic prophylaxis in preterm premature rupture of membranes: CNGOF preterm premature rupture of membranes guidelines].
Topics: Amoxicillin; Antibiotic Prophylaxis; Cephalosporins; Erythromycin; Escherichia coli; Escherichia coli Infections; Female; Fetal Membranes, Premature Rupture; France; Humans; Infant, Newborn; Neonatal Sepsis; Pregnancy; Premature Birth; Streptococcal Infections; Streptococcus agalactiae | 2018 |
Genomic features of a highly virulent, ceftiofur-resistant, CTX-M-8-producing Escherichia coli ST224 causing fatal infection in a domestic cat.
Topics: Animals; Animals, Domestic; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Cat Diseases; Cats; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fatal Outcome; Genome, Bacterial; Virulence | 2018 |
Comparative genetic characterization of third-generation cephalosporin-resistant Escherichia coli isolated from a layer operation system in Korea.
Topics: Animal Husbandry; Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Chickens; Drug Resistance, Bacterial; Eggs; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Poultry Diseases; Republic of Korea | 2019 |
Alarming levels of antimicrobial resistance among sepsis patients admitted to ICU in a tertiary care hospital in India - a case control retrospective study.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; beta-Lactamases; Case-Control Studies; Cephalosporins; Cross Infection; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Feces; Genetic Variation; HeLa Cells; Hospitalization; Humans; India; Intensive Care Units; Polymerase Chain Reaction; Prevalence; Retrospective Studies; Sepsis; Tertiary Care Centers | 2018 |
Urinary Tract Infection in Children.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Cystitis; Drug Resistance, Bacterial; Dysuria; Escherichia coli; Escherichia coli Infections; Fever; Humans; Infant; Pyelonephritis; Urinary Tract Infections | 2019 |
Hidden Carbapenem Resistance in OXA-48 and Extended-Spectrum β-Lactamase-Positive
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Conjugation, Genetic; Croatia; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Epidemiological Monitoring; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids | 2019 |
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Disease Models, Animal; Drug Therapy, Combination; Enzyme Inhibitors; Escherichia coli; Escherichia coli Infections; Hydrolysis; Indicators and Reagents; Mice; Microbial Sensitivity Tests; NADP; Survival Analysis; Treatment Outcome | 2018 |
Emergence of CMY-2-Producing Escherichia coli in Korean Layer Parent Stock.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Chickens; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Genotype; Plasmids; Poultry Diseases; Republic of Korea | 2019 |
Prevalence and genetic characterization of cephalosporin-resistant Enterobacteriaceae among dogs and cats in an animal shelter.
Topics: Animals; beta-Lactamases; Cats; Cephalosporins; Dogs; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Infections; Feces; Female; Genotyping Techniques; Japan; Male; Pets; Phylogeny; Prevalence; Rectum | 2019 |
Diversity of Extended-Spectrum Cephalosporin-Resistant
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Cephalosporins; Dairying; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Farms; Feces; Female; Lactation; Pennsylvania | 2019 |
Co-occurrence of clinically relevant β-lactamases and MCR-1 encoding genes in Escherichia coli from companion animals in Argentina.
Topics: Animals; Anti-Bacterial Agents; Argentina; beta-Lactamases; Cats; Cephalosporins; Colistin; Dogs; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Microbial Sensitivity Tests; Pets; Phylogeny; Plasmids; Urinary Tract Infections | 2019 |
Does urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli show same antibiotic resistance when it recurs?
Topics: Acute Disease; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Cephalosporins; Cystitis; Escherichia coli; Escherichia coli Infections; Female; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Middle Aged; Recurrence; Urinary Tract Infections | 2019 |
Epidemiology of paediatric gastrointestinal colonisation by extended spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates in north-west Cambodia.
Topics: Adolescent; Anti-Bacterial Agents; Cambodia; Carrier State; Cephalosporins; Child; Child, Preschool; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gastrointestinal Tract; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Parasitic Diseases; Prevalence; Risk Factors; Surveys and Questionnaires; Whole Genome Sequencing | 2019 |
Prevalence of and risk factor for community-onset third-generation cephalosporin-resistant Escherichia coli bacteremia at a medical center in Taiwan.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Prevalence; Risk Factors | 2019 |
Bio-surfactin stabilised silver nanoparticles exert inhibitory effect over New-Delhi metallo-beta-lactamases (NDMs) and the cells harbouring NDMs.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Biofilms; Cephalosporins; Escherichia coli; Escherichia coli Infections; Metal Nanoparticles; Microbial Sensitivity Tests; Silver; Surface-Active Agents | 2019 |
Detection of multidrug resistant Escherichia coli in the ovaries of healthy broiler breeders with emphasis on extended-spectrum β-lactamases producers.
Topics: Algeria; Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Chickens; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Microbial Sensitivity Tests; Ovary; Poultry Diseases | 2019 |
ESBLs and resistance to ceftazidime/avibactam and ceftolozane/tazobactam combinations in Escherichia coli and Pseudomonas aeruginosa.
Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2019 |
Detection of NDM-19, a novel variant of the New Delhi metallo-β-lactamase with increased carbapenemase activity under zinc-limited conditions, in Switzerland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Culture Media; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Mutation; Plasmids; Recombinant Proteins; Surgical Wound Infection; Switzerland; Zinc | 2019 |
Resistance to critically important antimicrobials in Australian silver gulls (Chroicocephalus novaehollandiae) and evidence of anthropogenic origins.
Topics: Animals; Anti-Infective Agents; Australia; Bird Diseases; Cephalosporins; Charadriiformes; Disease Reservoirs; Drug Resistance, Bacterial; Ecology; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Feces; Fluoroquinolones; Genotype; Humans; Phenotype; Phylogeny; Surveys and Questionnaires; Whole Genome Sequencing | 2019 |
First three Escherichia coli isolates harbouring mcr-1 in Uruguay.
Topics: Adult; Aged, 80 and over; Cephalosporins; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Gene Transfer, Horizontal; Humans; Male; Multilocus Sequence Typing; Rectum; Retrospective Studies; Uruguay | 2020 |
Use of continuous infusion ceftolozane-tazobactam with therapeutic drug monitoring in a patient with cystic fibrosis.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Cystic Fibrosis; Drug Administration Schedule; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Infusions, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Treatment Outcome | 2019 |
Phylogenetic association of fluoroquinolone and cephalosporin resistance of D-O1-ST648 Escherichia coli carrying blaCMY-2 from faecal samples of dogs in Japan.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cluster Analysis; Dog Diseases; Dogs; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Feces; Fluoroquinolones; Humans; Japan; Molecular Epidemiology; Multilocus Sequence Typing; Prevalence; Serotyping; Virulence Factors; Zoonoses | 2014 |
The detection of ESBL-producing Escherichia coli in patients with symptomatic urinary tract infections using different diffusion methods in a rural setting.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Escherichia coli; Escherichia coli Infections; Humans; India; Microbial Sensitivity Tests; Phenotype; Rural Population; Urinary Tract Infections | 2013 |
Pharmacokinetics-pharmacodynamics of tazobactam in combination with ceftolozane in an in vitro infection model.
Topics: Anti-Bacterial Agents; Area Under Curve; beta-Lactamases; Cephalosporins; Dose-Response Relationship, Drug; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Models, Biological; Molecular Sequence Data; Penicillanic Acid; Real-Time Polymerase Chain Reaction; Sequence Analysis, DNA; Tazobactam | 2013 |
The role of flies in spreading the extended-spectrum β-lactamase gene from cattle.
Topics: Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Cattle; Cattle Diseases; Cephalosporin Resistance; Cephalosporins; Diptera; Disease Reservoirs; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Feces; Gene Transfer, Horizontal; Humans; Japan; Microbial Sensitivity Tests; Plasmids; Prevalence | 2013 |
Cephalosporin resistant Escherichia coli from cancer patients in Cairo, Egypt.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Child; Child, Preschool; Cluster Analysis; DNA, Bacterial; Egypt; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Genotype; Humans; Molecular Typing; Neoplasms; Polymerase Chain Reaction; Retrospective Studies | 2013 |
Limited diversity in the gene pool allows prediction of third-generation cephalosporin and aminoglycoside resistance in Escherichia coli and Klebsiella pneumoniae.
Topics: Aminoglycosides; Anti-Bacterial Agents; Australia; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Pool; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2013 |
Temporal trends of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates in in- and outpatients in Switzerland, 2004 to 2011.
Topics: Adolescent; Adult; Aged; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Switzerland; Young Adult | 2013 |
Antibiotic trapping by plasmid-encoded CMY-2 β-lactamase combined with reduced outer membrane permeability as a mechanism of carbapenem resistance in Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Cell Membrane Permeability; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enzyme Activation; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Hydrolysis; Meropenem; Microbial Sensitivity Tests; Periplasm; Plasmids; Protein Binding; Thienamycins; Young Adult | 2013 |
Survival in the environment is a possible key factor for the expansion of Escherichia coli strains producing extended-spectrum β-lactamases.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Environmental Microbiology; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Sweden; Virulence | 2014 |
Extended-spectrum cephalosporin-resistant Escherichia coli in community, specialized outpatient clinic and hospital settings in Switzerland.
Topics: Ambulatory Care Facilities; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Chromosomes; Cluster Analysis; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Genotype; Hospitals; Humans; Microarray Analysis; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA; Switzerland | 2013 |
Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli over a 6-year period.
Topics: Aging; Bacteremia; beta-Lactamases; Biliary Tract Diseases; Cephalosporin Resistance; Cephalosporins; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Prevalence; Retrospective Studies; Urinary Tract Infections | 2013 |
Susceptibility to alternative oral antimicrobial agents in relation to sequence type ST131 status and Coresistance phenotype among recent Escherichia coli isolates from U.S. veterans.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Veterans | 2013 |
Molecular typing of CTX-M-producing escherichia coli isolates from environmental water, swine feces, specimens from healthy humans, and human patients.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; China; Cluster Analysis; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Feces; Fluoroquinolones; Genotype; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Multilocus Sequence Typing; Phylogeny; Polymerase Chain Reaction; Sequence Analysis, DNA; Swine; Water Microbiology | 2013 |
Antimicrobial resistance of F4+ Escherichia coli isolated from Swine in Italy.
Topics: Animals; Anti-Bacterial Agents; Antigens, Bacterial; Cephalosporins; Diarrhea; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fimbriae Proteins; Fluoroquinolones; Italy; Swine; Swine Diseases; Thiamphenicol | 2015 |
Impact of antibiotic use during hospitalization on the development of gastrointestinal colonization with Escherichia coli with reduced fluoroquinolone susceptibility.
Topics: Aged; Anti-Bacterial Agents; Carrier State; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Female; Fluoroquinolones; Gastrointestinal Tract; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Neoplasms; Prospective Studies; Risk Factors | 2013 |
Pharmacological basis of β-lactamase inhibitor therapeutics: tazobactam in combination with Ceftolozane.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Colony Count, Microbial; Computer Simulation; Drug Administration Schedule; Drug Combinations; Drug Dosage Calculations; Escherichia coli; Escherichia coli Infections; Gene Expression; Half-Life; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Statistical; Penicillanic Acid; Plasmids; Tazobactam | 2013 |
Risk factors for antimicrobial resistance in Escherichia coli found in GB turkey flocks.
Topics: Animal Husbandry; Animals; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Models, Statistical; Poultry Diseases; Risk Factors; Surveys and Questionnaires; Turkeys; United Kingdom | 2013 |
Prevalence and molecular characterization of AmpC-producing clinical isolates of Escherichia coli from southeastern Iran.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cefoxitin; Cephalosporins; Escherichia coli; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Humans; Iran; Microbial Sensitivity Tests; Mutation Rate; Plasmids | 2014 |
Effects of ceftiofur and chlortetracycline treatment strategies on antimicrobial susceptibility and on tet(A), tet(B), and bla CMY-2 resistance genes among E. coli isolated from the feces of feedlot cattle.
Topics: Animals; Anti-Bacterial Agents; Antiporters; Bacterial Proteins; beta-Lactamases; Cattle; Cattle Diseases; Cephalosporins; Chlortetracycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Microbial Sensitivity Tests | 2013 |
Detection of antibiotic residues and association of cefquinome residues with the occurrence of Extended-Spectrum β-Lactamase (ESBL)-producing bacteria in waste milk samples from dairy farms in England and Wales in 2011.
Topics: Animals; beta-Lactamases; Cattle; Cephalosporins; DNA, Bacterial; England; Escherichia coli; Escherichia coli Infections; Feces; Female; Mastitis, Bovine; Microbial Sensitivity Tests; Milk; Polymerase Chain Reaction; Serotyping; Statistics, Nonparametric; Surveys and Questionnaires; Wales | 2014 |
Community-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countries.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Risk Factors | 2014 |
Characterization of CTX-M-14 and CTX-M-15 producing Escherichia coli strains causing neonatal sepsis.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Clone Cells; Escherichia coli; Escherichia coli Infections; Female; Gene Expression; Gentamicins; Humans; Infant, Newborn; Microbial Sensitivity Tests; Plasmids; Sepsis | 2014 |
Characterization of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Denmark; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Gene Expression; Hospitals; Humans; Isoenzymes; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Plasmids | 2014 |
Distribution of strain type and antimicrobial susceptibility of Escherichia coli isolates causing meningitis in a large urban setting in Brazil.
Topics: Anti-Bacterial Agents; beta-Lactamases; Brazil; Cephalosporins; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Meningitis; Microbial Sensitivity Tests; Urinary Tract Infections | 2014 |
Risk factors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli bacteremia.
Topics: Age Factors; Aged; Bacteremia; beta-Lactamases; Case-Control Studies; Cephalosporins; Community-Acquired Infections; Decision Making, Computer-Assisted; Escherichia coli; Escherichia coli Infections; Humans; Middle Aged; Molecular Epidemiology; Republic of Korea; Risk Factors; Tertiary Care Centers; Urinary Tract Infections | 2014 |
CTX-M-producing Escherichia coli in Lithuania: associations between sites of infection, coresistance, and phylogenetic groups.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Galanin; Gentamicins; Humans; Lithuania; Phylogeny; Substance P | 2013 |
Emergence of AmpC-producing Escherichia coli in the broiler production chain in a country with a low antimicrobial usage profile.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Chickens; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Food Handling; Meat; Norway; Poultry Diseases; Prevalence | 2014 |
Comparison of broad-spectrum cephalosporin-resistant Escherichia coli isolated from dogs and humans in Hokkaido, Japan.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; DNA, Bacterial; Dog Diseases; Dogs; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Plasmids | 2014 |
Emergence and maintenance of multidrug-resistant Escherichia coli of canine origin harbouring a blaCMY-2-IncI1/ST65 plasmid and topoisomerase mutations.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Cefoxitin; Ceftazidime; Cephalosporins; Dermatitis, Atopic; DNA Gyrase; DNA Topoisomerase IV; Dogs; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Feces; Fluoroquinolones; Microbial Sensitivity Tests; Molecular Sequence Data; Multilocus Sequence Typing; Otitis; Plasmids | 2014 |
Unacceptably high error rates in Vitek 2 testing of cefepime susceptibility in extended-spectrum-β-lactamase-producing Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Microbial Sensitivity Tests; Polymerase Chain Reaction; Reproducibility of Results | 2014 |
Escherichia coli sequence type 354 coproducing CMY-2 cephalosporinase and RmtE 16S rRNA methyltransferase.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Male; Methyltransferases; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Pennsylvania; Plasmids; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
Association of veterinary third-generation cephalosporin use with the risk of emergence of extended-spectrum-cephalosporin resistance in Escherichia coli from dairy cattle in Japan.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cattle; Cattle Diseases; Cefpodoxime; Ceftizoxime; Cephalosporin Resistance; Cephalosporins; Disk Diffusion Antimicrobial Tests; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Japan; Risk | 2014 |
First report of the prevalence of extended-spectrum β-lactamase producing Escherichia coli in two Mongolian hospitals.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Mongolia; Phylogeny | 2014 |
Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
Topics: Acute Disease; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Catchment Area, Health; Cephalosporins; Cohort Studies; Comorbidity; Cross Infection; Drug Resistance, Multiple, Bacterial; Emergency Service, Hospital; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; France; Hospitalization; Hospitals, Teaching; Hospitals, Urban; Humans; Institutionalization; Long-Term Care; Middle Aged; Nalidixic Acid; Ofloxacin; Pyelonephritis; Retrospective Studies; Risk Factors | 2014 |
Incidence of extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates that test susceptible to cephalosporins and aztreonam by the revised CLSI breakpoints.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Humans; Incidence; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2014 |
Chromosomal location of blaCTX-M genes in clinical isolates of Escherichia coli from Germany, The Netherlands and the UK.
Topics: beta-Lactamases; Blotting, Southern; Cephalosporin Resistance; Cephalosporins; Chromosomes, Bacterial; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Genotype; Germany; Humans; Molecular Typing; Netherlands; Plasmids; Polymerase Chain Reaction; United Kingdom | 2014 |
Characterization of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli obtained from Danish pigs, pig farmers and their families from farms with high or no consumption of third- or fourth-generation cephalosporins.
Topics: Adult; Agriculture; Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Cross-Sectional Studies; Denmark; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Phylogeny; Plasmids; Swine; Swine Diseases; Young Adult | 2014 |
Comparative genomics of an IncA/C multidrug resistance plasmid from Escherichia coli and Klebsiella isolates from intensive care unit patients and the utility of whole-genome sequencing in health care settings.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gene Expression; Genetic Variation; Genome, Bacterial; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Maryland; Middle Aged; Phosphoproteins; Plasmids; Sequence Analysis, DNA | 2014 |
Spread of extended spectrum cephalosporinase-producing Escherichia coli clones and plasmids from parent animals to broilers and to broiler meat in a production without use of cephalosporins.
Topics: Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Cephalosporinase; Cephalosporins; Chickens; Denmark; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Foodborne Diseases; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Poultry; Poultry Diseases | 2014 |
Detection of carbapenem resistance genes and cephalosporin, and quinolone resistance genes along with oqxAB gene in Escherichia coli in hospital wastewater: a matter of concern.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Molecular Sequence Data; Phylogeny; Quinolones; Wastewater | 2014 |
Impact of third-generation-cephalosporin administration in hatcheries on fecal Escherichia coli antimicrobial resistance in broilers and layers.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Chickens; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Microbial Sensitivity Tests; Poultry Diseases; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
Increasing prevalence of extended-spectrum cephalosporin-resistant Escherichia coli in food animals and the diversity of CTX-M genotypes during 2003-2012.
Topics: Animals; beta-Lactamases; Cephalosporins; China; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Food Microbiology; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Genetic Variation; Genotype; Prevalence | 2014 |
In vivo activity of cefquinome against Escherichia coli in the thighs of neutropenic mice.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Chromatography, Liquid; Escherichia coli; Escherichia coli Infections; Female; Mice; Microbial Sensitivity Tests; Neutropenia; Tandem Mass Spectrometry; Thigh | 2014 |
Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea.
Topics: Anti-Bacterial Agents; Cefepime; Cell Survival; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Nitrofurantoin; Penicillins; Republic of Korea; Sulfadoxine; Treatment Outcome; Trimethoprim; Urinary Tract Infections | 2014 |
In vitro activity of ceftolozane-tazobactam as determined by broth dilution and agar diffusion assays against recent U.S. Escherichia coli isolates from 2010 to 2011 carrying CTX-M-type extended-spectrum β-lactamases.
Topics: Anti-Bacterial Agents; Cephalosporins; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Tazobactam; United States | 2014 |
Increased expression levels of chromosomal AmpC β-lactamase in clinical Escherichia coli isolates and their effect on susceptibility to extended-spectrum cephalosporins.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Cephalosporins; Chromosomes, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Sequence Alignment; Sequence Homology, Nucleic Acid; Substrate Specificity | 2015 |
The real practice of antibiotic prophylaxis for prostate biopsy in Korea where the prevalence of quinolone-resistant Escherichia coli is high.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy; Cephalosporins; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli Infections; Humans; Male; Prostate; Prostatic Neoplasms; Quinolones; Republic of Korea | 2014 |
Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in febrile neutropenic children.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefepime; Cephalosporins; Child; Escherichia coli; Escherichia coli Infections; Febrile Neutropenia; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies | 2015 |
Ceftibuten-induced filamentation of extended spectrum beta lactamase (ESBL)-producing uropathogenic Escherichia coli alters host cell responses during an in vitro infection.
Topics: Adenosine Triphosphate; Anti-Bacterial Agents; beta-Lactamases; Ceftibuten; Cell Line; Cephalosporins; Escherichia coli Infections; Escherichia coli Proteins; Humans; Interleukin-6; Interleukin-8; Reactive Oxygen Species; Uropathogenic Escherichia coli | 2015 |
Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant Escherichia coli infections after prostate biopsy.
Topics: Aged; Aminoglycosides; beta-Lactamases; Biopsy; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Male; Middle Aged; Prostatic Neoplasms; Prostatitis; Quinolones; Rectum; Republic of Korea; Retrospective Studies; Time Factors; Treatment Outcome; Ultrasonography | 2014 |
Molecular and phylogenetic characterization of multidrug resistant extended spectrum beta-lactamase producing Escherichia coli isolated from poultry and cattle in Odisha, India.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; Cattle; Cattle Diseases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Feces; Milk; Monobactams; Phylogeny; Poultry; Poultry Diseases; Sequence Analysis, DNA | 2015 |
In vivo evaluation of mutant selection window of cefquinome against Escherichia coli in piglet tissue-cage model.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Diffusion Chambers, Culture; Disease Models, Animal; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Microbial Sensitivity Tests; Mutation; Swine | 2014 |
Impact of the use of β-lactam antimicrobials on the emergence of Escherichia coli isolates resistant to cephalosporins under standard pig-rearing conditions.
Topics: Amoxicillin; Animal Husbandry; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; Cephalosporins; Drug Utilization; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Feces; Genotype; Microbial Sensitivity Tests; Molecular Typing; Plasmids; Swine | 2015 |
Trends in antimicrobial resistance in equine bacterial isolates: 1999-2012.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Gentamicins; Horse Diseases; Horses; Microbial Sensitivity Tests; Penicillin G; Streptococcus; Streptococcus equi; Sulfamethizole; Tetracyclines; Trimethoprim; United Kingdom | 2015 |
High Prevalence of Escherichia coli-Producing CTX-M-15 Extended-Spectrum Beta-Lactamases in Poultry and Human Clinical Isolates in Romania.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Chickens; Clone Cells; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Gene Expression; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Poultry Diseases; Prevalence; Replicon; Romania | 2015 |
Pharmacokinetics, bioavailability and PK/PD relationship of cefquinome for Escherichia coli in Beagle dogs.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Cephalosporins; Dog Diseases; Dogs; Escherichia coli; Escherichia coli Infections; Female; Injections, Intramuscular; Injections, Intravenous; Injections, Subcutaneous; Male; Microbial Sensitivity Tests | 2015 |
Clinical usefulness of the 2010 clinical and laboratory standards institute revised breakpoints for cephalosporin use in the treatment of bacteremia caused by Escherichia coli or Klebsiella spp.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Case-Control Studies; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella; Klebsiella Infections; Male; Middle Aged; Retrospective Studies; Urinary Tract Infections; Young Adult | 2015 |
Endoscopic retrograde cholangiopancreatography-associated AmpC Escherichia coli outbreak.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporin Resistance; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Disease Outbreaks; Duodenoscopes; Equipment Contamination; Escherichia coli; Escherichia coli Infections; Female; Humans; Infection Control; Male; Microbial Sensitivity Tests; Middle Aged | 2015 |
Antimicrobial resistance trends among canine Escherichia coli isolates obtained from clinical samples in the northeastern USA, 2004-2011.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Dog Diseases; Dogs; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Logistic Models; Multivariate Analysis; New England; Tetracycline; Time Factors | 2015 |
Cefepime induced acute interstitial nephritis--a case report.
Topics: Acute Kidney Injury; Cefepime; Cephalosporins; Ciprofloxacin; Escherichia coli Infections; Female; Humans; Infusions, Intravenous; Kidney Function Tests; Mastoiditis; Middle Aged; Nephritis, Interstitial; Rare Diseases; Risk Assessment; Treatment Outcome; Withholding Treatment | 2015 |
Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Case-Control Studies; Cefepime; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Michigan; Middle Aged; Retrospective Studies; Risk Factors | 2015 |
The use of third and fourth generation cephalosporins affects the occurrence of extended-spectrum cephalosporinase-producing Escherichia coli in Danish pig herds.
Topics: Animals; Cephalosporinase; Cephalosporins; Denmark; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Swine; Swine Diseases | 2015 |
[Resistance of clinical strains of pathogenic E. coli to antibiotics and bacteriophage in hospitalized children with escherichiosis in St. Petersburg].
Topics: Adolescent; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Chloramphenicol; Coliphages; Drug Resistance, Bacterial; Enteropathogenic Escherichia coli; Enterotoxigenic Escherichia coli; Escherichia coli; Escherichia coli Infections; Female; Hospitalization; Humans; Infant; Male; Microbial Sensitivity Tests; Nitrofurans; Russia | 2014 |
ERCP scopes: what can we do to prevent infections?
Topics: Carbapenems; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Disease Outbreaks; Duodenoscopes; Equipment Contamination; Escherichia coli; Escherichia coli Infections; Female; Humans; Infection Control; Male | 2015 |
In vitro bactericidal activity of cefepime and cefpirome against clinical isolates at Karachi.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cefpirome; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pakistan; Proteus; Proteus Infections; Respiratory Tract Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections | 2015 |
Impact of ceftiofur injection on gut microbiota and Escherichia coli resistance in pigs.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Gastrointestinal Microbiome; Swine | 2015 |
Characterization of Third-Generation-Cephalosporin-Resistant Shiga Toxin-Producing Strains of Escherichia coli O157:H7 in Japan.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cephalosporins; Escherichia coli Infections; Escherichia coli O157; Genotype; Humans; Japan; Plasmids; Shiga Toxin | 2015 |
Response of a clinical Escherichia coli strain to repeated cefquinome exposure in a piglet tissue-cage model.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Diffusion Chambers, Culture; Dose-Response Relationship, Drug; Escherichia coli Infections; Male; Microbial Sensitivity Tests; Random Allocation; Swine; Swine Diseases | 2015 |
First Description of an Extended-Spectrum Cephalosporin- and Fluoroquinolone- Resistant Avian Pathogenic Escherichia coli Clone in Algeria.
Topics: Algeria; Animals; Cephalosporins; Chickens; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Poultry Diseases | 2015 |
Trends in Expanded-Spectrum Cephalosporin-Resistant Escherichia coli and Klebsiella pneumoniae among Dutch Clinical Isolates, from 2008 to 2012.
Topics: Adult; Aged; Aged, 80 and over; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Netherlands; Young Adult | 2015 |
Comparative effectiveness of flomoxef versus carbapenems in the treatment of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae with emphasis on minimum inhibitory concentration of flomoxef: a retrospectiv
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Case-Control Studies; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2015 |
In Vivo Evolution of CMY-2 to CMY-33 β-Lactamase in Escherichia coli Sequence Type 131: Characterization of an Acquired Extended-Spectrum AmpC Conferring Resistance to Cefepime.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefepime; Ceftriaxone; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Male; Microbial Sensitivity Tests; Molecular Docking Simulation | 2015 |
Prevalence and Risk Factors for Colonization With Extended-Spectrum Cephalosporin-Resistant Escherichia coli in Children Attending Daycare Centers: A Cohort Study in the Netherlands.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carrier State; Cephalosporins; Child Day Care Centers; Child, Preschool; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Infant; Netherlands; Prevalence; Prospective Studies; Risk Factors | 2015 |
Increased Hydrolysis of Oximino-β-Lactams by CMY-107, a Tyr199Cys Mutant Form of CMY-2 Produced by Escherichia coli.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cysteine; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression; Genetic Loci; Humans; Hydrolysis; Isoenzymes; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Multilocus Sequence Typing; Mutation; Plasmids; Protein Structure, Secondary; Protein Structure, Tertiary; Substrate Specificity; Tyrosine | 2015 |
Effects of ceftiofur treatment on the susceptibility of commensal porcine E.coli--comparison between treated and untreated animals housed in the same stable.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Disease Susceptibility; Drug Resistance, Bacterial; Escherichia coli Infections; Feces; Female; Housing, Animal; Injections, Intramuscular; Microbial Sensitivity Tests; Swine; Swine Diseases | 2015 |
Soil-borne reservoirs of antibiotic-resistant bacteria are established following therapeutic treatment of dairy calves.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Cephalosporins; Drug Residues; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Oxytetracycline; Soil; Soil Microbiology; Thiamphenicol | 2016 |
Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea.
Topics: Anti-Bacterial Agents; Cefepime; Cefoxitin; Ceftazidime; Cephalosporins; Child; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Phylogeny; Republic of Korea; Urinary Tract Infections; Uropathogenic Escherichia coli; Virulence Factors | 2016 |
New Class 2 Integron In2-4 Among IncI1-Positive Escherichia coli Isolates Carrying ESBL and PMAβ Genes from Food Animals in Portugal.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Foodborne Diseases; Humans; Integrons; Plasmids; Portugal; Poultry; Swine | 2016 |
Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Finland; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged; Prospective Studies | 2016 |
Virulence Genes in Expanded-Spectrum-Cephalosporin-Resistant and -Susceptible Escherichia coli Isolates from Treated and Untreated Chickens.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Chickens; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Microbial Sensitivity Tests; Poultry Diseases; Virulence Factors | 2015 |
Epidemiological and clinical features for cefepime heteroresistant Escherichia coli infections in Southwest China.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Bile; Blood; Case-Control Studies; Cefepime; Cephalosporins; China; Drainage; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Genetic Variation; Hospitals, Teaching; Humans; Male; Middle Aged; Molecular Typing; Retrospective Studies; Risk Factors | 2016 |
First Characterization of CTX-M-15-Producing Escherichia coli Strains Belonging to Sequence Type (ST) 410, ST224, and ST1284 from Commercial Swine in South America.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Brazil; Cephalosporin Resistance; Cephalosporins; DNA Transposable Elements; Escherichia coli; Escherichia coli Infections; Gene Expression; Genotype; Meat; Microbial Sensitivity Tests; Plasmids; Swine; Swine Diseases | 2016 |
Antimicrobial Activities of Ceftaroline and Comparator Agents against Bacterial Organisms Causing Bacteremia in Patients with Skin and Skin Structure Infections in U.S. Medical Centers, 2008 to 2014.
Topics: Academic Medical Centers; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Skin; Staphylococcal Skin Infections; Streptococcal Infections; Streptococcus; Tigecycline; United States | 2016 |
Impact of the administration of a third-generation cephalosporin (3GC) to one-day-old chicks on the persistence of 3GC-resistant Escherichia coli in intestinal flora: An in vivo experiment.
Topics: Animals; Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Chickens; Escherichia coli; Escherichia coli Infections; Feces; Gastrointestinal Microbiome; Poultry Diseases | 2016 |
Antimicrobial Resistance Profiles in Escherichia coli O157 Isolates from Northern Colorado Dairies.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Colorado; Dairying; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Escherichia coli O157; Fluoroquinolones; Food Contamination; Food Microbiology; Microbial Sensitivity Tests; Milk; Penicillins; Red Meat; Sulfonamides; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
Antimicrobial-Resistant Fecal Bacteria from Ceftiofur-Treated and Nonantimicrobial-Treated Comingled Beef Cows at a Cow-Calf Operation.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Cephalosporin Resistance; Cephalosporins; Coinfection; Cross-Sectional Studies; Enterococcus; Escherichia coli; Escherichia coli Infections; Feces; Female; Gene Expression; Genes, Bacterial; Gram-Positive Bacterial Infections; Nebraska; Salmonella enterica; Salmonella Infections, Animal | 2016 |
Are first-generation cephalosporins obsolete? A retrospective, non-inferiority, cohort study comparing empirical therapy with cefazolin versus ceftriaxone for acute pyelonephritis in hospitalized patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Cephalosporins; Cohort Studies; Empirical Research; Escherichia coli; Escherichia coli Infections; Female; Hospitalization; Humans; Length of Stay; Leukocyte Count; Male; Middle Aged; Patient Readmission; Pyelonephritis; Retrospective Studies; Young Adult | 2016 |
The Clinical Characteristics of Neonatal Sepsis Infection in Southwest China.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; China; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2016 |
Comparative genetic characterization of Enteroaggregative Escherichia coli strains recovered from clinical and non-clinical settings.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Cephalosporins; Diarrhea; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Prevalence; Virulence Factors | 2016 |
Comparative virulotyping of extended-spectrum cephalosporin-resistant E. coli isolated from broilers, humans on broiler farms and in the general population and UTI patients.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Cephalosporins; Chickens; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Farms; Humans; Phylogeny; Poultry Diseases; Urinary Tract Infections; Virulence Factors | 2016 |
Circulating of CMY-2 β-lactamase gene in weaned pigs and their environment in a commercial farm and the effect of feed supplementation with a clay mineral.
Topics: Aluminum Silicates; Animal Feed; Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Chlortetracycline; Clay; Dietary Supplements; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Farms; Feces; Phylogeny; Plasmids; Swine; Swine Diseases; Weaning | 2016 |
Previous Antibiotic Exposure Increases Risk of Infection with Extended-Spectrum-β-Lactamase- and AmpC-Producing Escherichia coli and Klebsiella pneumoniae in Pediatric Patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Prospective Studies; Young Adult | 2016 |
Isolation and Characterization of Escherichia coli Sequence Type 131 and Other Antimicrobial-Resistant Gram-Negative Bacilli from Clinical Stool Samples from Veterans.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Genotype; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Phylogeny; Veterans | 2016 |
Transcriptional Response of Multiple ESBL Genes Within Escherichia coli Under Oxyimino-Cephalosporin Stress.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Cephalosporins; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Real-Time Polymerase Chain Reaction; Transcription, Genetic | 2017 |
Dynamics of extended-spectrum cephalosporin resistance in pathogenic Escherichia coli isolated from diseased pigs in Quebec, Canada.
Topics: Animals; Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Genetic Variation; Genotype; Molecular Typing; Prevalence; Quebec; Swine; Swine Diseases | 2016 |
Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors.
Topics: Adult; Aged; Anti-Bacterial Agents; Carrier State; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Germany; Hospitalization; Humans; Long-Term Care; Male; Middle Aged; Patient Admission; Prevalence; Prospective Studies; Rectum; Risk Factors | 2016 |
In Vitro Efficacy of Six Alternative Antibiotics against Multidrug Resistant Escherichia Coli and Klebsiella Pneumoniae from Urinary Tract Infections.
Topics: Amdinocillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefpodoxime; Ceftibuten; Ceftizoxime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Genotype; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Penicillins; Singapore; Trimethoprim; Urinary Tract Infections | 2016 |
Risk factors for occurrence of cephalosporin-resistant Escherichia coli in Norwegian broiler flocks.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Chickens; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Linear Models; Longitudinal Studies; Norway; Poultry Diseases; Risk Factors; Surveys and Questionnaires | 2016 |
Colonization of Enteroaggregative Escherichia coli and Shiga toxin-producing Escherichia coli in chickens and humans in southern Vietnam.
Topics: Animals; Anti-Infective Agents; Bacterial Typing Techniques; beta-Lactamases; Cephalosporins; Chickens; Diarrhea; Disease Outbreaks; Disease Reservoirs; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Farmers; Farms; Feces; Flagellin; Food Microbiology; Genetic Markers; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Poultry; Prevalence; Shiga Toxin; Shiga Toxin 1; Shiga Toxin 2; Shiga-Toxigenic Escherichia coli; Trans-Activators; Vietnam; Virulence Factors | 2016 |
Prevalence and risk factors for extended-spectrum β-lactamase- and AmpC-producing Escherichia coli in dairy farms.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Cattle; Cattle Diseases; Cephalosporins; Cross-Sectional Studies; Dairying; Dose-Response Relationship, Drug; Escherichia coli; Escherichia coli Infections; Feces; Female; Logistic Models; Male; Multivariate Analysis; Plasmids; Risk Factors; Sensitivity and Specificity; Surveys and Questionnaires | 2016 |
Escherichia coli Probiotic Strain ED1a in Pigs Has a Limited Impact on the Gut Carriage of Extended-Spectrum-β-Lactamase-Producing E. coli.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Microbiota; Probiotics; Swine | 2017 |
In Vitro-In Vivo Discordance with Humanized Piperacillin-Tazobactam Exposures against Piperacillin-Tazobactam-Resistant/Pan-β-Lactam-Susceptible Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Colistin; Culture Media; Disease Models, Animal; Drug Administration Schedule; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tobramycin; Treatment Outcome | 2016 |
Propensity score-matched analysis comparing the therapeutic efficacies of cefazolin and extended-spectrum cephalosporins as appropriate empirical therapy in adults with community-onset Escherichia coli, Klebsiella spp. and Proteus mirabilis bacteraemia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cohort Studies; Community-Acquired Infections; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Male; Middle Aged; Propensity Score; Proteus Infections; Proteus mirabilis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2016 |
OXA-48-producing ST372 Escherichia coli in a French dog.
Topics: Animals; beta-Lactamases; Carbapenems; Cats; Cephalosporins; Dogs; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins | 2017 |
A novel disrupted mcr-1 gene and a lysogenized phage P1-like sequence detected from a large conjugative plasmid, cultured from a human atypical enteropathogenic Escherichia coli (aEPEC) recovered in China.
Topics: Anti-Bacterial Agents; Bacteriophage P1; Cephalosporins; China; Colistin; Conjugation, Genetic; DNA Transposable Elements; Drug Resistance, Bacterial; Enteropathogenic Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fosfomycin; Humans; Lysogeny; Male; Plasmids; Sequence Analysis, DNA | 2017 |
Selection of broad-spectrum cephalosporin-resistant Escherichia coli in the feces of healthy dogs after administration of first-generation cephalosporins.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; DNA, Bacterial; Dog Diseases; Dogs; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Feces; Genotype; Male; Microbial Sensitivity Tests | 2017 |
Infection in burn patients in a referral center in Colombia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Burns; Catheter-Related Infections; Central Venous Catheters; Cephalosporins; Child; Child, Preschool; Colombia; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Folliculitis; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Oxacillin; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections; Wound Infection; Young Adult | 2017 |
Antibiotic Prophylaxis Is Associated with Subsequent Resistant Infections in Children with an Initial Extended-Spectrum-Cephalosporin-Resistant Enterobacteriaceae Infection.
Topics: Adhesins, Escherichia coli; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; Escherichia coli; Escherichia coli Infections; Female; Fimbriae Proteins; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests | 2017 |
Penetration into and exposure of cefozopran in pelvic retroperitoneal space exudate.
Topics: Anti-Bacterial Agents; Area Under Curve; Cefozopran; Cephalosporins; Escherichia coli; Escherichia coli Infections; Exudates and Transudates; Female; Humans; Hysterectomy; Lymph Node Excision; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Pelvis; Postoperative Complications; Retroperitoneal Space | 2008 |
Risk factors in community-acquired/onset urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Quinolones; Risk Factors; Urinary Tract Infections; Urologic Surgical Procedures | 2008 |
Impact of restriction of third generation cephalosporins on the burden of third generation cephalosporin resistant K. pneumoniae and E. coli in an ICU.
Topics: beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Critical Care; Drug Resistance, Microbial; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Infections; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Medication Therapy Management; Microbial Sensitivity Tests; Middle Aged; Organizational Policy; Piperacillin | 2009 |
[Risk factors and prognosis in 31 patients with extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactamases; Cephalosporins; Child; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Young Adult | 2008 |
Association between antimicrobial consumption and resistance in Escherichia coli.
Topics: Ambulatory Care Facilities; Amdinocillin Pivoxil; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Infective Agents; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Finland; Fluoroquinolones; Hospitals, Community; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Retrospective Studies; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 2009 |
Susceptibility of Escherichia coli strains isolated from outpatient children with community-acquired urinary tract infection in southern Switzerland.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Nitrofurantoin; Outpatients; Prospective Studies; Switzerland; Urinary Tract Infections; Urine | 2008 |
Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: a retrospective matched case-control study.
Topics: Aged; Anti-Bacterial Agents; Ascites; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Liver Cirrhosis; Male; Middle Aged; Peritonitis; Retrospective Studies; Risk Factors; Treatment Failure | 2009 |
A recent evaluation of empirical cephalosporin treatment and antibiotic resistance of changing bacterial profiles in spontaneous bacterial peritonitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ascitic Fluid; Bacterial Infections; Cefepime; Cefotaxime; Cephalosporins; Drug Resistance, Bacterial; Enterococcus; Escherichia coli Infections; Female; Humans; Infusions, Intravenous; Klebsiella Infections; Klebsiella pneumoniae; Leukocyte Count; Levofloxacin; Liver Cirrhosis; Male; Microbial Sensitivity Tests; Middle Aged; Neutrophils; Ofloxacin; Peritonitis; Pneumococcal Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections | 2010 |
Medical Imagery. Emphysematous cystitis.
Topics: Aged; Anti-Bacterial Agents; Blood; Cephalosporins; Cystitis; Emphysema; Emphysematous Cholecystitis; Escherichia coli; Escherichia coli Infections; Female; Humans; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder; Urine | 2010 |
Activity of mecillinam against Escherichia coli resistant to third-generation cephalosporins.
Topics: Amdinocillin; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Wales | 2010 |
Occurrence of ST23 complex phylogroup A Escherichia coli isolates producing extended-spectrum AmpC beta-lactamase in a French hospital.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; France; Hospitalization; Humans; Molecular Sequence Data; Mutation; Phylogeny; Promoter Regions, Genetic | 2010 |
Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis.
Topics: Acinetobacter Infections; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Escherichia coli Infections; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sepsis; Shock, Septic | 2010 |
Early-onset septicemia due to CMY-2-producing Escherichia coli in a woman with blunt abdominal trauma.
Topics: Abdominal Injuries; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Sepsis; Taiwan | 2009 |
[Change of ESBLs-KPN and ESBLs-ECO after antimicrobial intervention].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged | 2010 |
[Prevalence and antimicrobial susceptibility of Laribacter hongkongensis and enterotoxigenic Escherichia coli isolated from patients with diarrhea in Guangzhou].
Topics: Adolescent; Adult; Bacterial Infections; Cephalosporins; Child; Child, Preschool; China; Diarrhea; Drug Resistance, Bacterial; Enterotoxigenic Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Neisseriaceae; Prevalence; Young Adult | 2010 |
Epidemiology of Escherichia coli clinical isolates producing AmpC plasmidic beta-lactamase during a 5-year period in a French teaching Hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Cluster Analysis; DNA Fingerprinting; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; France; Genotype; Hospitals, Teaching; Humans; Plasmids; Prevalence; Sequence Analysis, DNA | 2010 |
Cefepime-resistant Gram-negative bacteremia in febrile neutropenic patients with hematological malignancies.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefepime; Cephalosporin Resistance; Cephalosporins; Escherichia coli; Escherichia coli Infections; Fever; Genes, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Klebsiella Infections; Klebsiella pneumoniae; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
The molecular characteristics of cefepime-susceptible Escherichia coli and Klebsiella spp. isolates with a positive β-lactamase screening test result but negative confirmation.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; China; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Plasmids; Polymerase Chain Reaction | 2010 |
Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Cephalosporins; Cluster Analysis; DNA Fingerprinting; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Genotype; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Sequence Analysis, DNA; United States; Virulence Factors | 2010 |
Risk factors for ceftiofur resistance in Escherichia coli from Belgian broilers.
Topics: Animals; Anti-Bacterial Agents; Belgium; Cephalosporins; Chickens; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Microbial Sensitivity Tests; Risk Factors; Surveys and Questionnaires | 2011 |
Comparison of CLSI 2009, CLSI 2010 and EUCAST cephalosporin clinical breakpoints in recent clinical isolates of Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca from the SMART Global Surveillance Study.
Topics: Anti-Bacterial Agents; Cephalosporins; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2010 |
Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; beta-Lactam Resistance; Cephalosporins; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; France; Genotype; Humans; Male; Middle Aged; Molecular Epidemiology; Molecular Typing; Phylogeny; Plasmids; Polymerase Chain Reaction; Prevalence; Sequence Analysis, DNA | 2011 |
CTX-M-type fluoroquinolone-resistant Escherichia coli: analysis of the colonization of residents and inanimate surfaces 1 year after a first case of urinary tract infection at a nursing home in France.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; France; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nursing Homes; Urinary Tract Infections | 2010 |
First description of bla(CTX-M-14)- and bla(CTX-M-15)-producing Escherichia coli isolates in Brazil.
Topics: Anti-Bacterial Agents; beta-Lactamases; Brazil; Cephalosporins; Diarrhea; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Integrons; Microbial Sensitivity Tests; Plasmids; Trachea | 2010 |
CTX-M-type extended-spectrum β-lactamases present in Escherichia coli from the feces of cattle in Ohio, United States.
Topics: Animals; beta-Lactamases; Cattle; Cattle Diseases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Foodborne Diseases; Genes, Bacterial; Genes, MDR; Livestock; Microbial Sensitivity Tests; Ohio; Plasmids | 2010 |
Cephalosporin and fluoroquinolone combinations are highly associated with CTX-M β-lactamase-producing Escherichia coli: a case-control study in a French teaching hospital.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carrier State; Case-Control Studies; Cephalosporins; Drug Therapy, Combination; Drug Utilization; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; France; Hospitals, Teaching; Humans; Male; Middle Aged | 2011 |
[Evolution of Escherichia coli resistance in community acquired peritonitis].
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Appendicitis; beta-Lactams; Cephalosporins; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Intestines; Male; Morocco; Peptic Ulcer Perforation; Peritonitis; Practice Guidelines as Topic; Prospective Studies | 2011 |
Bacteriology of infection in severe acute pancreatitis.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Cephalosporins; Comorbidity; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Longitudinal Studies; Male; Middle Aged; Outcome Assessment, Health Care; Pancreatitis; Prevalence; Prospective Studies; Severity of Illness Index; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2011 |
Extragenitourinary malakoplakia in a patient with myeloma clinically mimicking extramedullary myelomatous disease.
Topics: Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Escherichia coli Infections; Humans; Malacoplakia; Male; Metronidazole; Multiple Myeloma; Neoplasm Metastasis; Soft Tissue Neoplasms; Stem Cell Transplantation | 2011 |
Nationwide survey of antibacterial activity against clinical isolates from urinary tract infections in Japan (2008).
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Cephalosporins; Cystitis; Data Collection; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Quinolones; Urinary Tract Infections | 2011 |
IncN plasmids carrying bla CTX-M-1 in Escherichia coli isolates on a dairy farm.
Topics: Animals; beta-Lactamases; Cattle; Cattle Diseases; Cephalosporin Resistance; Cephalosporins; Czech Republic; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Gene Transfer, Horizontal; Plasmids; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length | 2011 |
Diagnostic utility of boronic acid inhibition with different cephalosporins against Escherichia coli producing AmpC β-lactamases.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamase Inhibitors; beta-Lactamases; Boronic Acids; Ceftazidime; Cephalosporins; DNA, Bacterial; Enzyme Inhibitors; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Humans; Microbial Sensitivity Tests | 2011 |
CMY-42, a novel plasmid-mediated CMY-2 variant AmpC beta-lactamase.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Molecular Sequence Data; Plasmids; Serine; Surgical Wound Infection; Valine | 2011 |
Cefepime resistance and associated risk factors among Escherichia coli strains isolated from clinical specimens.
Topics: Case-Control Studies; Catheters; Cefepime; Cephalosporin Resistance; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Iran; Length of Stay; Male; Risk Factors; Ventilators, Mechanical | 2011 |
In vitro activity of CXA-101 plus tazobactam (CXA-201) against CTX-M-14- and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Typing; Penicillanic Acid; Tazobactam | 2011 |
Clinical and microbiological analysis of adult perianal abscess.
Topics: Abscess; Adult; Aged; Anal Canal; Anus Diseases; Cephalosporins; Diabetes Mellitus; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Taiwan | 2011 |
Prevalence and characterization of cephalosporin resistance in nonpathogenic Escherichia coli from food-producing animals slaughtered in Poland.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cattle; Cephalosporins; Chickens; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Microbial Sensitivity Tests; Mutation; Poland; Poultry; Prevalence; Swine; Turkey | 2012 |
Surgical management of Skene's gland abscess/infection: a contemporary series.
Topics: Abscess; Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Drainage; Enterococcus; Escherichia coli Infections; Exocrine Glands; Female; Humans; Lactobacillus; Middle Aged; Quinolones; Recurrence; Retrospective Studies; Staphylococcal Infections; Streptococcal Infections; Treatment Failure; Urethral Diseases; Urinary Tract Infections; Watchful Waiting; Young Adult | 2012 |
Acute kidney injury from pyelonephritis in an elderly man: case report.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Diagnosis, Differential; Escherichia coli Infections; Humans; Male; Ofloxacin; Pyelonephritis; Renal Dialysis | 2011 |
False extended-spectrum {beta}-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porins.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Cefepime; Cefpirome; Cephalosporins; Clavulanic Acid; DNA; DNA, Recombinant; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enzyme Inhibitors; Escherichia coli; Escherichia coli Infections; Isoelectric Focusing; Microbial Sensitivity Tests; Plasmids; Porins; Reverse Transcriptase Polymerase Chain Reaction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Transformation, Bacterial | 2011 |
Ceftiofur use in finishing swine barns and the recovery of fecal Escherichia coli or Salmonella spp. resistant to ceftriaxone.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Humans; Logistic Models; Microbial Sensitivity Tests; North Carolina; Salmonella; Salmonella Infections, Animal; Swine; Swine Diseases | 2011 |
Household transmission of haemolytic uraemic syndrome associated with Escherichia coli O104:H4, south-western France, June 2011.
Topics: Abdominal Pain; Adult; Anti-Bacterial Agents; Cephalosporins; Child, Preschool; Contact Tracing; Diarrhea; Disease Outbreaks; Escherichia coli; Escherichia coli Infections; Family Characteristics; Feces; France; Hemolytic-Uremic Syndrome; Humans; Male; Shiga-Toxigenic Escherichia coli; Treatment Outcome | 2011 |
Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study.
Topics: Adult; Aged; Cephalosporins; Denmark; Diarrhea; Disease Outbreaks; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Glomerular Filtration Rate; Hemolytic-Uremic Syndrome; Humans; L-Lactate Dehydrogenase; Male; Middle Aged; Plasma Exchange; Platelet Count; Serotyping; Shiga-Toxigenic Escherichia coli | 2011 |
Outbreak genomics.
Topics: Bacterial Typing Techniques; beta-Lactamases; Cephalosporins; Disease Outbreaks; Drug Resistance, Bacterial; Escherichia coli Infections; Genome, Bacterial; Hemolytic-Uremic Syndrome; Humans; Penicillins; Sequence Analysis, DNA; Shiga-Toxigenic Escherichia coli | 2011 |
A novel variant, NDM-5, of the New Delhi metallo-β-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom.
Topics: Adult; Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Genetic Variation; Humans; India; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA; United Kingdom | 2011 |
Molecular characterization of resistance to extended-spectrum cephalosporins in clinical Escherichia coli isolates from companion animals in the United States.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cat Diseases; Cats; Cephalosporin Resistance; Cephalosporins; Conjugation, Genetic; Dog Diseases; Dogs; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Microbial Sensitivity Tests; Models, Molecular; Pets; Plasmids; United States | 2011 |
Increasing burden of hospital acquired infections: resistance to cephalosporin antibiotics among klebsiella and Escherichia coli.
Topics: Anti-Bacterial Agents; Cephalosporins; Cost of Illness; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; India; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests | 2011 |
[Right obstructive pyelonephritis due to supra-piriform herniation of the pelvic ureter: a clinical case].
Topics: Anti-Bacterial Agents; Cephalosporins; Drainage; Escherichia coli; Escherichia coli Infections; Female; Follow-Up Studies; Hernia, Abdominal; Herniorrhaphy; Humans; Middle Aged; Pelvis; Pyelonephritis; Radiography; Treatment Outcome; Ureteral Diseases | 2011 |
In vivo comparison of CXA-101 (FR264205) with and without tazobactam versus piperacillin-tazobactam using human simulated exposures against phenotypically diverse gram-negative organisms.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Combinations; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Penicillanic Acid; Phenotype; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Thigh | 2012 |
CTX-M-15 extended-spectrum β-lactamase in a shiga toxin-producing Escherichia coli isolate of serotype O111:H8.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Escherichia coli Infections; Humans; Serotyping; Shiga-Toxigenic Escherichia coli | 2012 |
Efficacy of doripenem against Escherichia coli and Klebsiella pneumoniae in experimental meningitis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Carbapenems; Cefepime; Cephalosporins; Disease Models, Animal; Doripenem; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Meningitis, Bacterial; Rabbits; Treatment Outcome | 2012 |
First-line treatment with cephalosporins in spontaneous bacterial peritonitis provides poor antibiotic coverage.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ascitic Fluid; Cephalosporins; Denmark; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Kaplan-Meier Estimate; Liver Cirrhosis; Male; Meropenem; Middle Aged; Mycoses; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Thienamycins | 2012 |
Prevalence of extended-spectrum cephalosporinase (ESC)-producing Escherichia coli in Danish slaughter pigs and retail meat identified by selective enrichment and association with cephalosporin usage.
Topics: Animals; Anti-Bacterial Agents; Bacteriological Techniques; Cattle; Cephalosporinase; Cephalosporins; Chickens; Culture Media; Denmark; DNA, Bacterial; Drug Utilization; Escherichia coli; Escherichia coli Infections; Feces; Genotype; Meat; Polymerase Chain Reaction; Prevalence; Sequence Analysis, DNA; Swine | 2012 |
Prevalence and characterisation of CTX-M β-lactamases amongst Escherichia coli isolates from healthy food animals in China.
Topics: Animals; Bacterial Typing Techniques; beta-Lactamases; Cattle; Cephalosporins; China; Conjugation, Genetic; Drug Resistance, Bacterial; Ducks; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Food Microbiology; Genes, Bacterial; Genetic Variation; Meat; Microbial Sensitivity Tests; Phylogeny; Plasmids; Prevalence; Swine | 2012 |
Molecular characterization of extended-spectrum-β-lactamase-producing and plasmid-mediated AmpC β-lactamase-producing Escherichia coli isolated from stray dogs in South Korea.
Topics: Animals; Animals, Wild; Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Dog Diseases; Dogs; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Gene Transfer, Horizontal; Microbial Sensitivity Tests; Phylogeny; Plasmids; Republic of Korea | 2012 |
Prevalence and characterization of multidrug-resistant and extended-spectrum beta-lactamase-producing Escherichia coli from pediatric wards of a Malaysian hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Child, Preschool; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Humans; Infant; Integrases; Malaysia; Microbial Sensitivity Tests; Phylogeny; Prevalence; Tertiary Care Centers | 2012 |
Relentless increase of resistance to fluoroquinolones and expanded-spectrum cephalosporins in Escherichia coli: 20 years of surveillance in resource-limited settings from Latin America.
Topics: Anti-Bacterial Agents; Bolivia; Cephalosporins; Child; Child, Preschool; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Genotype; Humans; Infant; Male; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Rectum; Sequence Analysis, DNA | 2013 |
Mechanisms of resistance to cephalosporin and emergence of O25b-ST131 clone harboring CTX-M-27 β-lactamase in extraintestinal pathogenic Escherichia coli from dogs and cats in Japan.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cat Diseases; Cats; Cephalosporins; Dog Diseases; Dogs; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Japan; Molecular Sequence Data; Phylogeny | 2012 |
Risk factors associated with extended spectrum beta-lactamase Escherichia coli (CTX-M) on dairy farms in North West England and North Wales.
Topics: Animals; beta-Lactamases; Cattle; Cattle Diseases; Cephalosporins; DNA, Bacterial; England; Escherichia coli; Escherichia coli Infections; Female; Logistic Models; Plasmids; Prevalence; Risk Factors; Wales | 2012 |
Quinolone-resistant Escherichia coli O127a:K63 serotype with an extended-spectrum-beta-lactamase phenotype from a food poisoning outbreak in China.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; China; Disease Outbreaks; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Foodborne Diseases; Genes, Bacterial; Genotype; Humans; Male; Phenotype; Quinolones; Young Adult | 2012 |
Correlation between levofloxacin consumption and the incidence of nosocomial infections due to fluoroquinolone-resistant Escherichia coli.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2016 |
First countrywide survey of third-generation cephalosporin-resistant Escherichia coli from broilers, swine, and cattle in Switzerland.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cattle; Cattle Diseases; Cephalosporins; Chickens; Cluster Analysis; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Genotype; Microbial Sensitivity Tests; Multilocus Sequence Typing; Poultry Diseases; Swine; Swine Diseases; Switzerland | 2012 |
Genotypes and cephalosporin susceptibility in extended-spectrum beta-lactamase producing enterobacteriaceae in the community.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Cross-Sectional Studies; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Young Adult | 2012 |
Assessment of human exposure to 3rd generation cephalosporin resistant E. coli (CREC) through consumption of broiler meat in Belgium.
Topics: Agriculture; Animals; Anti-Bacterial Agents; Belgium; Cephalosporins; Chickens; Cooking; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Humans; Meat; Models, Theoretical; Risk | 2012 |
[Strain of Escherichia coli resistant to broad-spectrum cephalosporin and amoxicillin/clavulanic acid].
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Urinary Tract Infections | 2012 |
A nationwide study of mechanisms conferring reduced susceptibility to extended-spectrum cephalosporins in clinical Escherichia coli and Klebsiella spp. isolates.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Humans; Isoelectric Focusing; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests; Norway; Polymerase Chain Reaction | 2012 |
Clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteremia in an area with high endemicity.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Endemic Diseases; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests | 2013 |
[Current data and trends about the resistance of Gram-negative pathogens to beta-lactams].
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalosporins; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Europe; Germany; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Population Surveillance; Serotyping | 2012 |
Voluntary ban on cephalosporin use in Danish pig production has effectively reduced extended-spectrum cephalosporinase-producing Escherichia coli in slaughter pigs.
Topics: Animal Husbandry; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; Carrier State; Cecum; Ceftriaxone; Cephalosporinase; Cephalosporins; Denmark; Diet; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Polymerase Chain Reaction; Prevalence; Swine | 2013 |
Urine from treated cattle drives selection for cephalosporin resistant Escherichia coli in soil.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Microbial Sensitivity Tests; Population Dynamics; Selection, Genetic; Soil Microbiology; Temperature; Urine | 2012 |
blaCTX-M-32 on an IncN plasmid in Escherichia coli from beef cattle in the United States.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cattle; Cattle Diseases; Cephalosporins; Chlortetracycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Plasmids; United States | 2013 |
Relationship between hospital antibiotic use and quinolone resistance in Escherichia coli.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Drug Utilization; Escherichia coli; Escherichia coli Infections; France; Hospitalization; Hospitals; Humans; Quinolones; Regression Analysis; Tetracyclines | 2013 |
[Bacteriology of community-acquired peritonitis in children treated in the university hospital of Marrakech].
Topics: Adolescent; Anti-Bacterial Agents; Ascitic Fluid; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Escherichia coli Infections; Female; Hospitals, University; Humans; Infant; Male; Metronidazole; Microbial Sensitivity Tests; Morocco; Peritonitis | 2013 |
Chromosomal and plasmid-mediated fluoroquinolone resistance mechanisms among broad-spectrum-cephalosporin-resistant Escherichia coli isolates recovered from companion animals in the USA.
Topics: Animals; Anti-Bacterial Agents; Cats; Cephalosporins; Chromosomes, Bacterial; Conjugation, Genetic; DNA Topoisomerases; DNA, Bacterial; Dogs; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Genes, Bacterial; Pets; Phylogeny; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA; United States | 2013 |
Higher-generation cephalosporin-resistant Escherichia coli in feral birds in Switzerland.
Topics: Animals; Animals, Wild; Anti-Bacterial Agents; Birds; Cephalosporins; Escherichia coli; Escherichia coli Infections; Genotype; Multilocus Sequence Typing; Phylogeny; Switzerland; Virulence Factors | 2013 |
Influence of therapeutic ceftiofur treatments of feedlot cattle on fecal and hide prevalences of commensal Escherichia coli resistant to expanded-spectrum cephalosporins, and molecular characterization of resistant isolates.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carrier State; Cattle; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Feces; Molecular Epidemiology; Molecular Typing; Prevalence; Skin | 2013 |
[Protective effects of snake venom antimicrobial peptide OH-CATH on E. coli induced rabbit urinary tract infection models].
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Host-Pathogen Interactions; Male; Microscopy, Electron, Transmission; Molecular Sequence Data; Peptides; Rabbits; Snake Venoms; Sulbactam; Urinary Bladder; Urinary Tract Infections | 2013 |
Characterization of a novel plasmid-mediated cephalosporinase (CMY-9) and its genetic environment in an Escherichia coli clinical isolate.
Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Cephalosporinase; Cephalosporins; Cloning, Molecular; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Genes, Bacterial; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction | 2002 |
Variation in approach to ESBL Enterobacteriaceae among infection control practitioners: results of an Ontario-wide survey.
Topics: beta-Lactamases; Cephalosporins; Data Collection; Disease Outbreaks; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella; Klebsiella Infections; Ontario | 2002 |
Relevance of antimicrobial agent-induced endotoxin release from in vitro cultured Escherichia coli and in vivo experimental infection with Gram-negative bacilli.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Disease Models, Animal; Endotoxins; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Male; Monocytes; Peritonitis; Rabbits; Tumor Necrosis Factor-alpha | 2003 |
High-level expression of ampC beta-lactamase due to insertion of nucleotides between -10 and -35 promoter sequences in Escherichia coli clinical isolates: cases not responsive to extended-spectrum-cephalosporin treatment.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Cloning, Molecular; DNA Fingerprinting; Escherichia coli; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Promoter Regions, Genetic; RNA, Ribosomal, 16S; Single-Strand Specific DNA and RNA Endonucleases | 2003 |
Decreased susceptibility to cefepime in a clinical strain of Escherichia coli related to plasmid- and integron-encoded OXA-30 beta-lactamase.
Topics: Aged; beta-Lactamases; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Integrons; Plasmids | 2003 |
Protection with antibody to tumor necrosis factor differs with similarly lethal Escherichia coli versus Staphylococcus aureus pneumonia in rats.
Topics: Administration, Inhalation; Animals; Antibodies; Bronchoalveolar Lavage Fluid; Cefotiam; Cephalosporins; Escherichia coli; Escherichia coli Infections; Injections, Intraperitoneal; Interleukin-6; Intubation, Intratracheal; Leukocyte Count; Lymphocyte Count; Male; Neutrophils; Oxygen; Oxygen Consumption; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Rats; Rats, Wistar; Sepsis; Staphylococcus aureus; Survival Analysis; Tumor Necrosis Factor-alpha | 2003 |
[Meningitis caused by multiresistant E. coli after an echo-directed transrectal biopsy].
Topics: Aged; Amoxicillin; Biopsy; Brain Damage, Chronic; Cefepime; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Confusion; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Male; Meningitis, Bacterial; Premedication; Prostate; Rectum; Ultrasonography; Vancomycin | 2003 |
Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans.
Topics: Animals; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Cattle; Cephalosporin Resistance; Cephalosporins; Cephamycins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Genotype; Humans; Microbial Sensitivity Tests; Phylogeny; Random Amplified Polymorphic DNA Technique; Serotyping; Swine; Virulence | 2003 |
A new TEM-derived extended-spectrum beta-lactamase (TEM-91) with an R164C substitution at the omega-loop confers ceftazidime resistance.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Chromatography, High Pressure Liquid; DNA, Bacterial; Drug Combinations; Enzyme Inhibitors; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Kinetics; Molecular Sequence Data; Point Mutation | 2003 |
Comparison of the E-test method with an automated bacterial identification and antimicrobial susceptibility detection system for screening extended-spectrum beta-lactamase producers.
Topics: Automation; Bacterial Typing Techniques; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests | 2003 |
Exploring the effectiveness of tazobactam against ceftazidime resistant Escherichia coli: insights from the comparison between susceptibility testing and beta-lactamase inhibition.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Ertapenem; Escherichia coli; Escherichia coli Infections; Lactams; Microbial Sensitivity Tests; Penicillanic Acid; Tazobactam | 2004 |
Determination of the in vivo pharmacodynamic profile of cefepime against extended-spectrum-beta-lactamase-producing Escherichia coli at various inocula.
Topics: Animals; beta-Lactamases; Cefepime; Cephalosporin Resistance; Cephalosporins; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Muscle, Skeletal; Thigh | 2004 |
High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution.
Topics: Amino Acid Sequence; Amino Acid Substitution; beta-Lactamases; Ceftazidime; Cephalosporin Resistance; Cephalosporins; DNA, Bacterial; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Escherichia coli Infections; Isoelectric Focusing; Kinetics; Molecular Sequence Data; Mutagenesis, Site-Directed; Plasmids; Pleura | 2004 |
Antibiotic susceptibility of bacteria most commonly isolated from bone related infections: the role of cephalosporins in antimicrobial therapy.
Topics: Bacterial Infections; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli Infections; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Osteomyelitis; Staphylococcal Infections; Streptococcal Infections; United States | 2004 |
Investigation of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Korea; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2004 |
Inhibitor-sensitive AmpC beta-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins.
Topics: Amino Acid Sequence; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Cephamycins; Cloning, Molecular; Culture Media; Enzyme Inhibitors; Escherichia coli; Escherichia coli Infections; Gene Deletion; Gene Transfer, Horizontal; Isoelectric Focusing; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Substrate Specificity | 2004 |
Antibiotic resistance among enterotoxigenic Escherichia coli from piglets and calves with diarrhea.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Cattle; Cattle Diseases; Cephalosporins; Diarrhea; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Microbial Sensitivity Tests; Swine; Swine Diseases | 2004 |
[Analysis of anti-microbial resistance of Escherichia coli that caused infection in urogenital system].
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Quinolones; Urinary Tract Infections | 2004 |
AmpC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins.
Topics: Aged; Aged, 80 and over; Amino Acid Sequence; Amino Acid Substitution; Bacterial Proteins; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Cloning, Molecular; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Kinetics; Molecular Sequence Data | 2004 |
Bacteria of preoperative urinary tract infections contaminate the surgical fields and develop surgical site infections in urological operations.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Humans; Japan; Male; Methicillin Resistance; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Specimen Handling; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Urinary Tract Infections; Urine; Urologic Surgical Procedures | 2004 |
Intravesical mass consisting of mucosa-associated lymphoid tissue.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Diagnosis, Differential; Escherichia coli; Escherichia coli Infections; Female; Humans; Hyperplasia; Lymphoid Tissue; Lymphoma, B-Cell, Marginal Zone; Urinary Bladder; Urinary Bladder Neoplasms | 2004 |
Novel SHV-derived extended-spectrum beta-lactamase, SHV-57, that confers resistance to ceftazidime but not cefazolin.
Topics: beta-Lactamases; Cefazolin; Ceftazidime; Cephalosporins; Cloning, Molecular; Conjugation, Genetic; Deoxyribonucleases, Type II Site-Specific; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Infant; Isoelectric Focusing; Kinetics; Male; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Open Reading Frames; Plasmids; Taiwan | 2005 |
Detection of multiple cephalosporin-resistant Escherichia coli from a cattle fecal sample in Great Britain.
Topics: Animals; Cattle; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Feces; Microbial Sensitivity Tests; Plasmids; United Kingdom | 2005 |
Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children.
Topics: Analysis of Variance; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Cephalosporins; Child; Child, Preschool; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Regression Analysis; Risk Factors | 2005 |
[Germs that produce the extended spectrum betalactamases].
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Emergencies; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Imipenem; Leukemia; Lymphoma, Non-Hodgkin; Male; Morocco; Neutropenia; Retrospective Studies; Shock, Septic; Time Factors | 2004 |
Comparative serum levels and protective activity of parenterally administered cephalosporins in experimental animals.
Topics: Animals; Cephalosporins; Dogs; Escherichia coli Infections; Female; Male; Mice; Rabbits; Saimiri; Species Specificity | 1974 |
Intravenous versus nebulized ceftazidime in ventilated piglets with and without experimental bronchopneumonia: comparative effects of helium and nitrogen.
Topics: Administration, Inhalation; Animals; Blood Gas Analysis; Bronchopneumonia; Ceftazidime; Cephalosporins; Escherichia coli Infections; Helium; Injections, Intravenous; Lung; Nebulizers and Vaporizers; Oxygen; Particle Size; Respiration, Artificial; Respiratory Mechanics; Swine; Ultrasonics | 2005 |
Trimethoprim-sulfamethoxazole induced rash and fatal hematologic disorders.
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Candidiasis, Oral; Cefepime; Cephalosporins; Chlorhexidine; Drug Eruptions; Escherichia coli; Escherichia coli Infections; Exanthema; Fatal Outcome; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Male; Meropenem; Neutropenia; Nystatin; Platelet Transfusion; Prednisolone; Recombinant Proteins; Thienamycins; Thrombocytopenia; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
CTX-M: changing the face of ESBLs in the UK.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; United Kingdom | 2005 |
Antibiotic resistance patterns in children hospitalized for urinary tract infections.
Topics: Adolescent; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Escherichia coli Infections; Humans; Infant; Retrospective Studies; Urinary Tract Infections | 2005 |
Clinical implications of extended spectrum beta-lactamase (ESBL) producing Klebsiella species and Escherichia coli on cefepime effectiveness.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Case-Control Studies; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome | 2005 |
Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Chromosomes, Bacterial; Deoxyribonucleases, Type II Site-Specific; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Genes, Bacterial; Hospitals; Humans; Molecular Epidemiology; Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Promoter Regions, Genetic; Sequence Analysis, DNA; Spain | 2005 |
[Cefprozil in the treatment of chronic maxillary sinusitis. Clinical and microbiological effectiveness and penetration into sinuses examination].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefprozil; Cephalosporins; Chronic Disease; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Male; Maxillary Sinusitis; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Treatment Outcome | 2005 |
Drug-resistant Escherichia coli, Rural Idaho.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Carrier State; Cephalosporins; Child; Child, Preschool; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Family Characteristics; Feces; Female; Humans; Idaho; Male; Microbial Sensitivity Tests; Middle Aged; Nalidixic Acid; Rural Population; Trimethoprim, Sulfamethoxazole Drug Combination | 2005 |
Transferable DHA-1 cephalosporinase in Escherichia coli.
Topics: Bacterial Proteins; beta-Lactams; Cephalosporin Resistance; Cephalosporinase; Cephalosporins; Conjugation, Genetic; Croatia; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Transfer, Horizontal; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction | 2006 |
Evaluation and importance of asymptomatic bacteriuria in pregnancy.
Topics: Adolescent; Adult; Age Distribution; Anti-Bacterial Agents; Bacteriuria; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Incidence; Kidney Pelvis; Maternal Age; Penicillins; Pregnancy; Prospective Studies; Ultrasonography | 2005 |
Detection of a novel variant bla(CTX-M-3) extended spectrum beta-lactamase gene in a community-acquired Escherichia coli isolate.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Child, Preschool; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Genetic Variation; Greece; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Urinary Tract Infections | 2006 |
Efficacy of ceftiofur and flunixin in the early treatment of bronchopneumonia in weaners.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bronchopneumonia; Cephalosporins; Clonixin; Cough; Escherichia coli; Escherichia coli Infections; Female; Lipopolysaccharides; Male; Pasteurella Infections; Pasteurella multocida; Swine; Swine Diseases; Treatment Outcome | 2006 |
Extended-spectrum beta-lactamases and plasmid-mediated AmpC enzymes among clinical isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Prevalence; Taiwan | 2006 |
Influence of endotoxin induced fever on the pharmacokinetics of intramuscularly administered cefepime in rabbits.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Cefepime; Cephalosporins; Endotoxins; Escherichia coli Infections; Fever; Half-Life; Injections, Intramuscular; Male; Rabbits | 2006 |
Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study.
Topics: Adolescent; Adult; Ampicillin; Anti-Infective Agents, Urinary; Cefdinir; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; In Vitro Techniques; Male; Microbial Sensitivity Tests; Middle Aged; Nitrofurantoin; North America; Outpatients; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2006 |
Molecular epidemiology of ceftiofur-resistant Escherichia coli isolates from dairy calves.
Topics: Animals; Cattle; Cattle Diseases; Cephalosporins; Dairying; DNA Primers; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Microbial Sensitivity Tests; Molecular Epidemiology; Pennsylvania; Polymerase Chain Reaction | 2006 |
Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2005 |
Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Administration Schedule; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Pseudomonas aeruginosa; Pseudomonas Infections | 2006 |
Cefepime pharmacodynamics in patients with extended spectrum beta-lactamase (ESBL) and non-ESBL infections.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Case-Control Studies; Cefepime; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Treatment Outcome | 2007 |
Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; DNA Fingerprinting; DNA Transposable Elements; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Genotype; Hospitals; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Polymerase Chain Reaction; Polymorphism, Genetic; Random Amplified Polymorphic DNA Technique; Recombination, Genetic; Sequence Analysis, DNA | 2006 |
Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cephalosporins; Cohort Studies; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2006 |
Use of cefepime for the treatment of infections caused by extended spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies | 2006 |
Abundance and phenotypic diversity of Escherichia coli isolates with diminished susceptibility to expanded-spectrum cephalosporins in faeces from healthy food animals after slaughter.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Chickens; Colony Count, Microbial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Microbial Sensitivity Tests; Phenotype; Poultry Diseases; Spain; Swine; Swine Diseases | 2007 |
Extended spectrum beta lactamase producing gram negative bacilli in a tertiary referral hospital of Assam--experience with two methods.
Topics: Academic Medical Centers; Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Escherichia coli; Escherichia coli Infections; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2006 |
Acute-phase response alters the disposition kinetics of cefepime following intravenous administration to rabbits.
Topics: Acute-Phase Reaction; Animals; Anti-Bacterial Agents; Area Under Curve; Cefepime; Cephalosporins; Escherichia coli; Escherichia coli Infections; Fever; Half-Life; Injections, Intravenous; Male; Rabbits | 2007 |
Escherichia coli aortic valve endocarditis.
Topics: Aged; Anti-Bacterial Agents; Aortic Valve; Bacteremia; Cefepime; Cephalosporins; Echocardiography, Transesophageal; Endocarditis, Bacterial; Escherichia coli; Escherichia coli Infections; Follow-Up Studies; Humans; Male; Microbial Sensitivity Tests; Time Factors; Treatment Outcome | 2007 |
Occurrence of CTX-M-1-producing Escherichia coli in pigs treated with ceftiofur.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Denmark; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Swine; Swine Diseases | 2007 |
A case of plasmid-mediated AmpC beta-lactamase-producing E. coli (PACE) and its implications.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Male; Plasmids; Urinary Tract Infections | 2006 |
Extended-spectrum beta-lactamases, food, and cephalosporin use in food animals.
Topics: Animals; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Food Microbiology; Meat; Poultry Products | 2007 |
Characteristics of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates from horses.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gene Transfer, Horizontal; Horse Diseases; Horses; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Sequence Data | 2007 |
Use of cefepime for the treatment of infections caused by extended spectrum: beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Hospitals, Urban; Humans; India; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Thienamycins | 2007 |
In vitro activity of cefditoren against clinical isolates of Escherichia coli from a Korean hospital.
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Korea; Microbial Sensitivity Tests | 2007 |
Risk factors of nosocomial infection with extended-spectrum beta-lactamase-producing bacteria in a neonatal intensive care unit in China.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Cephalosporins; China; Cohort Studies; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Logistic Models; Male; Microbial Sensitivity Tests; Multivariate Analysis; Respiration, Artificial; Retrospective Studies; Risk Factors | 2007 |
Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; beta-Lactamases; Carrier State; Case-Control Studies; Cephalosporins; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Prevalence; Risk Factors; Thailand | 2007 |
[Replacement of third-generation cephalosporins by piperacillin-tazobactam decreases colonization of extended-spectrum beta-lactamases-producing intestinal Escherichia coli].
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Intestines; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies | 2007 |
Urine bactericidal activity against Escherichia coli isolates exhibiting different resistance phenotypes/genotypes in an in vitro pharmacodynamic model simulating urine concentrations obtained after oral administration of a 400-milligram single dose of ce
Topics: Amdinocillin Pivoxil; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Microbial Sensitivity Tests; Models, Biological; Phenotype; Urinary Tract Infections; Urine | 2008 |
Uropathogens and empiric antibiotics for the treatment of urinary tract infections in spinal cord injured patients at rehabilitation center, Thai Red Cross Society during 2001 to 2005.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Cephalosporins; Escherichia coli Infections; Female; Health Status Indicators; Humans; Length of Stay; Male; Prevalence; Red Cross; Rehabilitation Centers; Retrospective Studies; Sickness Impact Profile; Societies, Medical; Spinal Cord Injuries; Thailand; Urinary Tract Infections | 2007 |
Escherichia coli isolate coproducing 16S rRNA Methylase and CTX-M-type extended-spectrum beta-lactamase isolated from an outpatient in the United States.
Topics: Ambulatory Care; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; RNA, Ribosomal, 16S; Sequence Analysis, DNA; United States | 2008 |
[ESBL--increasing resistance problems. Cephalosporins no longer obvious choice in diffuse infections].
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Male; Middle Aged; Risk Factors; Urinary Tract Infections | 2007 |
Intravenous cefotaxime in children with bacterial meningitis.
Topics: Biological Availability; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; In Vitro Techniques; Infant; Infant, Newborn; Injections, Intravenous; Male; Meningitis; Meningitis, Haemophilus; Meningitis, Pneumococcal; Pseudomonas Infections; Staphylococcal Infections; Streptococcal Infections; Streptococcus agalactiae | 1980 |
Modulating effect of subinhibitory concentrations of compound LY 127935 on the virulence of Escherichia coli in the mouse.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Escherichia coli; Escherichia coli Infections; Male; Mice; Mice, Inbred Strains; Moxalactam; Virulence | 1982 |
Successful moxalactam therapy for gram-negative bacillary meningitis in neonates.
Topics: Bacterial Infections; Cephalosporins; Cephamycins; Citrobacter; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Infant, Newborn; Klebsiella Infections; Male; Meningitis; Moxalactam | 1982 |
Activity of cefoperazone against ampicillin-resistant bacteria in agar and broth dilution tests.
Topics: Ampicillin; Bacteria; beta-Lactamases; Cefoperazone; Cephalosporins; Conjugation, Genetic; Culture Media; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Time Factors | 1982 |
Ceftazidime in septicaemia.
Topics: Adult; Aged; Ceftazidime; Cephalosporins; Coombs Test; Drug Eruptions; Escherichia coli Infections; Female; Fever; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Sepsis | 1983 |
[Chemotherapy with fosfomycin, cefoxitin, and cefotaxime in experimental E. coli-pleuropneumonia (author's transl)].
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cefoxitin; Cephalosporins; Dose-Response Relationship, Drug; Escherichia coli Infections; Female; Fosfomycin; Kinetics; Pleuropneumonia; Rats | 1981 |
Resistance to cefamandole: a collaborative study of emerging clinical problems.
Topics: Adult; Aged; Bacteroides Infections; beta-Lactamases; Cefamandole; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Isoelectric Focusing; Male; Middle Aged; Moxalactam; Penicillin Resistance; Penicillins | 1982 |
Update on drug therapy: VIII. Oral cephalosporins.
Topics: Administration, Oral; Adult; Cephalosporins; Child; Diarrhea; Escherichia coli Infections; Half-Life; Humans; Microbial Sensitivity Tests; Pneumonia, Staphylococcal; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections | 1981 |
Mecillinam alone and in combination with ampicillin or moxalactam in experimental Escherichia coli meningitis.
Topics: Amdinocillin; Ampicillin; Animals; Cephalosporins; Cephamycins; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Kinetics; Male; Meningitis; Mice; Moxalactam; Penicillanic Acid; Rabbits | 1982 |
Ceftazidime, ceftizoxime, cefotaxime and HR 221 in experimental chronic Escherichia coli pyelonephritis in rats.
Topics: Animals; Cefotaxime; Ceftazidime; Ceftizoxime; Cephalosporins; Chronic Disease; Drug Evaluation, Preclinical; Escherichia coli Infections; Pyelonephritis; Rats | 1983 |
[Studies on the combined effect of 6/N,N-hexyleneformamidine/-penicillanic acid (Preparation HX) and selected beta-lactam antibiotics on Escherichia coli and Salmonella. II. Studies in vivo].
Topics: Amdinocillin; Animals; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Cephradine; Drug Synergism; Escherichia coli Infections; Mice; Mice, Inbred BALB C; Penicillanic Acid; Salmonella Infections | 1982 |
Pharmacokinetics and bacteriological effect of ceftazidime in experimental Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli meningitis.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Escherichia coli Infections; Kinetics; Male; Meningitis; Meningitis, Haemophilus; Meningitis, Pneumococcal; Rabbits | 1983 |
Ceftazidime: a new approach in the treatment of moderate and severe infections.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Male; Meningitis; Middle Aged; Peritonitis; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Skin Diseases, Infectious; Urinary Tract Infections | 1983 |
Clinical studies on ceftazidime in surgery in Japan.
Topics: Ceftazidime; Cephalosporins; Escherichia coli Infections; Female; Humans; Japan; Male; Middle Aged; Postoperative Complications; Pseudomonas Infections; Staphylococcal Infections; Surgical Wound Infection | 1983 |
Quaternary heterocyclylamino beta-lactams. V. L-640,876 treatment of induced enterotoxigenic colibacillosis (scours) in calves and piglets.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Cephalosporins; Diarrhea; Escherichia coli Infections; Salmonella; Swine; Swine Diseases; Time Factors | 1983 |
Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluid. Implications for therapy of gram-negative bacillary meningitis.
Topics: Aged; Blood-Brain Barrier; Cephalosporins; Cephamycins; Escherichia coli Infections; Humans; Injections, Intravenous; Klebsiella Infections; Male; Meningitis; Middle Aged; Moxalactam | 1980 |
Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.
Topics: Bacterial Infections; Brain Abscess; Cephalosporins; Cephamycins; Escherichia coli Infections; Female; Half-Life; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infusions, Parenteral; Injections, Intramuscular; Kinetics; Klebsiella Infections; Male; Meningitis; Moxalactam; Salmonella Infections; Serratia marcescens | 1981 |
Successful treatment of gram-negative bacillary meningitis with moxalactam.
Topics: Adult; Cephalosporins; Cephamycins; Enterobacter; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis; Middle Aged; Moxalactam | 1981 |
Moxalactam in treatment of recurrent Escherichia coli meningitis and ventriculitis in an infant with agammaglobulinemia.
Topics: Agammaglobulinemia; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Cerebral Ventricles; Encephalitis; Escherichia coli Infections; Humans; Infant; Male; Meningitis; Moxalactam; Recurrence | 1981 |
[In vitro and in vivo antimicrobial activities of cefmetazole against Bacteroides fragilis].
Topics: Animals; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Cefmetazole; Cephalosporins; Cephamycins; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Stability; Escherichia coli Infections; Male; Mice; Mice, Inbred ICR | 1982 |
Ceftazidime in the treatment of urinary tract infection.
Topics: Aged; Ceftazidime; Cephalosporins; Enterococcus faecalis; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Pseudomonas Infections; Streptococcal Infections; Urinary Catheterization; Urinary Tract Infections | 1982 |
Comparison of cefamandole, cephalothin, ampicillin, and chloramphenicol in experimental Escherichia coli meningitis.
Topics: Ampicillin; Animals; Brain Chemistry; Cefamandole; Cephalosporins; Cephalothin; Chloramphenicol; Escherichia coli Infections; Female; Male; Meningitis; Rabbits; Time Factors | 1980 |
Failure of single doses of cefazolin and cefamandole to penetrate experimental chronic Escherichia coli abdominal abscesses.
Topics: Abdomen; Abscess; Animals; Cefamandole; Cefazolin; Cell Membrane Permeability; Cephalosporins; Chronic Disease; Escherichia coli Infections; Rabbits; Time Factors | 1980 |
Cephamycin C treatment of induced enterotoxigenic colibacillosis (scours) in calves and piglets.
Topics: Animals; Cattle; Cattle Diseases; Cephalosporins; Cephamycins; Diarrhea; Enterotoxins; Escherichia coli Infections; Swine; Swine Diseases | 1980 |
[Sefril in the treatment of toxic diarrhea in infants].
Topics: Cephalosporins; Cephradine; Diarrhea, Infantile; Enterobacteriaceae Infections; Enterotoxins; Escherichia coli Infections; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Klebsiella Infections; Proteus Infections; Proteus mirabilis; Proteus vulgaris | 1980 |
Characterization of cephalosporin resistance in clinical isolates of Escherichia coli.
Topics: Cefoxitin; Cephaloridine; Cephalosporinase; Cephalosporins; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Humans; Penicillinase | 1980 |
[Fundamental and clinical studies of cefuroxime in pediatric purulent meningitis (author's transl)].
Topics: Cefuroxime; Cephalosporins; Child, Preschool; Drug Evaluation; Escherichia coli Infections; Female; Humans; Infant; Male; Meningitis; Meningitis, Haemophilus | 1980 |
Nosocomial pneumonia.
Topics: Aminoglycosides; Cephalosporins; Cross Infection; Enterobacter; Enterobacteriaceae Infections; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Penicillin G; Pneumococcal Infections; Pneumonia; Pseudomonas Infections; Staphylococcal Infections | 1981 |
[Therapeutic effectiveness of metossimine associated with an aminoglycoside in a case of severe gram-negative sepsis].
Topics: Cefuroxime; Cephalosporins; Diabetes Complications; Drug Therapy, Combination; Escherichia coli Infections; Gastrointestinal Diseases; Gentamicins; Humans; Male; Middle Aged; Paromomycin; Proteus Infections; Sisomicin | 1981 |
Oral antibiotics in pedal infections.
Topics: Administration, Oral; Anti-Bacterial Agents; Cephalosporins; Erythromycin; Escherichia coli Infections; Foot Diseases; Humans; Penicillins; Proteus Infections; Pseudomonas Infections; Staphylococcal Infections; Surgical Wound Infection | 1980 |
[Study of cefamandole in neonatal purulent meningitis caused by E. coli (author's transl)].
Topics: Cefamandole; Cephalosporins; Drug Therapy, Combination; Escherichia coli Infections; Female; Gentamicins; Humans; Infant, Newborn; Infant, Newborn, Diseases; Meningitis | 1981 |
Valvular bacterial endocarditis in the dog.
Topics: Animals; Cephalosporins; Dog Diseases; Dogs; Embolism; Endocarditis, Bacterial; Escherichia coli Infections; Female; Gentamicins; Glomerulonephritis; Heart Murmurs; Heart Valve Diseases; Male; Penicillins; Staphylococcal Infections | 1982 |
TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus.
Topics: Animals; Bacteria; Cephalosporins; Escherichia coli Infections; Male; Methicillin Resistance; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Mutation; Staphylococcal Infections; Staphylococcus aureus | 1995 |
Transferable resistance to cefotaxime in nosocomial Klebsiella pneumoniae and Escherichia coli strains due to their production of extended-spectrum beta-lactamase in Slovakia.
Topics: beta-Lactamases; Cefotaxime; Ceftibuten; Cephalosporins; Conjugation, Genetic; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Humans; Hydrolysis; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Slovakia | 1995 |
Ceftiofur distribution in serum and milk from clinically normal cows and cows with experimental Escherichia coli-induced mastitis.
Topics: Animals; Body Temperature; Cattle; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Mammary Glands, Animal; Mastitis, Bovine; Metabolic Clearance Rate; Milk; Reference Values | 1995 |
Beta-lactam resistance among Escherichia coli and Klebsiella species blood culture isolates in Finnish hospitals. Finnish Study Group for Antimicrobial Resistance.
Topics: Bacteremia; beta-Lactam Resistance; Cefuroxime; Cephalosporins; Drug Utilization; Escherichia coli; Escherichia coli Infections; Finland; Humans; Klebsiella; Klebsiella Infections | 1994 |
[Clinical evaluation of S-1108 in children].
Topics: Bacterial Infections; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Escherichia coli Infections; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Respiratory Tract Infections; Streptococcal Infections; Streptococcus pyogenes; Urinary Tract Infections | 1993 |
Comparison of endotoxin release by different antimicrobial agents and the effect on inflammation in experimental Escherichia coli meningitis.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cefpirome; Cephalosporins; Chloramphenicol; Endotoxins; Escherichia coli Infections; Gentamicins; Inflammation; Male; Meningitis, Bacterial; Meropenem; Rabbits; Thienamycins | 1993 |
Analysis of beta-lactamases produced by cephalothin-susceptible Escherichia coli clinical isolates resistant to co-amoxiclav and ticarcillin-clavulanic acid. The CERIB Study Group.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Cephalosporins; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Humans; Isoelectric Focusing; Ticarcillin | 1995 |
Efficacy of meropenem in experimental meningitis.
Topics: Ampicillin; Animals; Carbapenems; Ceftazidime; Ceftriaxone; Cephalosporins; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Drug Evaluation; Drug Resistance, Microbial; Escherichia coli Infections; Gentamicins; Guinea Pigs; Haemophilus Infections; Haemophilus influenzae; Listeriosis; Meningitis, Bacterial; Meropenem; Neisseria meningitidis; Penicillin G; Pneumococcal Infections; Thienamycins | 1995 |
Impact of different classes antimicrobial agents on plasma endotoxin activity.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Blood Pressure; Cefotaxime; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Endotoxins; Escherichia coli; Escherichia coli Infections; Gentamicins; Imipenem; Male; Peritoneal Diseases; Peritoneum; Rats; Rats, Wistar; Thienamycins | 1996 |
Experimental endogenous septicaemia caused by Klebsiella pneumoniae and Escherichia coli in mice.
Topics: Ampicillin; Animals; Bacteremia; Ceftazidime; Cephalosporins; Cyclophosphamide; Disease Models, Animal; Escherichia coli Infections; Fluorouracil; Immunosuppressive Agents; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Penicillins; Pseudomonas Infections; Survival Analysis | 1996 |
Chronic granulomatous interstitial nephritis: unusual complication of acute pyelonephritis.
Topics: Acute Disease; Cephalosporins; Chronic Disease; Escherichia coli; Escherichia coli Infections; Female; Granuloma; Humans; Kidney; Middle Aged; Nephritis; Nephritis, Interstitial; Pyelonephritis; Tomography, X-Ray Computed; Urine | 1996 |
Successful pregnancy complicated by peritonitis in a 35- year old CAPD patient.
Topics: Administration, Oral; Adult; Amoxicillin; Blood Urea Nitrogen; Catheters, Indwelling; Cephalosporins; Cesarean Section; Chorioamnionitis; Combined Modality Therapy; Escherichia coli Infections; Female; Humans; Infant, Newborn; Infusions, Intravenous; Patient Care Team; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Pregnancy; Pregnancy Complications, Infectious; Puerperal Infection | 1996 |
Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation.
Topics: Adolescent; Adult; Aged; Bacteremia; beta-Lactamases; Case-Control Studies; Ceftazidime; Cephalosporins; Conjugation, Genetic; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multivariate Analysis; Plasmids | 1996 |
[In vitro and in vivo activities of sulopenem compared with those of imipenem and cephalosporins].
Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; beta-Lactam Resistance; Cefotaxime; Ceftizoxime; Cephalosporins; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Guinea Pigs; Imipenem; Klebsiella Infections; Lactams; Lung Diseases; Mice; Mice, Inbred ICR; Thienamycins | 1996 |
Synergistic effect of a recombinant N-terminal fragment of bactericidal/permeability-increasing protein and cefamandole in treatment of rabbit gram-negative sepsis.
Topics: Amino Acid Sequence; Animals; Anti-Infective Agents; Antimicrobial Cationic Peptides; Blood Gas Analysis; Blood Glucose; Blood Proteins; Cefamandole; Cephalosporins; Colony Count, Microbial; Drug Synergism; Endotoxins; Escherichia coli Infections; Hemodynamics; Lactates; Male; Membrane Proteins; Rabbits; Recombinant Proteins; Shock, Septic | 1996 |
Spontaneous bacterial empyema in a patient with hepatitis C virus cirrhosis and sterile ascitic fluid.
Topics: Ascitic Fluid; Bacterial Infections; Ceftriaxone; Cephalosporins; Empyema, Pleural; Escherichia coli Infections; Female; Hepatitis C; Humans; Liver Cirrhosis; Middle Aged | 1996 |
Bacteremia versus endotoxemia in experimental mouse leukopenia--role of antibiotic chemotherapy.
Topics: Animals; Antibodies, Monoclonal; Bacteremia; Ceftazidime; Cephalosporins; Cyclophosphamide; Endotoxemia; Escherichia coli; Escherichia coli Infections; Female; Galactosamine; Imipenem; Immunity, Innate; Interferon-gamma; Leukopenia; Mice; O Antigens; Thienamycins | 1996 |
Adrenobronchial fistula complicating a neonatal adrenal abscess: treatment by percutaneous aspiration and antibiotics.
Topics: Abscess; Adrenal Gland Diseases; Anti-Bacterial Agents; Bronchial Fistula; Cefotaxime; Cephalosporins; Contrast Media; Escherichia coli Infections; Fistula; Gentamicins; Humans; Infant, Newborn; Injections, Intravenous; Lung Diseases; Male; Needles; Netilmicin; Suction; Tomography, X-Ray Computed | 1997 |
Efficacy of cefquinome for treatment of cows with mastitis experimentally induced using Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Injections, Intramuscular; Lactation; Mammary Glands, Animal; Mastitis, Bovine | 1997 |
Comparative susceptibility of clinical isolates producing extended spectrum beta-lactamases to ceftibuten: effect of large inocula.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftibuten; Cephalosporins; Disease Outbreaks; Escherichia coli; Escherichia coli Infections; Hospitals; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nursing Homes | 1997 |
[Evaluation of antibiotics used for enterohemorrhagic Escherichia coli O157 enteritis--effect of various antibiotics on extracellular release of verotoxin].
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Bacterial Toxins; Cefdinir; Cephalosporins; Drug Resistance, Microbial; Enteritis; Escherichia coli Infections; Escherichia coli O157; Hemolytic-Uremic Syndrome; Humans; Kanamycin Resistance; Purpura, Thrombotic Thrombocytopenic; Shiga Toxin 1 | 1997 |
Potentiating effect of EDTA-Tris on the activity of antibiotics against resistant bacteria associated with otitis, dermatitis and cystitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Buffers; Cephaloridine; Cephalosporins; Cystitis; Dermatitis; Dog Diseases; Dogs; Drug Synergism; Edetic Acid; Enrofloxacin; Escherichia coli Infections; Female; Fluoroquinolones; Kanamycin; Male; Otitis; Proteus Infections; Proteus mirabilis; Pseudomonas Infections; Quinolones; Staphylococcal Infections; Time Factors; Tromethamine | 1997 |
Ototoxicity resulting from intracochlear perfusion of Streptococcus pneumoniae in the guinea pig is modified by cefotaxime or amoxycillin pretreatment.
Topics: Amoxicillin; Animals; Antibiotic Prophylaxis; Cefotaxime; Cephalosporins; Ear Diseases; Electrophysiology; Escherichia coli; Escherichia coli Infections; Guinea Pigs; Hair Cells, Auditory; Hearing Loss, Central; Microscopy, Electron, Scanning; Penicillins; Pneumococcal Infections; Scala Tympani; Streptococcus pneumoniae | 1998 |
[Retrospective analysis of the relationship between HUS incidence and antibiotics among patients with Escherichia coli O157 enterocolitis in the Sakai outbreak].
Topics: Adolescent; Anti-Bacterial Agents; Cephalosporins; Child; Disease Outbreaks; Enterocolitis; Escherichia coli Infections; Escherichia coli O157; Female; Hemolytic-Uremic Syndrome; Humans; Japan; Male; Retrospective Studies; Time Factors | 1998 |
Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli isolates producing TEM-10 and TEM-43 beta-lactamases from St. Louis, Missouri.
Topics: beta-Lactamases; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Missouri; Molecular Sequence Data | 1998 |
Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?
Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Escherichia coli; Escherichia coli Infections; False Negative Reactions; False Positive Reactions; Humans; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Reproducibility of Results | 1998 |
Bacterial orchitis in a baby with imperforate anus.
Topics: Anus, Imperforate; Cefixime; Cefotaxime; Cephalosporins; Escherichia coli Infections; Humans; Infant; Male; Orchitis; Recurrence; Ultrasonography, Doppler, Color | 1998 |
[The drug sensitivity of enterohemorragic Escherichia coli and antibiotics treatment for hemorrhagic enterocolitis--from an outbreak of enterocolitis in Sakai city].
Topics: Administration, Oral; Ampicillin; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Child; Disease Outbreaks; Drug Resistance, Microbial; Enterocolitis; Escherichia coli Infections; Escherichia coli O157; Fosfomycin; Humans; Japan; Kanamycin; Penicillins | 1997 |
Obstructive jaundice due to multiple hepatic abscesses.
Topics: Bacteroides Infections; Cefozopran; Cephalosporins; Cholestasis; Drainage; Escherichia coli Infections; Humans; Infusions, Intravenous; Klebsiella Infections; Liver Abscess; Male; Middle Aged | 1998 |
Effect of food on absorption of cefadroxil and cephalexin in dogs.
Topics: Absorption; Animals; Cefadroxil; Cephalexin; Cephalosporins; Dog Diseases; Dogs; Eating; Escherichia coli Infections; Male; Staphylococcal Infections | 1998 |
Diversification of Escherichia coli expressing an SHV-type extended-spectrum beta-lactamase (ESBL) during a hospital outbreak: emergence of an ESBL-hyperproducing strain resistant to expanded-spectrum cephalosporins.
Topics: beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Cross Infection; Disease Outbreaks; Escherichia coli; Escherichia coli Infections; Gene Dosage; Humans; Microbial Sensitivity Tests; Phenotype; Poland | 1999 |
Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Homes for the Aged; Humans; Klebsiella; Klebsiella Infections; Male; Multivariate Analysis; Nursing Homes; Plasmids | 1999 |
In vitro activities of cephalosporins and quinolones against Escherichia coli strains isolated from diarrheic dairy calves.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Cattle; Cattle Diseases; Cephalosporin Resistance; Cephalosporins; Colony Count, Microbial; Diarrhea; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Virulence | 1999 |
[Transitory biliary pseudolithiasis appearing quickly after ceftriaxone treatment].
Topics: Ceftriaxone; Cephalosporins; Child; Cholelithiasis; Escherichia coli Infections; Female; Humans; Pyelonephritis; Risk Factors; Time Factors | 1999 |
Short-course ceftriaxone therapy in spontaneous bacterial peritonitis.
Topics: Adolescent; Adult; Ceftriaxone; Cephalosporins; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Liver Diseases; Male; Middle Aged; Peritonitis; Prospective Studies | 1998 |
Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum beta-lactamase production.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Cefoxitin; Cephalosporin Resistance; Cephalosporins; Cephamycins; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Promoter Regions, Genetic; Sequence Analysis, DNA | 1999 |
Survey of extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea.
Topics: Bacterial Proteins; beta-Lactamases; Cefoxitin; Ceftazidime; Cephalosporins; Conjugation, Genetic; Escherichia coli; Escherichia coli Infections; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Korea; Microbial Sensitivity Tests; Point Mutation; Polymerase Chain Reaction | 1999 |
Characterization of expanded-spectrum cephalosporin resistance in E. coli isolates associated with bovine calf diarrhoeal disease.
Topics: Animals; beta-Lactamases; beta-Lactams; Cattle; Cattle Diseases; Cephalosporin Resistance; Cephalosporins; Diarrhea; Escherichia coli; Escherichia coli Infections; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Polymerase Chain Reaction; Virulence | 1999 |
[Monitoring antibiotic resistance in Argentina. The WHONET program, 1995-1996].
Topics: Cephalosporins; Drug Resistance, Microbial; Enterococcus; Escherichia coli Infections; Europe; Female; Gentamicins; Haemophilus influenzae; Humans; Klebsiella Infections; Klebsiella pneumoniae; Latin America; Male; Oxacillin; Population Surveillance; Staphylococcus aureus; Streptococcal Infections; United States; Urinary Tract Infections; World Health Organization | 1999 |
Treatment of urinary tract infections.
Topics: Amoxicillin; Cephalosporins; Child; Child, Preschool; Cystitis; Escherichia coli Infections; Female; Humans; Infant; Infant, Newborn; Male; Penicillins; Sulfamethoxazole; Treatment Outcome; Urinary Tract Infections; Urography | 1999 |
Failure of pre-diarrheal antibiotics to prevent hemolytic uremic syndrome in serologically proven Escherichia coli O157:H7 gastrointestinal infection.
Topics: Adult; Cefmenoxime; Cephalosporins; Child; Child, Preschool; Escherichia coli Infections; Escherichia coli O157; Female; Hemolytic-Uremic Syndrome; Humans; Male; Time Factors; Treatment Failure | 1999 |
TLA-1: a new plasmid-mediated extended-spectrum beta-lactamase from Escherichia coli.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactamases; Cefotaxime; Cephalosporins; Cloning, Molecular; Conjugation, Genetic; Escherichia coli; Escherichia coli Infections; Humans; Isoelectric Focusing; Kinetics; Mexico; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids | 2000 |
Efficacy of cefepime and amikacin in the empiric treatment of febrile neutropenic children with cancer.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Escherichia coli Infections; Female; Fever; Fever of Unknown Origin; Humans; Infant; Male; Neoplasms; Neutropenia; Staphylococcal Infections; Streptococcal Infections; Treatment Outcome | 2000 |
Synergistic bactericidal effect of cephalexin and normal cord serum (NCS) against Escherichia coli K1 strains isolated from children with urinary tract infections (UTI).
Topics: Blood Bactericidal Activity; Cephalexin; Cephalosporins; Child; Drug Synergism; Escherichia coli; Escherichia coli Infections; Female; Fetal Blood; Humans; Infant, Newborn; Microbial Sensitivity Tests; Pregnancy; Urinary Tract Infections | 1999 |
The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Diarrhea; Escherichia coli Infections; Escherichia coli O157; Feces; Female; Hemolytic-Uremic Syndrome; Humans; Infant; Logistic Models; Male; Prospective Studies; Risk; Trimethoprim, Sulfamethoxazole Drug Combination | 2000 |
Antimicrobial resistance in enteric porcine Escherichia coli strains in Spain.
Topics: Amoxicillin; Animals; Animals, Newborn; Anti-Bacterial Agents; Cephalosporins; Colistin; Diarrhea; Drug Resistance, Microbial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests; Nebramycin; Neomycin; Quinolones; Spain; Swine; Swine Diseases | 2000 |
[Normotensive hydrocephalus complicating recurrent E. coli meningitis].
Topics: Aged; Alcoholism; Ceftriaxone; Cephalosporins; Escherichia coli Infections; Humans; Hydrocephalus, Normal Pressure; Male; Meningitis, Bacterial; Recurrence; Tomography, X-Ray Computed | 1998 |
Back pain in an elderly man--more than just a fall.
Topics: Accidental Falls; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Back Pain; Bacteremia; Ceftriaxone; Cephalosporins; Diagnosis, Differential; Discitis; Drug Therapy, Combination; Escherichia coli Infections; Gentamicins; Humans; Lumbar Vertebrae; Male; Penicillins | 2000 |
Validation of a noninvasive, real-time imaging technology using bioluminescent Escherichia coli in the neutropenic mouse thigh model of infection.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cell Count; Cephalosporins; Ciprofloxacin; Diagnostic Imaging; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Luminescent Measurements; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Muscular Diseases; Neutropenia; Tetracycline | 2001 |
Cefpodoxime screening of Escherichia coli and Klebsiella spp. by Vitek for detection of organisms producing extended-spectrum beta-lactamases.
Topics: beta-Lactamases; Cefpodoxime; Ceftizoxime; Cephalosporins; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests; Sensitivity and Specificity | 2000 |
Nucleotide sequence and characterization of a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-10) isolated in Spain.
Topics: beta-Lactamases; Cefotaxime; Cephaloridine; Cephalosporins; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data | 2001 |
Urinary tract infection in neurogenic bladder.
Topics: Acute Disease; Anti-Infective Agents, Urinary; Carbapenems; Cephalosporins; Chronic Disease; Epididymitis; Escherichia coli Infections; Female; Fever; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Male; Prostatitis; Pseudomonas Infections; Pyelonephritis; Urinary Bladder; Urinary Bladder, Neurogenic; Urinary Catheterization; Urinary Tract Infections | 2001 |
Another look at differences in the susceptibility of Escherichia coli and Klebsiella pneumoniae to cephalothin and cefazolin.
Topics: Cefazolin; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Taiwan | 2001 |
Prevalence of resistance to antimicrobials of Escherichia coli isolates from clinical sources at a private hospital in Trinidad.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Gentamicins; Hospitals, Private; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Penicillins; Tetracycline; Trinidad and Tobago | 2001 |
[Abscess of seminal vesicle: conservative treatment].
Topics: Abscess; Cefuroxime; Cephalosporins; Escherichia coli Infections; Genital Diseases, Male; Humans; Male; Middle Aged; Seminal Vesicles | 2001 |
Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime.
Topics: Bacteremia; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Isoelectric Point; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Treatment Outcome | 2002 |
Extended-spectrum beta-lactamases: frequency, risk factors, and outcomes.
Topics: beta-Lactamases; Ceftazidime; Cephalosporins; Chicago; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; Urban Population | 2002 |
Bactericidal effect of combinations of antibiotic and antineoplastic agents against Staphylococcus aureus and Escherichia coli.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Ceftazidime; Cephalosporins; Doxorubicin; Drug Interactions; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Etoposide; Fluorouracil; Meropenem; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Thienamycins; Tobramycin | 2002 |
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Carrier State; Case-Control Studies; Cefepime; Cephalosporins; Cross Infection; Drug Therapy, Combination; Drug Utilization Review; Escherichia coli Infections; Feces; Female; Formularies, Hospital as Topic; Gentamicins; Hospitals, Community; Hospitals, Urban; Humans; Infection Control; Klebsiella Infections; Length of Stay; Male; Middle Aged; Pennsylvania; Prevalence; Risk Factors; Sulbactam | 2002 |
Beta-lactamases involved in resistance to broad-spectrum cephalosporins in Escherichia coli and Klebsiella spp. clinical isolates collected between 1994 and 1996, in Barcelona (Spain).
Topics: beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella; Spain | 2002 |
[Bacteriological studies on cefatrizine (S-640 P) (author's transl)].
Topics: Animals; Cephalexin; Cephalosporins; Drug Evaluation, Preclinical; Escherichia coli; Escherichia coli Infections; Klebsiella; Klebsiella Infections; Mice; Microbial Sensitivity Tests; Protein Binding; Proteus Infections; Salmonella; Shigella; Species Specificity; Staphylococcal Infections; Streptococcal Infections; Streptococcus; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles | 1976 |
Cefotaxime (HR 756) and nephrotoxicity.
Topics: Acetylglucosaminidase; Adolescent; Aged; Bronchopneumonia; Cephalosporins; Child; Escherichia coli Infections; Female; Humans; Kidney Function Tests; Kidney Tubules, Proximal; Male | 1979 |
Is your dosage really necessary? Antibiotic dosage in urinary infection.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Escherichia coli; Escherichia coli Infections; Humans; Penicillins; Proteus Infections; Proteus mirabilis; Urinary Tract Infections | 1977 |
Hemodialysis-associated infections: treatment with cephapirin.
Topics: Cephalosporins; Cephapirin; Escherichia coli Infections; Humans; Renal Dialysis; Staphylococcal Infections | 1978 |
Cefazolin and cephradine: relationship between antibacterial activity in vitro and in mice experimentally infected with Escherichia coli.
Topics: Animals; Blood Bactericidal Activity; Cefazolin; Cephalosporins; Cephradine; Dose-Response Relationship, Drug; Escherichia coli; Escherichia coli Infections; Male; Mice; Microbial Sensitivity Tests; Protein Binding | 1978 |
Efficacy and safety of cefamandole plus either gentamicin or tobramycin in therapy of severe gram-negative bacterial infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cefamandole; Cephalosporins; Drug Therapy, Combination; Endometritis; Escherichia coli Infections; Female; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia; Proteus Infections; Proteus vulgaris; Pyelonephritis; Sepsis; Tobramycin | 1978 |
Cefazolin and cephradine: relationship between serum concentrations and tissue contents in mice.
Topics: Animals; Cefazolin; Cephalosporins; Cephradine; Escherichia coli Infections; Male; Mice; Models, Theoretical; Muscles | 1978 |
[Animal studies on antibacterial activity of 10 cephalosporins (author's transl)].
Topics: Animals; Cephalosporins; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Estradiol; Female; Injections, Intramuscular; Pyelonephritis; Rats | 1978 |
The intraperitoneal use of cephazolin.
Topics: Adolescent; Appendicitis; Cefazolin; Cephalosporins; Child; Escherichia coli Infections; Humans; Ileum; Infant, Newborn; Intestinal Perforation; Peritoneal Cavity; Peritonitis; Therapeutic Irrigation | 1978 |
[Problems of antibiotic therapy].
Topics: Cefoxitin; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Escherichia coli Infections; Humans; Intensive Care Units; Urinary Tract Infections | 1978 |
Therapy of serious infections with cefamandole.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefamandole; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Sepsis; Staphylococcal Infections; Streptococcal Infections | 1978 |
New cephalosporins with 7-acyl groups derived from beta-ketoacids. I. 7-(beta-Ketoacylamino)cephalosporins.
Topics: Animals; Bacteria; Cephalosporins; Chemical Phenomena; Chemistry; Escherichia coli Infections; Keto Acids; Male; Mice; Mice, Inbred ICR | 1978 |
New cephalosporins with 7-acyl groups derived from beta-ketoacids. II. Further modifications of 7-(3-oxobutyrylamino)-cephalosporins.
Topics: Animals; Bacteria; Cephalosporins; Chemical Phenomena; Chemistry; Escherichia coli Infections; Keto Acids; Male; Mice; Mice, Inbred ICR; Structure-Activity Relationship | 1978 |
A new cephalosporin. SCE-963: 7-[2-(2-aminothiazol-4-yl)-acetamido]-3-[[[1-(2-dimethylaminoethyl)-1h-tetrazol-5-yl]-thio]methyl]ceph-3-em-4-carboxylic acid. Chemistry and structure-activity relationships.
Topics: Animals; Bacteria; Cephalosporins; Escherichia coli Infections; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Structure-Activity Relationship | 1978 |
[Progress in antibacterial chemotherapy].
Topics: Bacterial Infections; Carbenicillin; Cefamandole; Cefazolin; Cefoxitin; Cephalosporins; Dose-Response Relationship, Drug; Escherichia coli Infections; Humans; Klebsiella Infections; Penicillins; Ticarcillin | 1978 |
Antibacterial efficacy of cefazolin and cephradine in neutropenic mice.
Topics: Agranulocytosis; Animals; Cefazolin; Cephalosporins; Cephradine; Dose-Response Relationship, Drug; Escherichia coli; Escherichia coli Infections; Male; Mice; Neutropenia; Neutrophils | 1979 |
[Progress in antibacterial chemotherapy].
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Cephalosporins; Cephalothin; Enterobacter; Enterobacteriaceae Infections; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Proteus Infections; Pseudomonas Infections | 1978 |
[Basic and clinical examinations of CS-1170 in pediatrics (author's transl)].
Topics: Adolescent; Age Factors; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Escherichia coli Infections; Female; Half-Life; Humans; Infant; Klebsiella Infections; Male; Proteus Infections; Staphylococcal Infections | 1979 |
[Treatment of E. coli meningitis with cefmetazole. Report of two cases with favorable response and determination of the concentrations in CSF (author's transl)].
Topics: Ampicillin; Cephalosporins; Cephamycins; Escherichia coli; Escherichia coli Infections; Humans; Infant; Injections, Intravenous; Male; Meningitis; Penicillin Resistance | 1979 |
Investigations on the effectiveness of cefazedone in experimental E. coli pyelonephritis.
Topics: Animals; Cephalosporins; Escherichia coli Infections; Female; Kinetics; Pyelonephritis; Rats | 1979 |
Antibiotic activity of cefazedone in experimental pyelonephritis.
Topics: Animals; Cephalosporins; Cephalothin; Escherichia coli Infections; Female; Kidney; Pyelonephritis; Rats | 1979 |
[New antibiotics].
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Cephalosporins; Escherichia coli Infections; Gram-Negative Aerobic Bacteria; Humans; Klebsiella Infections; Penicillin Resistance; Penicillins; Pseudomonas Infections; Sepsis | 1979 |
Cephacetrile in the treatment of female pelvic inflammatory disease.
Topics: Adolescent; Adult; Cephalosporins; Escherichia coli Infections; Female; Gonorrhea; Humans; Middle Aged; Pelvic Inflammatory Disease; Streptococcal Infections | 1976 |
Cephazolin: a comparison to ampicillin in respiratory and urinary infections with dosage regulation by a nomogram.
Topics: Ampicillin; Cefazolin; Cephalosporins; Dose-Response Relationship, Drug; Drug Hypersensitivity; Escherichia coli Infections; Haemophilus Infections; Half-Life; Humans; Kidney Failure, Chronic; Klebsiella Infections; Pneumococcal Infections; Proteus Infections; Respiratory Tract Infections; Staphylococcal Infections; Urinary Tract Infections | 1976 |
Orally active 7-phenylglycyl cephalosporins. Structure-activity studies related to cefatrizine (SK&F 60771).
Topics: Animals; Bacteria; Cephalosporins; Chemical Phenomena; Chemistry; Escherichia coli Infections; Male; Mice; Structure-Activity Relationship; Time Factors | 1976 |
C-2801X, a new cephamycin-type antibiotic II. Isolation and characterization.
Topics: Adipates; Amino Acids; Animals; Cephalosporins; Cephamycins; Chemical Phenomena; Chemistry; Escherichia coli Infections; Hydrolysis; Male; Mice | 1976 |
Relationships between in vitro susceptibility and efficacy in experimental mouse infection-protection assay of cefazolin and cephalothin using Escherichia coli strains.
Topics: Animals; Cefazolin; Cephalosporins; Cephalothin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Male; Mice; Microbial Sensitivity Tests | 1976 |
Semisynthetic cephalosporins. Synthesis and structure-activity relationships of 7-sulfonylacetamido-3-cephem-4-carboxylic acids.
Topics: Animals; Cephalosporins; Enterobacter; Escherichia coli; Escherichia coli Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Salmonella paratyphi A; Shigella dysenteriae; Staphylococcus aureus; Structure-Activity Relationship; Sulfones | 1976 |
Dual-action cephalosporin utilizing a novel therapeutic principle.
Topics: Ampicillin; Cephalosporins; Cyclic N-Oxides; Escherichia coli; Escherichia coli Infections; Microbial Sensitivity Tests; Penicillin Resistance; Sulfhydryl Compounds; Urinary Bladder Diseases | 1976 |
3-acyloxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acids. An improved synthesis and biological properties.
Topics: Animals; Cephalosporins; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Methods; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pyogenes; Thiophenes | 1975 |
[Cephalosporin antibiotics from microbiologic viewpoint. A comparison of antibacterial and pharmacokinetic properties].
Topics: Bacteria; Cephalexin; Cephaloridine; Cephalosporins; Cephalothin; Drug Evaluation; Escherichia coli Infections; Haemophilus Infections; Humans; Protein Binding; Proteus Infections; Staphylococcal Infections | 1975 |
Dosage adjustments of cefazolin according to the pharmacokinetics of this new cephalosporin.
Topics: Cefazolin; Cephalosporins; Creatinine; Escherichia coli Infections; Glomerular Filtration Rate; Humans; Klebsiella Infections; Monitoring, Physiologic | 1975 |
[Conservative treatment of brain abscess complicating neonatal Escherichia coli meningitis].
Topics: Brain Abscess; Cephalosporins; Escherichia coli Infections; Female; Humans; Infant, Newborn; Meningitis, Bacterial; Tomography, X-Ray Computed | 1992 |
Comparison of the antibacterial effects of cefepime and ceftazidime against Escherichia coli in vitro and in vivo.
Topics: Animals; Cefepime; Ceftazidime; Cephalosporins; Escherichia coli; Escherichia coli Infections; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests | 1992 |
beta-Lactamase produced by a highly beta-lactam-resistant strain of Bacteroides fragilis: an obstacle to the chemotherapy of experimental mixed infections.
Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Cefmetazole; Cephalosporins; Drug Resistance, Microbial; Escherichia coli Infections; Exudates and Transudates; Male; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains; Substrate Specificity | 1991 |
Pharmacokinetics and antibacterial efficacy of cefpirome (HR 810) in experimental Escherichia coli and Haemophilus influenzae type b meningitis.
Topics: Animals; Cefpirome; Cephalosporins; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Haemophilus influenzae; Male; Meningitis, Haemophilus; Microbial Sensitivity Tests; Rabbits | 1991 |
Studies on beta-lactam antibiotics. III. Syntheses and antibacterial activities of new 3-(1,3-dithiolan-2-yl)cephalosporins, YM-22508, YM-16457 and their prodrug-type esters.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Chemical Phenomena; Chemistry; Escherichia coli Infections; Kinetics; Mice; Molecular Structure; Staphylococcal Infections; Streptococcal Infections; Streptococcus pyogenes | 1991 |
In vivo efficacy of cefcanel daloxate in comparison with cefaclor.
Topics: Absorption; Animals; Bacterial Infections; Cefaclor; Cephalosporins; Disease Models, Animal; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Prodrugs; Staphylococcal Infections | 1990 |
Antibacterial activity of four cephalosporins in an experimental infection in relation to in vitro effect and pharmacokinetics.
Topics: Agranulocytosis; Animals; Cefamandole; Ceftazidime; Ceftriaxone; Cefuroxime; Cephalosporins; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Mice; Protein Binding; Specific Pathogen-Free Organisms | 1990 |
Cephalosporin 3'-quinolone esters with a dual mode of action.
Topics: Animals; Anti-Infective Agents; Cefotaxime; Cephalosporins; Chemical Phenomena; Chemistry; Ciprofloxacin; Enterobacter; Escherichia coli Infections; Fleroxacin; Fluoroquinolones; Hydrolysis; Mice; Molecular Structure; Pneumococcal Infections; Prodrugs; Quinolones; Rats; Staphylococcus aureus; Structure-Activity Relationship | 1990 |
New aminothiazolylglycylcephalosporins with a 1,5-dihydroxy-4-pyridone-2-carbonyl group. I. Synthesis and biological activity of cephalosporin derivatives leading to MT0703.
Topics: Animals; Cephalosporins; Chemical Phenomena; Chemistry; Escherichia coli Infections; Klebsiella Infections; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Microbial Sensitivity Tests; Pseudomonas Infections; Spectrophotometry; Structure-Activity Relationship | 1990 |
New aminothiazolylglycylcephalosporins with a 1,5-dihydroxy-4-pyridone-2-carbonyl group. II. Synthesis and antibacterial activity of MT0703 and its diastereomers.
Topics: Animals; Cephalosporins; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Escherichia coli Infections; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Pseudomonas Infections; Stereoisomerism; Structure-Activity Relationship | 1990 |
Efficacy of ceftiofur hydrochloride for treatment of experimentally induced colibacillosis in neonatal swine.
Topics: Administration, Oral; Animals; Animals, Newborn; Cephalosporins; Dose-Response Relationship, Drug; Drug Evaluation; Escherichia coli Infections; Feces; Female; Injections, Intramuscular; Male; Swine; Swine Diseases; Time Factors | 1990 |
Patterns and mechanisms of beta-lactam resistance among isolates of Escherichia coli from hospitals in the United States.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Chromosomes, Bacterial; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Humans; Isoelectric Focusing; Nucleic Acid Hybridization; Plasmids | 1990 |
Relevance of protein binding to cephalosporin antimicrobial activity in vivo.
Topics: Animals; Bacterial Infections; Biological Availability; Cefazolin; Cefoxitin; Ceftazidime; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Escherichia coli Infections; Female; Kinetics; Protein Binding; Rabbits; Staphylococcal Infections | 1990 |
Comparative study of the effects of four cephalosporins against Escherichia coli in vitro and in vivo.
Topics: Animals; Cefepime; Cefoperazone; Ceftazidime; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Escherichia coli; Escherichia coli Infections; Female; Mice | 1990 |
A new aminothiazolylcephalosporin having 1-carboxyethoxyimino group, ME1228.
Topics: Animals; Bacteria; Bacterial Infections; Cephalosporins; Chemical Phenomena; Chemistry; Escherichia coli Infections; Isomerism; Male; Mice; Mice, Inbred ICR; Pseudomonas Infections | 1990 |
Comparative chemotherapeutic activity of cefpirome and imipenem in experimental infections.
Topics: Abscess; Animals; Bacterial Infections; Cefotaxime; Cefpirome; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Granuloma; Imipenem; Male; Mice; Mice, Hairless; Mice, Inbred C3H; Pneumonia; Rats; Rats, Inbred Strains; Sepsis; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections | 1990 |
Inactivation of cefuroxime and cefotaxime by Bacteroides fragilis in vitro, and its influence on the treatment of an experimental Escherichia coli/Bacteroides fragilis mixed infection.
Topics: Amoxicillin; Animals; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Cefotaxime; Cefuroxime; Cephalosporins; Clavulanic Acids; Escherichia coli; Escherichia coli Infections; Female; Metronidazole; Mice; Microbial Sensitivity Tests | 1989 |
In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefpodoxime; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Chemical Phenomena; Chemistry; Enterobacteriaceae Infections; Escherichia coli Infections; Hexosyltransferases; Klebsiella Infections; Mice; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding; Proteus Infections; Staphylococcal Infections; Streptococcal Infections | 1987 |
Duration of antibiotic prophylaxis. An experimental study.
Topics: Animals; Cephalosporins; Disease Models, Animal; Drug Administration Schedule; Escherichia coli Infections; Female; Half-Life; Mice; Mice, Inbred Strains; Premedication; Staphylococcal Infections; Surgical Wound Infection | 1986 |
Antibiotic prophylaxis in vascular surgery: pharmacokinetic study of four commonly used cephalosporins.
Topics: Animals; Aorta; Bacterial Infections; Cefamandole; Cefazolin; Cefoxitin; Cephalosporins; Dogs; Escherichia coli Infections; Kinetics; Moxalactam; Muscles; Staphylococcal Infections; Time Factors; Tissue Distribution; Vascular Surgical Procedures | 1986 |
Penetration of cefuzoname into the cerebrospinal fluid of rabbits.
Topics: Animals; Ceftizoxime; Cephalosporins; Escherichia coli Infections; Half-Life; Meningitis; Rabbits; Staphylococcal Infections | 1986 |
Therapeutic effect of SF-2103A, a novel carbapenem antibiotic, in combination with cefotaxime, cefoperazone and other cephalosporins.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cefoperazone; Cefotaxime; Cephalosporins; Drug Stability; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infections; Kinetics; Proteus Infections; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1986 |
Comparative laboratory studies on alpha-methoxyimino furyl- and phenylacetamido cephalosporins: structure-activity relationships.
Topics: Animals; Bacteria; Cefazolin; Cefuroxime; Cephalosporins; Escherichia coli Infections; Half-Life; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Saimiri; Structure-Activity Relationship | 1986 |
Which cephalosporin for wound prophylaxis? An experimental comparison of three drugs.
Topics: Animals; Cefamandole; Cefazolin; Cefotaxime; Cephalosporins; Escherichia coli Infections; Feces; Female; Mice; Staphylococcal Infections; Surgical Wound Infection | 1985 |
[Microbiological evaluation of a new synthetic cephalosporin, cephapirin (author's transl)].
Topics: Acetamides; Animals; Bacteria; Blood; Cephaloridine; Cephalosporins; Cephalothin; Drug Stability; Escherichia coli; Escherichia coli Infections; Hydrogen-Ion Concentration; Male; Mice; Penicillinase; Pneumococcal Infections; Pyridines; Solutions; Staphylococcal Infections; Staphylococcus; Streptococcus pneumoniae; Tetrazoles; Thiadiazoles | 1974 |
Diagnosis and management of infections associated with immunosuppression. New antibiotics of potential importance for immunosuppressed patients.
Topics: Amino Sugars; Bacteria; Carbenicillin; Cephalexin; Cephaloridine; Cephalosporins; Cephalothin; Escherichia coli Infections; Glycosides; Immunization, Passive; Immunosuppression Therapy; Kanamycin; Penicillin Resistance; Penicillins; Proteus Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Structure-Activity Relationship | 1973 |
[In vitro and in vivo antibacterial activity of cephapirin (author's transl)].
Topics: Acetamides; Ampicillin; Animals; Bacteria; Cephalexin; Cephaloridine; Cephalosporins; Cephalothin; Escherichia coli; Escherichia coli Infections; Klebsiella pneumoniae; Mice; Penicillin G; Penicillin Resistance; Penicillinase; Proteus; Proteus mirabilis; Proteus vulgaris; Pseudomonas aeruginosa; Pyridines; Salmonella; Shigella; Staphylococcal Infections; Sulfides | 1974 |
[The effects of antibiotics on indices of immunity during treatment of endomyometritis following infectious abortion].
Topics: Abortion, Septic; Adolescent; Adult; Anti-Bacterial Agents; Antitoxins; Carbenicillin; Cephalosporins; Complement System Proteins; Endometritis; Escherichia coli Infections; Female; Humans; Methicillin; Muramidase; Penicillin G; Pregnancy; Staphylococcal Infections; Streptococcal Infections; Tetracycline; Tetracyclines | 1974 |
Antimicrobial drugs for treatment of infections caused by aerobic gram-negative bacilli.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbenicillin; Cephalosporins; Chloramphenicol; Dysentery, Bacillary; Escherichia coli Infections; Gentamicins; Haemophilus Infections; Humans; Kanamycin; Klebsiella Infections; Polymyxins; Proteus Infections; Pseudomonas Infections; Salmonella Infections; Sulfonamides; Tetracycline | 1974 |
Studies of absorption, excretion, antibacterial and clinical effect of cephalexin.
Topics: Administration, Oral; Adolescent; Adult; Agar; Aged; Candidiasis; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Nausea; Proteus; Proteus Infections; Staphylococcal Infections; Streptococcal Infections; Streptococcus; Streptococcus pneumoniae; Streptococcus pyogenes; Urinary Tract Infections; Vulvovaginitis | 1970 |
Antibacterial therapy in childhood.
Topics: Anti-Bacterial Agents; Cephalosporins; Child; Diarrhea; Drug Resistance, Microbial; Escherichia coli Infections; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Meningitis; Respiratory Tract Infections; Sepsis; Staphylococcal Infections; Urinary Tract Infections | 1973 |
Semisynthetic cephalosporins. Synthesis and structure-activity relationships of 7-mandelamido-3-cephem-4-carboxylic acids.
Topics: Amides; Animals; Bacteria; Cephalosporins; Dogs; Escherichia coli Infections; Klebsiella Infections; Magnetic Resonance Spectroscopy; Mandelic Acids; Mice; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Stereoisomerism; Structure-Activity Relationship | 1974 |
[Experimental infection system in the inflammatory pouch of rats and the effect of cephalosporins].
Topics: Animals; Cephaloridine; Cephalosporins; Cephalothin; Escherichia coli; Escherichia coli Infections; Male; Mucins; Rats; Staphylococcal Infections; Staphylococcus; Sulfides; Tetrazoles; Thiadiazoles | 1973 |
Correlations between in vitro sensitivity testing and therapeutic response in urinary tract infections.
Topics: Bacteriuria; Cephalosporins; Drug Resistance, Microbial; Escherichia coli Infections; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pseudomonas Infections; Statistics as Topic; Urinary Tract Infections | 1973 |
[Antibacterial chemotherapy of the chronic bronchitis syndrome].
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Carbenicillin; Cephalosporins; Chloramphenicol; Chronic Disease; Drug Synergism; Escherichia coli Infections; Gentamicins; Humans; Penicillin G; Pseudomonas Infections; Staphylococcal Infections; Sulfonamides; Syndrome; Tetracycline; Trimethoprim | 1974 |
[Urosepsis in urinary calculi].
Topics: Adult; Ampicillin; Carbenicillin; Cephalosporins; Drug Therapy, Combination; Escherichia coli Infections; Female; Gentamicins; Humans; Klebsiella Infections; Male; Nephrectomy; Proteus Infections; Pseudomonas Infections; Sepsis; Urinary Calculi | 1974 |
Cephacetrile: chemotherapy and toxicology in laboratory animals.
Topics: Acetamides; Animals; Cephaloridine; Cephalosporins; Cephalothin; Dogs; Escherichia coli Infections; Female; Guinea Pigs; Injections, Subcutaneous; Lethal Dose 50; Male; Mice; Nitriles; Proteus Infections; Pyelitis; Pyelonephritis; Rabbits; Rats | 1974 |
[Cephacetrile (C 36278-Ba), a new antibiotic of the cephalosporin group. Pharmacokinetics and clinical investigation].
Topics: Acetamides; Amniotic Fluid; Bile; Cephalosporins; Creatinine; Drug Evaluation; Escherichia coli Infections; Half-Life; Humans; Male; Nitriles; Osteomyelitis; Pneumococcal Infections; Prostate; Proteus Infections; Respiratory Tract Infections; Staphylococcal Infections; Streptococcal Infections; Urinary Tract Infections | 1974 |
["Velocef squibb" in the treatment of respiratory and urinary infections (author's transl)].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cephalosporins; Enterobacter; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Proteus Infections; Respiratory Tract Infections; Urinary Tract Infections | 1973 |
[Fundamental studies on synthetic cephalosporin antibiotics. 2. Therapeutic effects of oral administration on experimental infections in mice and their distribution in the body].
Topics: Ampicillin; Animals; Cephaloridine; Cephalosporins; Cephalothin; Cloxacillin; Dicloxacillin; Escherichia coli Infections; Kidney; Liver; Lung; Mice; Oxacillin; Penicillin Resistance; Penicillins; Pneumococcal Infections; Staphylococcal Infections; Streptococcal Infections | 1967 |
Synthesis of 6-aminopenicillanic acid derivatives. IV. 6-(syndone-3-acetamido) penicillanates and 7-(sydone-3-acetamido) cephalosporanates.
Topics: Acetates; Ampicillin; Animals; Cephalosporins; Cephalothin; Chemical Phenomena; Chemistry; Escherichia coli; Escherichia coli Infections; Injections, Subcutaneous; Klebsiella; Klebsiella Infections; Mice; Oxadiazoles; Penicillins; Salmonella typhi; Staphylococcal Infections; Staphylococcus | 1968 |
[Cephalosporins as new antibiotics].
Topics: Cephalosporins; Enteritis; Escherichia coli Infections; Gonorrhea; Humans; Influenza, Human; Klebsiella Infections; Pneumococcal Infections; Proteus Infections; Staphylococcal Infections; Streptococcal Infections; Whooping Cough | 1968 |
[Bacteriological studies on cephalexin, an oral synthesized cephalosporin].
Topics: Animals; Cephalosporins; Drug Resistance, Microbial; Drug Stability; Escherichia coli; Escherichia coli Infections; Hydrogen-Ion Concentration; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus | 1969 |
Clinical experience with cephalexin in New Zealand.
Topics: Aged; Cephalosporins; Escherichia coli Infections; Humans; Klebsiella Infections; Male; New Zealand; Respiratory Tract Infections; Urinary Tract Infections | 1970 |
Clinical evaluation of cephalexin in urinary tract infection.
Topics: Cephalosporins; Escherichia coli Infections; Humans; Klebsiella Infections; Proteus Infections; Staphylococcal Infections; Urinary Tract Infections | 1970 |
Cephalexin in chronic and recurrent urinary infections: laboratory and clinical studies.
Topics: Aged; Cephalosporins; Chronic Disease; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Proteus Infections; Urinary Tract Infections | 1970 |
Some cephalosporins in clinical use and their structure-activity relationships.
Topics: Animals; Bacteria; Cephalosporins; Drug Resistance, Microbial; Escherichia coli Infections; Humans; Mice; Rats; Staphylococcal Infections | 1970 |
A urological evaluation of cephalexin.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Chemical Phenomena; Chemistry; Chronic Disease; Escherichia coli Infections; Evaluation Studies as Topic; Female; Humans; Hydrogen-Ion Concentration; Klebsiella Infections; Male; Middle Aged; Solubility; Urinary Tract Infections | 1971 |
Recent developments in the treatment of infectious diseases. II. Alternatives to penicillin in the treatment of infections caused by gram-positive organisms.
Topics: Anti-Bacterial Agents; Cephalosporins; Escherichia coli Infections; Humans; Infections; Lincomycin; Penicillins; Protozoan Infections; Pseudomonas Infections; Salmonella Infections; Staphylococcal Infections | 1971 |
The treatment of bacterial cystitis, comparing cephalexin with sulfisoxazole.
Topics: Cephalosporins; Cystitis; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Proteus Infections; Staphylococcal Infections; Sulfisoxazole | 1971 |
[Therapy of bacterial eye infections].
Topics: Anti-Bacterial Agents; Bacillus subtilis; Cephalosporins; Cornea; Escherichia coli Infections; Eye Diseases; Humans; Infections; Neisseria; Penicillins; Pneumococcal Infections; Proteus Infections; Staphylococcal Infections; Streptococcal Infections; Tetracycline | 1969 |
[Clinical application of cephaloridine and cephalothin].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cephaloridine; Cephalosporins; Cephalothin; Cholecystitis; Escherichia coli Infections; Female; Humans; In Vitro Techniques; Injections, Intramuscular; Male; Middle Aged; Respiratory Tract Infections; Staphylococcal Infections | 1965 |
Cephaloridine therapy for genitourinary infections.
Topics: Aged; Cephaloridine; Cephalosporins; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Male; Neisseria; Pneumococcal Infections; Proteus Infections; Staphylococcal Infections; Streptococcal Infections; Urinary Tract Infections | 1967 |